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Summary
Development of the synovial joint is complex involving a sequence of precisely 
controlled events. Separation of the cartilage anlagen involves differential matrix 
turnover and requires mechanical stimuli, the loss o f mechanical stimuli results in 
joint fusion. Synthesis of hyaluronan at the developing joint line occurs and its 
continued synthesis is necessary for maintenance of ffictionless movement in the adult 
joint.
Hyaluronan is synthesised by synovial fibroblasts and as a component of the synovial 
fluid and synovium, helps maintain a consistent volume and viscosity of synovial 
fluid when the joint is flexed. Reduction in hyaluronan concentration within the 
synovial fluid is associated with osteoarthritis and rheumatoid arthritis. Joints become 
painful to move and mobility is lost. The study aimed to investigate whether synovial 
cells from osteoarthritic knees were able to respond to mechanical stimuli and if so, 
were cells able to modulate hyaluronan synthesis. Results at the cellular level would 
be the first step in considering exercise based therapies as a treatment for 
osteoarthritis.
A four point bending mechanical loading jig was used to apply mechanical strain to 
synovial cells. Results indicate that synovial cells from osteoarthritic knees are 
capable of responding to a brief period of mechanical stimuli and modulate 
hyaluronan release. Differential expression of the three HAS genes was also observed 
upon mechanical strain. It was clear however, that the response to strain varied 
depending on cell passage. As a result, the development of an immortalised synovial 
cell line was investigated. Data obtained however, showed that ectopic hTERT 
expression alone was not sufficient to immortalise synovial cells.
Development o f exercise based therapies for the treatment of osteoarthritis will 
require a considerable amount of further work. This study however, has demonstrated 
that alterations in hyaluronan synthase expression and subsequent hyaluronan 
synthesis by synovial cells occurs upon mechanical stimuli and thus provides a 
foundation for future studies.
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Chapter 1 
General Introduction
1.1 General Introduction
1.1.1 The Synovial Joint
An extensive range of friction free movement is provided by the synovial joint and 
joint capsule structure is vital to joint function. The fluid-filled cavity is positioned 
between the opposing articular cartilages of the long bones and is surrounded by a 
thick fibrous sheath, lined by the much thinner synovium. The capsule is supported 
by ligaments and tendons providing protection from loading yet allowing a wide 
range of movement. Nerves and blood vessels pass through the capsule and are 
important in the active protection of the capsule and its ligaments.
Fibrous
layer
Synovium
Synovial
cavity
Articular
cartilage
®  ^  <
I  t 1
Bone
Figure 1.1.1 Schematic diagram of the diarthrodial joint (adapted from Colour Textbook of 
Histology, 1997).
1.1.2 Development of the Joint
The factors controlling joint development are not well understood. It is thought that 
the joint develops from a distinct population of cells but the lack of specific biological 
or molecular markers for these cells only acts to impede research into joint 
development. Joint development can be divided into two stages; an initial 
condensation stage and a second separation phase (Bemays, 1878; Mitrovic, 1978).
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Intially, the homogeneous, avascular mesenchymal core of the limb bud condenses to 
form the cartilaginous anlagen. The cartilage anlagen are then separated by a narrow, 
dense blastemal mesenchyme region known as the interzone. The interzone is 
comprised of three layers -  the two outer most layers eventually form the articular 
cartilage and the intermediate layer allows the cavity to form.
During the separation phase, the periphery of the cartilage blastema forms the 
synovial mesenchyme. The mesenchymal cells here are arranged in parallel with the 
boundary of the synovial cavity and are flattened in appearance (Whillis, 1940). 
Within the synovial mesenchyme distinct cell condensations can be observed and give 
rise to the menisci, ligaments and tendons (McDermott, 1943; Mitrovic, 1978; 
Whillis, 1940). Blood vessels are present at the periphery of the joint at sites of 
maximal tissue loosening (Mitrovic, 1977).
Tissue loosening and cell degeneration occurs in the intermediate layer of the 
interzone allowing the space between the opposing cartilage anlagen to form 
(Mitrovic, 1977). Separation of the skeletal elements starts in the periphery of the 
joint with discontinuous clefts coalescing to form a single cavity (Mitrovic, 1978). 
Within the intermediate layer as tissue loosening occurs an accumulation of interstitial 
fluid is seen and it is now known that this contains hyaluronan (Craig et al., 1990; 
Dowthwaite et al., 2003; Mitrovic, 1978). Once separation occurs, the cartilaginous 
elements are expanded by chondrification of the surrounding blastemal tissue by 
appositional growth and the intra-articular structures of the joint remain in the same 
position relative to the adult joint (Haines, 1947; Mitrovic, 1977).
At the early stages of joint development, gene expression is uniform between the 
skeletal elements and joint interzone whereas during the later stages, differential gene 
expression between the skeletal elements and interzonal cells are reflected in the 
morphological differences of these regions (Craig et al., 1987; Koyama et al., 1995; 
Nalin et al., 1995). Gene expression by cells of the developing joint allows the 
synthesis of families of signalling molecules, which can control cellular 
communication and influence joint development (Francis-West et al., 1999; Nalin et 
al., 1995). One of the largest families is the bone morphogenic proteins (BMP), a
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subgroup of the TGFp family. The BMPs were initially associated with a role in 
inducing bone differentiation but further research has shown BMPs are involved in a 
diverse range of biological processes including cell proliferation, cell differentiation 
and cell-fate determination (Chang et al., 1994; Hogan, 1996; Kingsley, 1994; Rosen 
and Thies, 1992). A close relative of the BMPs are the growth and differentiation 
factors (GDF). Indeed, GDF-5 has been shown to signal through the same receptors 
as the BMP family (Nishitoh et al., 1996). The expression of four members of the 
BMP/GDF family during joint development especially in the chondrogenic regions in 
the later stages of development has lead to the belief that BMPs/GDFs do play a role 
in joint development (Hogan, 1996; Lyons et al., 1989; Lyons et al., 1990; Rosen et 
al., 1996; Storm et al., 1994; Zou et al., 1997). It has been shown that these signalling 
molecules can either work alone or synergistically to modulate chondrogenesis by 
controlling chondrocyte proliferation and differentiation and in recruiting non- 
chondrogenic cells (Brunet et al., 1998; Chen et al., 1991; Duprez et al., 1996; Storm 
et al., 1994; Storm and Kingsley, 1996). The activity of BMP-3 and 4 have also been 
shown to enhance cartilage matrix synthesis in vitro, contributing to maintenance of 
the cartilage phenotype (Luyten et al., 1994; Luyten et al., 1992; Vukicevic et al.,
1989). Misexpression of either BMP or GDF-5 resulted in skeletal limb defects due 
to alterations in cell proliferation or condensation emphasising the importance of 
these genes in controlling cartilage development and skeletal morphogenesis 
(Duboule, 1995; Duprez et al., 1996; Gruneberg and Lee, 1973).
From this research it can be seen that the sequence of events allowing for joint 
formation are specific and controlled. A combination of a number of factors such as 
cell necrosis, apoptosis, vascular influences, cellular migration and differential matrix 
synthesis at the presumptive joint line have all been suggested to be involved in 
separation of the cartilage anlagen (Bemays, 1878; Craig et al., 1987; Edwards et al., 
1994; Milaire, 1947; Mitrovic, 1978; Mitrovic, 1977). The exact stimuli that are 
responsible for instigating cavity formation and maintaining the joint cavity are at 
present unknown, although mechanical factors are thought to play a major regulatory 
role in this process (Anderson and Brorasmussen, 1961; Dowthwaite et al., 1998; Fell 
and Canti, 1934; Mitrovic, 1977; Murray and Drachman, 1969; Osborne et al., 2002). 
The removal of mechanical stimuli by neuromuscular blockers in ovo or in limb organ
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culture prevents cavitation in uncavitated joints (primary fusion) (Drachmann and 
Sokoloff, 1966; Osborne et al., 2002). Additionally, removal of mechanical stimuli 
after cavitation has occurred results in a secondary fusion of the joint cavity 
(Drachmann and Sokoloff, 1966; Fell and Canti, 1934; Hamburger and Waugh, 1940; 
Murray and Drachman, 1969).
As mentioned previously, tissue loosening in the interzone allows the cartilage 
anlagen to separate. Apoptosis and cells necrosis have been implicated in joint 
formation as a reason for cell loss within the interzone. Cells within the intermediate 
layer of the interzone showed degeneration and characteristics of cell necrosis and it 
has been suggested that this occurs to eliminate cells that would otherwise undergo 
chondrogenesis (Mitrovic, 1978). However, apoptosis is unlikely to act alone in 
producing the fully formed joint space, as a very high proportion of cells would have 
to undergo cell death in order to clear the cavity of cells (Craig et al., 1990; Mitrovic,
1978).
It is clear that the separation of the cartilaginous elements along the potential joint line 
requires a local change in extracellular matrix to allow a joint space to form. This 
alteration in ECM properties could be due to enzymatic or mechanical breakdown of 
adherent ECM molecules, the synthesis of non-adherent components or indeed could 
involve both synthesis and catabolism of the extracellular matrix (Edwards, 1994a; 
Mitrovic, 1977).
There is little evidence for enzymatic degradation occurring along the presumptive 
joint line. Indeed, Mitrovic (1978) found no evidence of protease or lipase activity in 
the developing joint however, presence of acid phosphatase activity along the joint 
line was detected, but disappeared when cavitation began. This suggests that 
lysosomal enzymes are involved in the modification of the extracellular matrix 
(ECM), yet if these enzymes are to degrade components then they need to be 
endocytosed which would involve the action of matrix metalloproteinases (MMPs) 
(Milaire, 1947; Mitrovic, 1977). At present evidence is currently lacking for 
increased local levels of MMP activity at the developing joint line (Edwards et al., 
19%).
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1.1.3 Mechanical Stimuli & Joint development
As mentioned above, movement has long been regarded as essential for joint cavity 
formation. Disruption of cell-cell cohesion at the joint line arising from mechanical 
forces generated by muscle activity could allow separation to occur (Drachmann and 
Sokoloff, 1966; Mitrovic, 1982). Conversly, Hasty et al. (1993) have shown that in 
myogenin deficient mice, the joint forms even though there is no contracting skeletal 
muscle to generate mechanical forces. Passive motion within the uterus as a driving 
factor in the process of joint cavitation cannot therefore be ruled out as a factor. 
Interestingly, histological evidence of tissue loosening and accumulation of synovial 
fluid within the cavity are first seen when fetal movements are recognized by the 
mother (McDermott, 1943; Whillis, 1940). Studies in chick and human limbs have 
shown that there is very little, if any, growth in interzone cells but those of the 
cartilaginous anlagen show division and growth (Lewis, 1977). Thus, the local 
mechanical forces from the differential growth rate between the cartilaginous and 
synovial components may be involved in cavity formation. As paralysis has only a 
small effect on the growth rates (Edwards and Wilkinson, 1996) mechanical stimuli 
might not be the only factor responsible for formation of the joint line, as cavities are 
still able to form. Therefore, it is likely that the disruptive mechanical forces involved 
do not act alone in producing the well-defined joint line.
Movement induced mechanical stimuli could alter the synthesis and degradation of 
ECM during development of the joint cavity (Dowthwaite et al., 1998; Dowthwaite et 
al., 2003; Pitsillides et al., 1999). This biochemical change in ECM components is a 
certain probability as a loss of tensile properties in the interzone leads to tissue 
loosening and eventual cell separation. Although working on chick joints, which 
show analogy to mammals except they contain fibrocartilage as opposed to hyaline 
articular cartilage, Craig et al. (1987) showed less type II collagen concomitant with 
an increase in type I collagen during cavitation. Work by Nalin et al. (1995) showed 
evidence for type I collagen and type II collagen expression in the interzonal cells 
prior to cavitation yet at cavitation only type I collagen was observed in the interzone 
cells. These studies suggest differential matrix turnover does occur during joint 
development.
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As well as the removal of adherent molecules within the joint line an increase in the 
synthesis of non-adherent components such as hyaluronan (HA) could also be 
involved in joint cavitation. Indeed, evidence for differential hyaluronan synthesis at 
the joint line is becoming more apparent and mechanical stimuli could be responsible 
for hyaluronan synthesis. As already discussed, immobilised limbs fail to form 
cavities and this failure to cavitate is associated with alterations in HA synthesis at the 
developing joint line (Pitsillides, 1999).
1.1.4 Hyaluronan & Joint Development
Hyaluronan was first isolated in 1934 by Meyer & Palmer and its extraction from the 
umbilical cord, vitreous humour of the eye, synovial fluid and streptococci all led to 
the discovery of its physiochemical characteristics (Blumberg and Ogston, 1958; 
Comper and Laurent, 1978; Kendall et al., 1937; Meyer, 1947). HA is classed as a 
glycosaminoglycan (GAG) due to its repeating disaccharide units of D-glucuronic 
acid linked to N-acetyl-D-glucosamine that forms a negatively charged, high 
molecular weight polysaccharide. Although belonging to the GAG family, it lacks a 
covalently linked polypeptide and is unsulphated.
CH
CH c = o cooHC OHHO NH
OH
NH HO
COO HOc = o
OHCH3
Figure 1.1.2 The repeating glucuronic acid and V-acetylglucosamine subunits of hyaluronan 
(reproduced from Biochemistry, 1995).
Previously, HA was considered to act simply as a space-filling molecule secreted into 
a cavity which had developed by another mechanism. Now, evidence suggests a
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much more critical role, with local synthesis of HA occurring at the first signs of 
cavitation and continuing after development to help maintain a fully functional joint 
(Craig et al., 1990; Pitsillides et al., 1995).
As stated earlier, a change in ECM components appears to be involved in cavity 
formation. Anderson & Brorasmussen (1961) demonstrated the accumulation of a 
metachromatic substance at the joint line and following this work, Anderson (1961) 
showed that this could contain HA. Indeed, it was later shown that this 
metachromatic substance was HA and that HA was present at the joint line 
concominant with the first signs of cavitation (Craig et al., 1990). This work also 
showed that labelling for HA was more intense in the developing synovial tissue than 
in the tissue surrounding the cartilage anlagen and that the HA binding sites remained 
localized to the cavity and were maintained as the joint enlarges. The development of 
cytochemical assays and immunolabelling studies allowed the synthesis of HA by 
local cells to be assessed. Work by Pitsillides et al.( 1995) concentrated on the activity 
of uridine-diphosphoglucose-dehydrogenase (UDPGD), the enzyme involved in 
producing precursors for HA. An increase in UDPGD activity occurred in the 
interzonal cells suggesting an increase in HA synthesis. The precursors produced by 
UDPGD could enter glycosaminoglycan (GAG) synthesis and not HA synthesis but 
low levels of sulphate incorporation at the joint line suggested the UDP-glucuronate 
synthesized by UDPGD is preferentially incorporated into HA rather than chondriotin 
sulphate synthesis (Hascall VC et al., 1991; HinchclifFe, 1977; Pitsillides et al., 1995). 
The expression of CD44, a HA binding protein, by the cells of the interzone further 
supports the involvement of HA in joint formation (Dowthwaite et al., 1998; 
Edwards, 1994b; Pitsillides et al., 1995). From these studies, it is evident that the 
interzonal cells have a high UDPGD activity that is maintained during and after 
cavitation in order to synthesise large amounts o f HA for cavity development.
Toole (1981) demonstrated that low concentrations of HA promoted cell aggregation 
whereas high concentrations of HA promote cell separation. The high levels of HA 
produced along the joint line would, therefore, promote cell separation as hyaluronan 
binding proteins (HABPs) become saturated accounting for the loss of tensile 
properties in the ECM (Toole, 1981). Dowthwaite et al. (1998) used low molecular
7
weight oligosaccharides of HA to disrupt HArHABP interactions in developing chick 
joints. This distruption in HA:HABP interactions resulted in fused joints and these 
fusions were associated with decreases in UDPGD activity and HABP expression.
These results show that HA is essential in cavity formation, yet the signals which 
promote HA synthesis remain unclear. Recent work by Dowthwaite et al. (2003) 
involved subjecting embryonic chick fibrocartilage cells to mechanical strain and then 
assessing levels of HA synthesized, the UDPGD activity and expression of HABP. 
This work showed that mechanically induced stimuli are probably a major regulatory 
factor in joint cavity formation as UDPGD activity increased when cells were 
subjected to strain producing higher amounts of HA. An increase in the number of 
occupied HABP sites was also observed.
1.1.5 Synovium
The synovium develops from the peripheral, vascularised tissue surrounding the 
presumptive joint cavity. As the joint flexes, the synovium needs to be able to move 
with the joint yet still surround the cavity. Thus, it needs to increase its surface area 
as the joint develops. There are three mechanisms that could facilitate this increase in 
synovium area. The spontaneous growth of new tissue matrix is the first possibility 
but little evidence exists to support this mechanism (Henderson, 1987b). The second 
mechanism involves irreversible stretching and reorganisation of the cellular and 
matrix components, with movement playing a key factor (Drachmann and Sokoloff, 
1966). The final mechanism of increasing the surface area involves separation or 
splitting of the lining tissue. Lamellar projections on the synovial surface may 
perforate and then separate to give further projections, or splitting of collagen bundles 
deep within the tissue followed by remodelling of the matrix may produce a larger 
continuous surface (Henderson, 1987a).
The synovium is 50-60pm in thickness in the human knee joint and 10-20pm in the 
rabbit knee (Levick and McDonald, 1989; Steven et al., 1991) and is split into two 
layers; the intima and subintima. Previously, it was difficult to distinguish between 
these two layers but now their different morphologies have been established. The
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intima consists almost solely of synovial macrophages and synovial fibroblasts, the 
main cell types of the synovium. The subintima, which can be absent in some species 
is less cellular but synovial macrophages, synovial fibroblasts, mast cells and 
adipocytes are present. The proportion of collagen bundles is higher in the subintima 
than the intima and throughout the subintima there runs a rich, specialised capillary 
network (Mason et al., 1999).
Subintima Intima Joint cavity Cartilage
Figure 1.1.3 Schematic diagram of the synovial joint. SFB=synovial Fibroblast; SMP=synovial 
macrophage; C=capillary; HA=hyaluronan molecule.
The synovium lies on a layer of either areolar, fibrous or adipose tissue and this layer 
influences the cells on the synovial surface and the degree of vascularisation of the 
subintima. Areolar synovium consists of a thick, cellular intima and a subintima that 
is formed from loose connective tissue rich in blood vessels. The fibrous type has a 
thin cellular lining that contains relatively few cells lying on a collagenous subintima 
(Key, 1932). There is no basal lamina, so the cells are in direct contact with the 
synovial fluid thus allowing the passage of plasma components and macromolecules 
synthesised by the synovial cells, such as hylauronan, to pass into the synovial fluid 
(Ghadially, 1983; Mason et al., 1999).
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1.1.5.1 Cells of the Synovium
There are two main cell populations within the synovium. The macrophage-like type 
A cells and the fibroblast-like type B cells. The type A cells are similar to mature 
macrophages in other tissues and so are referred to as synovial macrophages (SMP). 
The type B cells show a wide range of properties, some of which are similar to 
fibroblasts, and are often referred to as synovial fibroblasts (SFB). Both cell types are 
distinct from each other, showing structural and functional differences yet are able to 
interact via adhesion molecules and cell surface receptors (Edwards, 1999b).
1.1.5.2 Origin of the Synovial Cells
The origins of both types of synovial lining cells remain in question. The first theory 
is that they derive from connective tissue cells that arrive at the synovial surface with 
their behaviour then determined by neighbouring cells (Barratt et al., 1977; 
Luckenbill and Cohen, 1967). The second is that they are a distinct synovial lining 
cell line defined during development, which then divide in situ to give the final 
phenotype (Edwards and Willoughby, 1982; Fell, 1978; Key, 1932).
Evidence for SMPs, first seen around the blood vessels of the developing joint (Okada 
et al., 1981), suggest that they are derived from a bone marrow cell line and once in 
the synovium show functional specialisation by interacting with SFBs (Edwards and 
Willoughby, 1982; Hogg et al., 1985). Further support for the macrophage lineage 
comes from macrophage deficient mice which contain no SMPs in the synovium 
(Naito et al., 1991).
Division of SFBs occurs at a very low rate, indicated by the low DNA content within 
the cells (Henderson, 1987a; Mohr et al., 1975). If this is the case, then slow turnover 
between cell death and cell division suggests that the synovial cells are rarely 
damaged in healthy synovium. This low rate of cell division may be attributed to cell 
migration to the synovium from the underlying connective tissue, with the type B cell 
phenotype being determined by local signals once migratory cells are within the 
tissue. Wilkinson et al. (1993) have shown that injections of air into subcutaneous 
tissue led to the formation of synovial type membranes, but the fibroblasts here lack
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some of the typical SFB characteristics such as high UDPGD activity. Other signals, 
either chemical or mechanical, could be required to induce the SFB phenotype.
Recent work by De Bari et al., (2001) supports the theory of a distinct synovial lining 
cell line predetermined in a restricted population during embryogenesis. This, and 
work by Nishimura et al., (1999) and Fickert et al., (2003) shows that the cells of 
synovial tissue can undergo chondrogenesis, myogenesis and osteogenesis 
highlighting the possibility that a mesenchymal stem cell is present within the adult 
synovial membrane.
Synovial Fibroblasts
SFBs contain a large nucleus, and a small amount of cytoplasm occupied by an 
extensive network of rough endoplasmic reticulum (Iwanaga et al., 2000). One of the 
main properties of the SFBs that differs from other fibroblasts is their ability to 
synthesise HA. The enzyme UDPGD, which is responsible for converting UDP- 
glucose to UDP-glucuronate, is considered the rate limiting step in HA synthesis as it 
provides the precursor sugars for HA synthesis (McGarry and Gahan, 1985; Molz and 
Danishefsky, 1971). Elevated UDPGD activity is associated with the intimal layer of 
the synovium and it has been shown that the resident SFBs are responsible for this 
activity (Pitsillides and Blake, 1992; Wilkinson et al., 1992). Further work by 
Pitsillides et al. (1993) has shown the UDPGD activity in intimal fibroblasts is six or 
more times higher than in the cells of the subintima. It is not know what controls 
UDPGD activity, though in diseased synovium this activity is down-regulated, 
leading to a decrease in HA synthesis (Pitsillides et al., 1994). One possibility could 
be the continued surface shearing forces occurring during movement of the joint, 
since surface cells in contact with the synovial fluid show the highest UDPGD 
activity (Edwards, 1994b).
The second enzyme involved in HA synthesis, and present in high quantities within 
the SFBs, is hyaluronan synthase (HAS) (Edwards, 1999a). This enzyme consists of 
seven putative membrane-spanning domains, two at the N-terminal end and the 
remainder at the C-terminal end. The catalytic site and binding sites for the HA 
precursors are thought to exist between these two regions (Weigel et al., 1997). HA
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chains are elongated by the alternate transfer of the precursors UDP-glucuronic acid 
and UDP-N-acetylglucosamine. This process takes place on the inner aspect of the 
plasma membrane allowing the HA macromolecule to be secreted from the cell 
surface where it can be shed into the synovial fluid or be retained by the cell in the 
form of a pericellular coat (Prehm, 1984; Spicer et al., 1997).
There are three HAS enzymes encoded by three separate but related HAS genes 
forming part of the mammalian HAS gene family (Spicer and McDonald, 1998). 
Although these genes show homology to each other, the HAS enzymes that they code 
for exhibit distinct properties, at least in in vitro. The size o f the HA chain can vary 
depending on the HAS enzyme. In vitro, HAS1 and HAS2 yield products of 2 x 105 
to 2 x 106 Da whereas, HAS3 synthesises a smaller HA chain with a Mr o f 1 x 105 to 1 
x 106 Da (Itano et al., 1999). The rate at which HAS is able to elongate the HA chain 
also differs such that HAS1 and HAS2 synthesise HA almost ten times faster than 
HAS3 (Itano et al., 1999), yet what governs this difference in elongation rate remains 
unknown.
The factors controlling has expression remain unknown although Jacobson (2000) and 
Recklies (2001) have both shown that various cytokines and growth factors such as 
IGF, FGF, TGFp and IL-1, can differentially induce expression of the three HAS 
genes, and this corresponds to observed increases in HAS protein levels. It has also 
been demonstrated that HAS gene expression can be modulated by mechanical stimuli 
(Dowthwaite et al., 1999). This study demonstrated that after application of 
mechanical strain to chick fibrocartilage cells, HAS3 expression was induced.
Thus, HAS gene expression, HAS enzyme synthesis and subsequent HA synthesis rely 
on a number of factors including cell type and external stimuli (Dowthwaite et al., 
1998; Jacobson et al., 2000; Recklies et al., 2001; Spicer et al., 1997). The advantage 
of three HAS isoforms, able to respond to different stimuli, could provide the cell 
with the flexibility it needs to control HA synthesis and in respond to differing 
externally generated cues.
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The vascular cell adhesion molecule (VCAM-1) is constitutively expressed by SFBs 
(Morales-Ducret et al., 1992). Its expression is thought to be predetermined, although 
it could require a signal from the SMPs to be expressed (Edwards, 1994c). VCAM-1 
is able to bind to VLA-4, the a4pl integrin on SMPs. It is conceivable, therefore, that 
this interaction between SFBs and SMPs anchors the SMPs in the matrix of the 
synovium. This allows granulocytes to enter the fluid-filled cavity and remove the 
waste components, which can then be reabsorbed by the SMPs thus keeping the 
synovial cavity free of waste or cell debris that would otherwise accumulate and 
interfere with joint function (Edwards, 1994c; Fairbum et al., 1993).
VCAM-1 is co-expressed with decay accelerating factor (DAF; CD55). High 
expression of DAF by SFBs, even before cavity formation has begun, is observed 
(Edwards and Wilkinson, 1996). This early expression is thought to be the result of 
positional information but may also be dependent on mechanical stimuli produced by 
shear stresses along the presumptive joint line (Edwards, 1999b).
Synovial Macrophages
The cytoplasm of the SMPs is filled with loosely arranged ER and a prominent Golgi 
complex with a scattering of vacuoles and vesicles often in close proximity to the 
cavity (Shannon and Graham, 1971; Southwick and Bensch, 1971; Wyllie et al., 
1964). SMPs show strong non-specific esterase activity and this property is often 
used as a marker to distinguish the SMPs from SFBs (Broker et al., 1990). Like all 
other macrophages, those in the synovium are phagocytic and covered by microvilli 
and microplicae. It has been demonstrated that the SMPs are active in the uptake of 
foreign substances that have been injected into the joint cavity (Iwanaga et al., 2000). 
Thus, a role of adsorption and degradation of cell debris, antigens and extracellular 
components is suggested for the synovial SMPs (Okada et al., 1981; Senda et al., 
1999; Shannon and Graham, 1971).
The well-developed vesicular and lysosomal system of SMPs suits the critical role of 
keeping the synovial cavity free of waste so allowing full movement of the joint. The 
position of the SMPs within the synovium is also significant as they absorb debris that 
needs to be excreted from the synovial cavity and deposit it in the lymphatic system
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where it can be removed. While some reports state that SMPs are unevenly 
distributed in the synovium, others report that they congregate at the tips of the 
synovial villi (Iwanaga et al., 2000; Stikichi et al., 1999). SMPs are also present at 
high density at the synovium-cartilage junction. Here, SMPs are likely to be involved 
in disposing of waste from the cartilage (Senda et al., 1999).
1.1.5.3 Extracellular Matrix
The composition of synovial extracellular matrix (ECM) is essential in maintaining 
healthy joint function and comprises sixty six percent o f the synovial volume (Price et 
al., 1996). The movement, positioning and content of macromolecules within the 
synovium provides sufficient outflow resistance to retain the correct volume and 
composition of synovial fluid within the synovial cavity (Price et al., 1995).
The cells of the synovium are separated by 2pm gaps with the interstitial spaces 
subdivided with components of the ECM including collagens, glycoproteins and 
proteoglycans (Levick, 1996). There is no defined basement membrane so the cell 
layer’s discontinuous interstitial matrix is exposed directly to the synovial fluid 
allowing for exchange of nutrients and waste products.
Collagen
Collagen is responsible for resisting the tensile forces and shear stresses that 
synovium can experience (Kempson, 1974). The collagens are usually defined by the 
presence of a distinctive triple helical domain containing peptide chains with the 
repeating triplet of Gly-X-Y, where X and Y are often proline and hydroxyproline 
(Sandell et al., 1999). These chains combine to form collagen fibers that are protected 
from protease attack as the amide bonds between the chains are within the molecule. 
A rich diversity of collagens has now been discovered and although they are unique in 
structure their role as structural proteins is essential (Ayad and Sandell, 1996). 
Collagens within the synovium account for 20-50% of tissue dry weight. This high 
content of collagens in the synovium reduces the cross-sectional area available for 
fluid flow enhancing the synovium’s ability to retain synovial fluid within the cavity 
(Eyre and Muir, 1975; Price et al., 1996).
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Collagens I, III, IV, V and VI have all been detected within the synovium (Ashhurst, 
1991; Levick and McDonald, 1990; Linck et al., 1983; Pollock et al., 1990; Worrall et 
al., 1991). Collagen type VI is rich in the cell binding motif RGD and has been 
implicated in the binding of matrix molecules such as HA and laminin. Thus, this 
collagen could anchor synoviocytes to the matrix so ordering matrix architecture 
(Kielty et al., 1992; Pollock et al., 1990; Wolf and Carsons, 1991). The network 
forming collagen type IV is a component of basement membranes but in the 
synovium it forms fine striated microfibrils that surround the SFBs. Non-striated 
microfibrils of collagen type VI are confined to the intima whilst collagen type III, the 
major striated fibrillar collagen extends into the subintima (Mason et al., 1999). Type 
I collagen interacts with collagen type III helping maintain fibril formation and 
growth (Sandell et al., 1999). Collagens type I, type III and type V extend into the 
subintima organising fibrils into parallel bundles that produce a criss-cross 
arrangement that could provide some of the elastic properties of the synovium (Levick 
et al., 1999).
Glycoprotein
Glycoproteins are another important group of molecules within the synovial ECM. A 
role in cytoskeletal organisation, cell migration, growth and differentiation has been 
suggested for synovial glycoproteins due to the presence of specific binding domains 
(Henderson, 1987b). Fibronectin is one such glycoprotein consisting of two large 
subunits, which are joined by disulphide bonds near their carboxy termini with each 
folded subunit linked by polypeptide chains. Fibronectin shows a pericellular 
distribution (Revell et al., 1995) and Linck et al. (1983) have provided evidence that 
fibronectin bound HA may function to control protein exchange between the 
synovium and synovial fluid.
Laminin is a flexible complex that is formed from three long polypeptide chains. 
These, like fibronectin, contain functional binding regions that are able to bind to 
collagens and laminin receptors. Laminin is another component of basement 
membranes but although LN-1, LN-10 and LN-11 have all been detected in the 
synovial ECM there is no distinct basement membrane in the synovial cell layer 
(Ghadially, 1983; Konttinen et al., 1999). However, both fibronectin and laminin are
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located in the basal part of the cell layer along with collagen type IV another 
component of basement membranes (Pollock et al., 1990).
Integrins are specific cell surface receptors (Hynes, 1992), influencing cell adhesion 
and migration. These molecules are the principle receptors in binding cells to their 
ECM and although this interaction is weak the integrins are at a high density on the 
cell surface. The main laminin receptor in the synovium is the integrin a6pi, but the 
collagen receptors a ip i and a2pi also bind laminin in the synovium (Sorokin et al.,
1990). Pirila et al. (2001) have shown that a6pl is specific to the SFBs. In the 
synovium, integrins are thought to attach the SFBs to the matrix but their involvement 
in cellular signalling suggests they could also regulate the release of MMPs 
(Konttinen et al., 1999).
Proteoglycan
Proteoglycan (PG) monomers consist of glycosaminoglycans bound to a protein core. 
The PG properties are then determined by the GAGs bound to the protein 
(Hardingham and Fosang, 1992; Jackson et al., 1991; Paulsson et al., 1987). PGs are 
able to interact non-covalently and form proteoglycan aggregates such as aggrecan or 
versican (fig. 1.1.4). Aggrecan is found in many connective tissues including that of 
the cartilage matrix. Aggrecan allows the tissues to withstand compressive loads 
(Hascall, 1988; Mason et al., 1982; McDevitt, 1988) and is formed by the covalent 
attachment of keratan-sulphate and chondroitin-sulphate chains to a core protein. The 
monomers then become non-covalently bound to a HA molecule with link proteins 
stabilizing the interaction between HA molecule and PG monomer (Hardingham,
1979). Within the synovium the highly negatively charged PGs are able to occupy 
very large hydrophobic volumes and along with the collagen network contribute to the 
strength and stiffness of the synovium (Hascall and Hascall, 1981; Jackson et al.,
2001). The PGs, decorin and biglycan have been found in the synovium (Bianco et 
al., 1990; Vogel and Trotter, 1987; Worrall et al., 1992). These two PGs have both 
been found carrying either chondrotin sulphate or dermatan sulphate chains yet little 
else is known about which PGs carry particular GAGs within the synovium The 
levels of GAGs however, have been calculated and from this data the total GAG 
concentration within the synovial ECM has been estimated at 4.1 mg ml'1 (Price et al.,
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contrast to cartilage, Price et al. (1995) showed that keratan sulphate was present in 
higher concentrations than the chondroitin sulphates within the synovium and there 
was a higher ratio of chondroitin-4-sulphate to chondroitin-6-sulphate. These studies 
would suggest that the difference in GAG distribution is a reflection of the different 
roles of synovium and cartilage within the joint.
Proteoglycan Monomer Proteoglycan Aggregate 
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Figure 1.1.4 Diagrammatic representation of proteoglycan monomer and aggregate.
1.1.6 Synovial Fluid
The synovial fluid (SF) is an ultrafiltrate of plasma, and as a result its composition is 
very similar to plasma, with the addition of molecules synthesised and secreted by the 
SFBs (Levick, 1996). The concentration of electroclytes and small solutes, like urea, 
are almost identical as these can pass easily through the membranes. Glucose 
concentration is lower in the SF than the plasma as chondrocytes utilise this sugar as 
an energy source. Plasma proteins are also seen at lower levels as they are sieved by 
the capillary walls. The addition of HA and lubricin secreted by the SFBs completes 
SF composition (Jay et al., 2000; Mason et al., 1999; Pitsillides and Blake, 1992).
The capillaries of the synovium play an important role in synovial fluid production. 
Capillaries are abundant within the synovium, concentrated 35pm below the surface 
with the lymphatics lying deeper in the subsynovium (Knight and Levick, 1983). The 
capillaries show polarized distribution towards the joint cavity and the presence of 
polarized fenestrations on the capillaries reduces the distance solutes need to travel
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facilitating fluid production (Levick, 1995; Levick, 1996; Yamashita and Ohkubo, 
1993)(fig. 1.1.5).
Figure 1.1.5 Fenestrations are shown at the surface of a synovial capillary (reproduced from 
Levick etaly 1996).
The volume of the synovial fluid is 1.0ml within the normal human knee joint and this 
remains constant even though the joint is continually flexed (Mason et al., 1999). The 
composition and volume of fluid within the cavity is essential, reducing friction 
between the articular cartilage surfaces so allowing free movement of the joint. The 
high concentration of HA contributes to the SF’s functionality. HA is a linear 
polymer with a molecular mass of several million kDa and intermolecular and 
intramolecular interactions allow for the formation of a random coil figuration in 
solution, even at very low HA concentrations (Laurent, 1970). This secondary 
structure of HA, discovered by x-ray diffraction and spectroscopy, shows the 
occurrence of intramolecular reactions between the polar groups of the HA molecule. 
These H-bonds between the sugar residues and water molecules act to stabilise and 
stiffen the HA molecule, forming a helical arrangement (Scott, 1998). The 
conformation the HA molecule adopts allows it to form a flexible molecular network 
that will enable shear stresses to be applied, as the HA coils can deform and elongate 
absorbing the strain (Wik and Wik, 1998).
The synovial fluid reduces friction and wear by providing a smooth and low-ffiction 
coating for the articular cartilage surfaces. The SF is suited to the role with a low 
friction coefficient resulting in part from one of its components called lubricin 
(McCutcheon, 1967). Lubricin was first isolated and characterised over 30 years ago
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and shows similar structural properties to proteoglycans with oligosaccharides 
attached to a core protein (Swann et al., 1985; Swann et al., 1981; Swann et al., 1977). 
Lubricin, like HA, is synthesised by the SFBs and secreted into the SF (Jay et al., 
2000). This places lubricin in the ideal position to act as a boundary lubricant within 
the SF (Swann et al., 1981). More recently, work by Jay et al. (2000) showed 
proteolytic removal of lubricin from SF dramatically increased friction within the 
joint.
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Figure 1.1.6 Schematic diagram of proposed ‘filtercake’ hypothesis.
The architecture of the synovium is very important in maintaining the synovial fluid. 
The continued trans-synovial fluid flow between synovium and synovial fluid allows 
the transport of nutrients and the removal of waste products during joint movement, 
while maintaining a constant volume of SF. Observations from previous work have 
suggested that flow is able to occur simultaneously both into and out of the synovial 
cavity at different points over the synovial surface (Levick and McDonald, 1994). The
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rate o f the fluid flow into the cavity has been calculated at approximately 2-4pl.h.cm2 
synovium in the human synovial joint (Levick, 1987).
When the joint is flexed an increase in the intra-articular fluid pressure (IAP) is 
observed (Levick, 1991). This pressure results in an increase in synovial surface area, 
an increase in interstitial spaces within the synovium and an increase in 
macromolecule concentration (Price et al., 1996). Normally, if IAP were to increase 
then this would be accompanied by an increase of fluid into the synovial cavity 
because of the reduction in hydraulic resistance. However, molecular sieving is 
thought to occur at the SF/synovium interface creating a filtercake effect (fig. 1.1.6). 
The larger hydrated HA molecules are unable to pass into the interstitial spaces of the 
synovium. This counteracts the increase in IAP by producing outflow resistance, so 
maintaining a constant volume of viscous fluid within the cavity.
1.1.7 Synovium & Cartilage
Cartilage is an avascular tissue utilizing both aerobic and anaerobic respiration (Lane 
et al., 1977). However, its sparse cell distribution results in a metabolic rate of less 
than one hundredth of other cells (Barratt et al., 1977). In most joints, half of the 
articular cartilage is in contact with the synovium or the synovial fluid (Forrester, 
1978). Movement of the joint ensures a route for molecular exchange as cartilage and 
synovium move over each other (Simkin and Pizzomo, 1974). As the SF is washed 
through the joint cavity it can replenish its nutritional content and remove waste 
products from the cartilage (Maroudas, 1970). During joint immobilization, glucose 
diffusion is slow resulting in lowered synthesis leading to overall matrix loss. This 
process supports the role of joint movement being necessary for the supply of oxygen 
and nutrients to the cartilage and also for the removal of its waste products via the 
synovium.
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1.1.8 Osteoarthritis
Osteoarthritis (OA) is a painful and disabling disease that shows variable distribution 
throughout the joints of the body. In a healthy joint, the cartilage is organised with a 
low cell to matrix ratio. The chondrocytes maintain tissue homeostasis allowing 
dissipation of compressive loads during movement o f the joint. Cells of the synovium 
also contribute to joint mobility by synthesising components of the synovial fluid 
filling the joint cavity. As OA progresses, the organised cartilage matrix, including 
proteoglycans and collagens breaks down and the synovium extends further into the 
cavity. Neighbouring chondrocytes try to rescue the damaged matrix but the process 
is disordered (Sandell and Aigner, 2001). The constituents of the synovial fluid alter 
and this adds to the reduction in joint mobility. Eventually subchondral bone is 
exposed, and the increased stress causes microfractures and cysts. The eventual 
outcome is an inflamed, painful joint with restricted movement.
Previous research into OA has suggested injury to the joint, genetic factors or an as 
yet unknown stimulus maybe responsible for disease onset (Fukui et al., 2001; 
Hedbom and Hauselmann, 2002; Smith et al., 1997; Terchek et al., 2002). Regardless 
of aetiology, it is clear that the relatively steady state of anabolic and catabolic 
processes that exist in normal healthy cartilage becomes uncoupled. In early OA, 
structural changes occur in the OA cartilage ECM. Type II collagen and aggrecan are 
two of the major components of cartilage matrix providing the mechanical properties 
of compressive resistance and elasticity. As synovial^cells and chondrocytes respond 
to inflammatory stimuli, aggrecan is one of the .first matrix components to be lost 
(Mankin and Lippiello, 1970). ADAMTs (a disingtigrin and metalloproteinase with /  
thrombospondin motifs) particularly AD AMTS-4 and ADAMTS-5 have been 
implicated in aggrecan degradation in arthritis (Tortorella et al., 2001). This 
proteoglycan loss is thought to be reversible whereas, the later stages of matrix 
degradation, involving loss of collagens is irreversible (Mort and Billington, 2001). 
Another family member of the metalloproteases found within OA cartilage are the 
MMPs and these are responsible for collagen degradation (Billinghurst et al., 1997; 
Chubinskaya et al., 1999; Knauper et al., 1996; Vincenti et al., 1994). Recently it has 
been suggested that aggrecan protects the collagen from enzymatic cleavage but once 
aggrecan has been broken down then the collagen is exposed to MMP proteolysis
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(Dahlberg et al., 2000; Kozaci et al., 1997; Pratta et al., 2003). Ultimately the 
structural integrity of the matrix is lost.
The chondrocytes respond to the initial stimuli by trying to rescue the damaged 
matrix. Enhanced expression and activity of anabolic growth factors such as TGF-p 
and IGF-I have been observed in OA cartilage and synovial fluid, presumably to try 
and increase collagen and PG content (Hedbom and Hauselmann, 2002; McQuillan et 
al., 1986; Middleton and Tyler, 1992; Morales and Hascall, 1988). The release of 
several pro-inflammatory cytokines eg. IL-lp, IL -la  and TNFa, believed to be the 
principle mediators of OA, also occurs in OA cartilage (Fukui et al., 2001; Tetlow et 
al., 2001). These pro-inflammatoiy cytokines stimulate catabolic processes inhibiting 
biosynthesis of essential components of cartilage ECM (Sandell and Aigner, 2001) 
while also increasing activity of degenerative enzymes such as MMPs and ADAMTs 
(Goldring et al., 1988; Tetlow et al., 2001; Tortorella et al., 2001). The effect each 
cytokine has on matrix degradation is not only dependent on cytokine concentration 
but the effect of modulating cytokines (IL-6, IL-8) and also anti-inflammatory 
cytokines (IL-4, IL-10) must be taken into consideration (Chomarat et al., 1995; 
Feldmann and Maini, 2001; Firestein, 2003; Fukui et al., 2001; Lubberts et al., 2000).
Clusters of chondrocytes are observed within OA cartilage. This proliferation 
prevents synthesis of new matrix yet proliferation would increase the numbers of cells 
able to synthesis matrix components (Rothwell and Bentley, 1973; Schumacher et al.,
2002). Although the chondrocytes show an increase in synthetic rate, they are unable 
to produce ‘normal’ cartilage matrix (Lippiello et al., 1977; Matyas et al., 1995);. 
Again, this loss of ordered tissue adds to the loss in the mechanical properties of the 
cartilage.
Increased synthesis of nitric oxide (NO), a highly reactive free radical, has been 
shown to occur in vitro upon stimulation with IL-lp and TNFa (Palmer et al., 1993). 
If the same occurs within the OA joint then increased concentrations of ILp and TNFa 
during OA could add to the degradation of the cartilage ECM as NO can inhibit 
collagen and PG synthesis as well as increasing MMP activity (Hauselmann et al., 
1994).
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Although the major pathogenic processes are located within the cartilage, components 
released from the cartilage into the synovial fluid act to modulate synovial cells into a 
response that might contribute to disease progression as the synovial cells are also 
able to release soluble cytokines and be a source of proteases (Hedbom and 
Hauselmann, 2002; Pelletier et al., 1995; Saito et al., 2002). Smith et al. (1997) 
demonstrated an increased synthesis of proinflammatory cytokines within the 
synovium correlating with an increase in articular cartilage damage, potentiating 
disease progression.
OA has a high prevalence within the population with between 1.3-1.75 million people 
affected in England and Wales alone (Reginster, 2002). Due to the ageing population, 
the incidence of OA will only increase unless beneficial treatments are found. Along 
the pathway from the first signs of cartilage matrix degradation to the loss of areas of 
cartilage within the joint, there are several possible points for intervention. Inhibition 
of pro-inflammatory cytokines, induction of anabolic enzymes, inhibitors of MMPs 
and ADAMTs are routes many believe will help in preventing or at least slowing 
down the progression of this disease (Malfait et al., 2002; Yao et al., 2001). Some 
protease inhibitors, however, have proved unsuccessful due to the complexity of 
cartilage metabolism and also because of the inability to determine severity of OA 
(Mort and Billington, 2001). Combining other strategies, including detection of 
biochemical disease markers within the synovial fluid, cartilage, or synovium to 
indicate the stage of OA, with biologic agents might prove a more beneficial 
approach. Cell and tissue transplantation is also a possibility and already in use in the 
form of autologous cartilage implantation (ACI). However, this is not recommended 
for treatment of late stage OA (Jackson et al., 2001). More recently the discovery of a 
cartilage progenitor cell has lead to the viable possibility that chondroprogenitor cells 
can be expanded in vitro and transplanted back into the defect where they will be able 
to generate new cartilage and replace areas of damage (Archer et al., 2000; 
Dowthwaite et al., 2004). As these methods remain in their infancy at present, then 
treatment of OA is temporary at first using analgesics, NSAIDs and corticosteroids to 
reduce pain and inflammation. A recommendation of weight loss and gentle exercise 
can also help alleviate pain and improve joint mobility. If these treatments fail then 
disease progression ultimately results in joint replacement surgery.
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1.1.9 Rheumatoid Arthritis
Rheumatoid arthritis (RA) is the most common inflammatory arthritis affecting 
almost one percent of the world’s population (Robbins et al., 2003). In the mid-20th 
century it became clear that this debilitating disease could be the result of 
autoimmune attack and since then research has accumulated to support this hypothesis 
(Firestein, 2003; Zvaifler, 1973).
During RA, the synovium’s usually flat surface is thrown into villi, the core of which 
contain aggregates of inflammatory cells including polymorphs, lymphocytes, plasma 
cells, mast cells and macrophages (Collins, 1949; Davies, 2003; Fassbender, 1985). 
T-cells are also present in this infiltrate but their response in vitro when in the 
presence of RA synovial cells alters. A lower proliferative rate was observed, 
especially in comparison to other antigen-mediated processes (Smeets et al., 1998; 
Stastny, 1976). Presence of T-cell cytokines/chemokines were in low abundance in 
the RA synovium compared with cytokines synthesised by the SFBs and SMPs. This 
cytokine imbalance allows induction of MMP synthesis and the inhibition of collagen 
synthesis leading to tissue degeneration (Burger et al., 1998; Hyka et al., 2001).
Hyperplasia of the synovium is one of the main factors associated with RA and 
although SFBs have been shown to undergo rapid proliferation in vivo in the presence 
of immune and inflammatory cells, it is still not known whether this hyperplasia is 
due to cell proliferation or whether it is a breakdown in the apoptosis signal (Davies, 
2003; Leung et al., 2002; Tanaka et al., 2002). Chronic inflammation is thought to 
lead to DNA damage and experiments inhibiting p53, a gene involved in the cell cycle 
and apoptosis, results in fibroblasts with characteristics similar to SFBs from RA 
tissue.
As the synovium proliferates, it encroaches upon the cartilage at the periphery of the 
joint and eventually overgrows the surface of the cartilage forming a pannus. Here 
the SFBs show an activated phenotype expressing adhesion molecules and secreting 
factors such as matrix degrading enzymes including aggrecanases and MMPs 
(Deleuran et al., 1992; Foey et al., 2000; Woolley et al., 1977). There are a broad 
array of cytokines and chemokines also synthesised by both types of synovial cells,
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which potentiate the inflammatory response (Cheon et al., 2002; Scott et al., 1997). 
The result of this response is the eventual degradation of the cartilage matrix (Smeets 
et al., 2001; van der Laan et al., 2003).
Increased vascularisation is evident in RA synovium. The lymphatic vessels become 
more numerous and prominent within both layers of the synovium (Davies, 2003; Xu 
et al., 2003). Another effect of the disease is the increase in volume of the synovial 
fluid resulting in swollen joints, one of the main symptoms of RA (Davies, 2003; 
Freemont et al., 1983). Eventually focal joint erosions can be seen. These usually 
occur at the joint margins but focal bone resorption is also observed in the 
subchondral bone and these subchondral lesions can penetrate the overlying cartilage. 
Evidence suggests that osteoclasts mediate this process via signals from cytokines and 
inflammatory mediators (Goldring, 2002).
Synovial
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Bone-Derived 
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Figure 1.1.7 Diagram showing the bi-directional erosion of cartilage. The predominant cell types 
observed in the synovial pannus are SMPs, SFBs, mast cells and neutrophils (adapted from 
Molecular Mechanisms in Rheumatoid A rthritis, 1995).
Proinflammatory cytokines produced locally in RA synovial joints contribute directly 
or indirectly to RA pathogenesis. Biological agents which modulate these cytokines 
are one of the main treatments in targeting the disease. As the cytokine network is so 
complex, then blocking proinflammatory pathways while leaving anti-inflammatory 
pathways unaffected is very difficult. This has lead to novel gene therapies where in
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vitro cells are manipulated and injected into specific sites within the joint so targeting 
the exact area of inflammation. Due to their involvement with inflammation, the 
transcription factor NF-k(3 and cell cycle gene p53 have been targeted as ideal 
candidates for this research (Makarov et al., 1997; Taniguchi et al., 1999).
1.1.10 Diseased Synovium
There are a number of changes within the synovium associated with both RA and OA 
and one of these is the modification of the synovial architecture. Instead of an even 
distribution of SFBs and SMPs within the synovium, the SMPs migrate to occupy the 
outer most layer of the intima (Worrall et al., 1991). This strategic positioning of 
SMPs nearer to the cavity allows the removal of waste products and cell debris that 
accumulates in the SF. There is also an increase in cell numbers due to leucocyte 
infiltration and the proliferation of SFBs (Henderson, 1987a) (fig. 1.1.9A).
Pitsillides et al. (1994) have shown alterations in HA synthesis in inflamed synovium 
compared to normal synovium. In normal synovium, HA was present throughout the 
intima with faint labelling in the subintima, whereas in RA and OA tissue, HA 
labelling was uniform throughout the intima and subintima, corresponding to a change 
in cell position with inflammation. UDPGD activity in normal synovium correlates 
with HA labelling. UDPGD activity is elevated in the intima compared to the 
subintima. RA synovium shows a decrease in UDPGD activity but this activity is 
uniform throughout both layers of the synovium. OA synovium varies, some samples 
show UDPGD activity similar to normal synovium while others are similar to RA 
tissue depending on the degree of infiltration present (Pitsillides and Blake, 1992; 
Wilkinson et al., 1992).
It has already been established that the maintenance of a high HA concentration in SF 
and synthesis of the correct sized HA polymer is important for joint function. HA 
concentration in the SF of RA and OA patients is lower than that of normal SF 
leading to reduced viscosity. This decrease in HA concentration results from an 
alteration in UDPGD activity and subsequently decreased HA synthesis during
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Figure 1.1.8 The synovium of a 71 year old male. Note the thin intimal layer 
(arrowed).
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Figure 1.1.9 Synovium from 70 year old male diagnosed with osteoarthritis.
A) Note the high cell density of the synovial surface. B) Note the 
leucocyte infiltration (arrowed, MagX125).
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disease (Miyaguchi et al., 2001; Wik and Wik, 1998; Yamada et al., 2000). Whether 
this change is a result of HA dilution, HA degradation or changes in HA synthesis is 
still not clearly understood. The ratio of freeibound HA within RA synovium is 
higher than that of normal synovium yet in vitro lower molecular weight HA is 
synthesized (Pitsillides et al., 1994). The smaller the HA molecule the more mobile it 
is and so it can pass more easily through the synovium and into the capillaries. As a 
result, high plasma HA serum levels are seen in patients suffering from RA (Balazs et 
al., 1967; Sundblad, 1953). These levels of serum HA are often assessed as a sign of 
the severity of the disease. OA tissue can show a response similar to either normal or 
RA tissue depending on the degree of infiltration and recently, Miyugachi et al. 
(2001) have shown the presence of a low molecular weight HA in the synovial fluid 
from OA patients. This low molecular weight product could be a result of HAS3 
expression as this produces the smallest HA polysaccharide in vitro and has a higher 
Pmax than HAS2 (Spicer and McDonald, 1998). A smaller HA molecule would 
explain the increased mobility of HA into the circulation and therefore the decrease in 
synovial fluid viscosity during disease. Synovial fibroblasts from OA tissues show 
HAS1 message levels that are more abundant than HAS2 and HAS3 message levels in 
vitro yet in vivo HAS1 and HAS2 message levels are similar, with HAS3 showing the 
least abundance (Recklies et al., 2001). The expression of the three HAS genes are 
higher in vivo than in vitro which suggests an increased level of HA biosynthesis in 
tissue. These three enzymes are essential for HA synthesis, yet little is known about 
their regulatory factors, especially in diseased tissues. Dowthwaite et al (1999) have 
demonstrated an increase in HA S3 expression in fibrocartilage cells subjected to 
mechanical strain while HAS2 expression remained constitutive. If the same was to 
occur in the synovium, then movement of the joint could regulate HAS gene 
expression in the synovial cells, maintaining HA concentrations within the synovial 
fluid and so allowing friction free articulation of the joint. Thus, the reintroduction of 
mechanical stimuli to immobile OA joints could be beneficial in increasing HA 
synthesis and increasing mobility.
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1.1.11 Aims of the Project
Mechanical stimuli play a critical role in joint cavitation and the alterations in HA 
synthesis which occur along the presumptive joint line during joint development have 
been linked to mechanical stimuli. Continued flexion of the joint and hence HA 
synthesis is essential in maintaining a fully functioning adult joint. During 
osteoarthritis however, there is a reduction in the concentration of HA within the 
synovium and synovial fluid contributing to joint pain and immobility. This could be 
due to the cells reducing their HA synthesis as a facet o f the disease. The loss of 
mechanical stimuli to the cells however, may lead to a further reduction in HA 
synthesis.
This study aims to determine whether the synovial cells derived from OA samples are 
still capable of modulating HA synthesis in response to mechanical strain by using a 
four-point bending mechanical loading jig. This study should provide us with a 
greater understanding of HAS regulation and subsequent HA synthesis within the 
synovial joint and the role mechanical stimuli plays in maintaining this synthesis.
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Chapter 2
Effects of Long Term Culture on 
________Synovial Cells_______
2.1 Introduction
The synovium consists mainly of two cell types, the synovial fibroblasts (SFB) and 
the synovial macrophages (SMP). These two different cell populations interact to 
maintain the healthy synovium (Chomarat et al., 1995; Edwards, 1999). Mast cells, 
T-cells, B-cells, endothelial cells, leukocytes and neutrophils are also present within 
the synovium and these cell types increase in number during during OA and RA 
contributing to the inflammatory response (Collins, 1949; Davies, 2003; Fassbender, 
1985).
Experiments conducted with cells isolated from the synovium requires the phenotypic 
features to be as close as possible to that observed in vivo to produce reliable and 
reproducible results. Isolation of synovial cells can involve the digestion of the 
synovium using collagenase/trypsin or by explant outgrowth. However, with both 
these techniques a mixed population of cells is obtained and alters with time in 
culture. Alterations in growth rates and an increase in the frequency of genotype 
changes can be seen to occur (Clarris and Fraser, 1968; Ermis et al., 1995; Tsai et al., 
1996). The data suggest the synovial cells deviate from their in vivo phenotype 
during in vitro growth. It is often the case that researchers use synovial cells from 
different passages to conduct their experiments. If the change in synovial cell cultures 
is significant between passages then variability in results could occur.
Generation of cell lines for future experimentation requires the in vitro culture of cells 
isolated from normal, OA and RA synovium. The aim of this work was to investigate 
the type of synovial cells obtained from the synovium and the effects of repeated- 
passage have on SFBs and SMPs and their respective markers, allowing the 
determination of whether to use low or high passage cells for future experiments.
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2.2 Materials and Methods
2.2.1 Synovium Samples
Synovium was obtained at the time of surgical knee replacement for degenerative 
osteoarthritis with the relevant ethical approval. Samples were obtained from both 
female (n=4) and male (n=3) patients with an age range 63-82 years (table.2.2.1).
Excised tissue was placed into sterile phosphate buffered saline (PBS) and stored at 
4°C until collection. The samples were cultured on the same day as they were excised.
Sample Sex Age (years)
OA9 Female 72
OA10 Female 73
OA11 Male 65
OA12 Female 63
OA13 Female 82
OA14 Male 66
OA15 Male 66
T able 2.2.1 Details of synovium sam ples obtained at knee jo in t rep lacem ent surgery .
2.2.2 Cell Isolation & Culture
Synovial cells were isolated from diced tissue by digestion in 295IU mg ml'1 type I 
collagenase (Sigma, Poole, UK) in Dulbecco’s 50% Minimal Essential Medium/ 50% 
Nutrient Mix F I2 (DMEM/F12; Life Technologies Ltd, Glasgow, UK) and placed on 
a roller for 3 hours at 37°C with vigorous shaking every 30 minutes. Following 
digestion, DMEM/F12 was removed into a sterile tube and an equal amount of 
DMEM/F12 added to the remaining synovium. The sample was vigorously shaken, 
media removed and placed into another sterile tube. Both fractions were centrifuged 
at 1000 x g for 5 minutes at 4°C and pelleted cells were suspended in DMEM/F12 
containing 1% penicillin-streptamycin (104IU ml ’/lO4 pg ml*1; Sigma), L-glutamine 
(200mM; Life Technologies, Paisley, UK), hydrocortisone (4mg ml'1; Sigma)[40mg 
hydrocortisone powder dissolved in 5ml 100% ethanol and 5ml sterile PBS], Insulin- 
Transferrin-Selenium (200mM; Life Technologies) and 20% foetal calf serum
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(Sigma) [DMEM/F12+]. Following centrifugation at 1000 x g for 5 minutes at 4°C, 
cells were resuspended in DMEM/F12+ and the fractions combined. Cells were 
counted, seeded as required and incubated at 37°C in a 5% CC^/air atmosphere.
Cell Passage
Once isolated, cells were plated into T75 flasks and allowed to reach confluence with 
a media change of DMEM/F12+ every four days. Primary cultures were grown to 
confluence, trypsinised (Appendix 2.1) and re-seeded at a 1:2 ratio in T75 flasks.
2.2.3 Immunocytochemistry
Cells seeded in 35 mm dishes were grown to confluence, the media removed and cells 
washed in PBS. The cells were fixed in 95% ethanol (Sigma) for 10 minutes and the 
cells washed in PBS.
Cells were incubated with blocking serum diluted in PBS-T for 20 minutes at room 
temperature to prevent unspecific binding of primary antibody. Excess serum was 
removed and the primary antibody diluted (table 2.2.2) in PBS-T, applied to the cells 
and incubated overnight at 4°C. The cells were washed 3 times in PBS-T (5 minutes 
each) then incubated with appropriate secondary antibody. The alexa fluor 488 
(Molecular Probes Europe, The Netherlands) used depended on the primary antibody 
(table 2.2.2). The secondary antibody was diluted to lOpg ml"1 in 1% blocking serum 
for 60 minutes at room temperature. Cells were then washed in PBS ( 3 X 5  minutes) 
and one drop of Vectashield plus propidium iodide (Vector Labs, UK) was applied 
and the cells cover slipped.
Negative controls consisted of PBS-T instead of primary antibody or relevant 
mouse/rabbit IgGs. Positive controls used were frozen sections of synovium due to 
the lack of human cell cultures available.
Cell Counts
One hundred cells or more were counted per 35mm dish from three random areas on 
the dish. Labelled and non-labelled cells were noted and one-way ANOVA tests were
36
applied to the cell counts with Tukey post-hoc tests. This statistical test was used to 
allow the comparison of data from more than two samples.
Name of 
Clone
Antigen
Specificity
Subclass Dilution Source Reference
BRIC 128 CD55 IgM 1:10
IBGRL
Research
Products,
Bristol.
Mushens R et 
al., (1990)
J Immunol 
Meth 131:83-89
N-19 Integrin a6 IgG 1:500
Chemicon 
International 
Inc, CA, USA
Hynes RO 
(1992) Cell 
69:11
UCHM-1 CD14 IgG 1:50
Chemicon 
International 
Inc, CA, USA
Linch DC et al., 
Blood (1984) 
63:566
KP1 CD68 IgG 1:50
Dako, 
Cambridgshire 
, UK
Warnke, RA et 
al., Am J Pathol 
(1989) 
135:1089
P3C4 VCAM-1 IgM 1:100
Chemicon 
International 
Inc, CA, USA
Blood (1993) 
81:2272
T able 2.2.2 List of synovial cell m arkers.
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2.3 Results
The expression of the macrophage marker CD 14 in synovial cell cultures can be seen 
in fig.2.3.1A. The expression of CD 14 was seen to significantly decrease with 
repeated passage (fig.2.3.1C). The expression of the macrophage marker CD68 was 
present in the synovial membrane and was maintained in synovial cell cultures 
(fig.2.3.2A & B). The expression of this macrophage marker was seen to significantly 
decrease with repeated passage (fig.2.3.2E).
Expression of the fibroblast marker VCAM-1 observed in the synovial membrane is 
maintained in synovial cell cultures (fig.2.3.3A & B) yet there was no significant 
difference in the number of labelled cells in passage 1 cultures compared to repeated- 
passage cells (fig.2.3.3E). Expression of integrin a6 was seen in the synovial 
membrane and in synovial cultures. Significantly more cells expressed integrin a6 at 
passage 2 cells compared with passage 1 cells (fig.2.3.4A & B). The expression of 
this integrin showed significantly decreased expression in passage 5 and passage 6 
cultures compared with passage 2 cells (fig.2.3.4D). Expression of CD55 was 
observed in the synovial membrane and in cultured cells at each passage (fig.2.3.5A &
B). No significant differences in CD55 expression was found between passage 1 and 
the repeated passage cells (fig.2.3.5F).
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Figure 2.3.1 Immunolabelling for CD 14. A representative synovial cell culture (A) 
labelled for CD 14. Negative controls o f no primaiy antibody showed no labelling in 
cultured cells (B). Percentage expression of CD 14 in repeated passage OA synovial 
cell cultures (C). *<P<0.05 compared to passage 1 cultures.
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Figure 2.3.2 Immunolabelling for CD68. Immunolabelling of a representative 
synovial membrane (A) and synovial cell culture (B) labelled for CD68. Negative 
controls of no primary antibody (A & C) and mouse IGGs (D) showed no labelling in 
synovial membrane or cultured cells. Percentage expression of CD68 in repeated 
passage OA synovial cell cultures (E). *<P<0.05 compared to passage 1 cultures.
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Figure 2.3.3 Immunolabelling for VCAM-1. Immunolabelling of a representative 
synovial membrane (A) and synovial cell culture (B) labelled for VCAM-1. Negative 
controls of no primary antibody showed no labelling in synovium (C) or cultured cells 
(D). Percentage expression of VCAM-1 in repeated passage OA synovial cell 
cultures (E).
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Figure 2.3.4 Immunolabelling for integrin a6. Immunolabelling of a representative 
synovial membrane (A) and synovial cell culture (B) labelled for integrin a6. 
Negative controls of no primary antibody showed no labelling in synovium (C). 
Percentage expression of integrin a6 in repeated passage OA synovial cell cultures 
(D). *<P<0.05 compared to passage 1 cultures.
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Figure 2.3.5 Immunolabelling for CD55. Immunolabelling of a representative 
synovial membrane (A) and synovial cell culture (B) labelled for CD55. Negative 
controls of no primary antibody showed no labelling in synovium (C) or cultured cells
(D). Percentage expression of CD55 in repeated passage OA synovial cell cultures
(E).
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2.4 Discussion
The synovial membrane is a relatively acellular structure which shows hyperplasia 
and cell infiltration during OA and RA (Davies, 2003; Henderson, 1987). The main 
cell types of the synovial membrane are the SFBs and SMPs and these two cell types 
can be distinguished from each other by a series of cell markers. Immunofluorescent 
labelling for CD 14 positive macrophages and VCAM-1 and integrin alpha6 positive 
fibroblasts was observed in the OA synovial membrane and relates to previous 
published studies (Morales-Ducret et al., 1992; Pirila et al., 2001; Smith et al., 2003; 
Wilkinson et al., 1992; Wilkinson et al., 1993). Labelling for CD68 and CD55 is seen 
in the synovial membrane but these cell markers can label for fibroblasts and 
macrophages so do not clearly define the cell types (Falini et al., 1993).
Removing cells from their in vivo environment will alter their phenotype to some 
extent but the isolation of both SFBs and SMPs were observed in cell cultures from 
synovial tissue with the maintenance of cell phenotype. However, it seems that the 
long-term in vitro culture of synovial cells results in a cell type and cell phenotype 
change (Clarris and Fraser, 1968; Ermis et al., 1995; Marsh et al., 1978; Tsai et al., 
1996; Zimmerman et al., 2001). A loss of SMPs with repeated-passage is a common 
occurrence in cell culture and in this study early passage cells labelled more 
extensively for SMP markers than late passage cells (Zimmerman et al., 2001). The 
loss of SMPs could lead to the conclusion that the late passage cultures consist solely 
of SFBs. This might indeed be the case but the loss of CD55 and integrin alpha6 
labelling suggests that although the cultures are labelling for fibroblast markers they 
are losing the stimuli to maintain their phenotype in culture, leading to the loss of 
synovial fibroblast characteristics. The loss of cell markers has been reported 
previously so is not uncommon to this study (Edwards et al., 1997). The decrease in 
expression of cell markers could be a result of the loss of the SMPs. The SFBs and 
SMPs have been shown to interact within the synovium so removing the SMPs from 
cell cultures could prove detrimental to the SFBs (Chomarat et al., 1995; Edwards, 
1999).
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In conclusion, cell culture inevitably results in a modification of the cell as it is 
removed from iQ  in vivo environment. Fortunately cell culture techniques have 
progressed to such an extent that the in vitro growth conditions are as representative 
of the in vivo growth conditions as possible. Within long term cultures however, the 
synovial cell cultures show alterations. The loss of macrophages and other infiltrating 
cells with repeated-passage cultures and the loss of fibroblast marker expression on 
the synovial fibroblasts suggests that the lower passage cells are more representative 
of the true synovial cell. As a result future experiments in this study will use synovial 
cell cultures at passage 1, passage 2 and passage 3.
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Chapter 3
Effects of Mechanical Strain on 
Hyaluronan Synthesis in Synovial Cells
3.1 Introduction
The sequence of events involved in joint cavity formation are complex and controlled. 
A full explanation for the separation of the cartilage anlagen allowing formation of the 
fluid-filled cavity is yet to be provided. However, it has been established that a 
process of cell loss combined with the turnover of matrix molecules occurs allowing 
the cells of the interzone to separate and form a joint cavity (Archer et al., 1994; 
Edwards, 1994; Fell and Canti, 1934; Mitrovic, 1971; Mitrovic, 1974).
Hyaluronan, the unsulphated glycosaminoglycan, was originally thought of as a 
space-filling molecule but it is now clear that HA plays a major role in joint 
cavitation. Hyaluronan is one of the matrix molecules detected at the first signs of 
cavitation and the large quantities of HA synthesised along the presumptive joint line 
are thought necessary for cell separation by a process of receptor saturation (Craig et 
al., 1990; Toole, 1981). UDPGD, the enzyme responsible for providing HA 
precursors for HA synthesis, can also be detected along the presumptive joint line and 
it has been determined that the UDP-glucoronate synthesized by UDPGD enters HA 
synthesis and not GAG synthesis (Hinchcliffe, 1977; Pitsillides et al., 1995). The 
presence of the HA binding protein, CD44, on the interzonal cells emphasizes the 
importance of HA in joint cavitation. Indeed, the disruption of HA:HABP 
interactions using low molecular weight HA oligosaccharides prevents joint 
cavitation, further highlighting the importance of HA in the cavitation process 
(Dowthwaite et al., 1998; Pitsillides et al., 1995).
Mechanical stimuli have been suggested as a mechanism influencing joint formation 
and HA synthesis. Removal of mechanical stimuli in uncavitated joints, either in ovo 
or in limb organ cultures, has been shown to prevent cavitation (Drachmann and 
Sokoloff, 1966; Fell and Canti, 1934; Osborne et al., 2002). More recently, the effects 
of mechanical stimuli on developing chick fibrocartilage cells have been 
demonstrated. The cells responded to brief periods of mechanical strain with an 
increase in media HA detected twenty minutes post strain. At twenty four hours, HA 
concentrations were maintained and increased CD44 expression was also observed
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(Dowthwaite et al., 1998; Dowthwaite et al., 2003). As a result mechanical stimuli 
have been suggested to influence HA metabolism within the developing joint and 
movement of the adult joint is the likely stimulus for the continued synthesis of HA.
In OA joints, the synovium shows alterations in HA synthesis and subsequently the 
concentration of HA within the synovial fluid decreases. As the disease progresses, 
friction-free articulation of the joint is reduced, leading to loss of mechanical stimuli 
as the joint becomes immobile. The advantages of being able to increase HA 
synthesis and so increase HA within the joint cavity using precise mechanical stimuli 
would prove a less invasive and practical treatment for OA. Indeed, a number of 
studies involving controlled exercise programs combining walking, aerobic and 
muscle strengthening exercises have shown an increase in flexibility of the joint and 
significant decreases in pain within a short period of time (Fisher et al., 1993; Minor 
et al., 1989; Penninx et al., 2001; Rejeski et al., 1998; Sullivan et al., 1998). It has 
also been shown that non-weight bearing or dynamic aerobic exercises did not 
aggravate the OA joints as no indication of joint inflammation was found (Beals et al., 
1985). Furthermore, the participants reported a decrease in knee pain. Cessation of 
these exercises resulted in the loss of the functional benefits obtained, demonstrating 
movement of the joint results in improvements in mobility. This work demonstrates 
that although the exact mechanisms of HA synthesis are still unknown it is likely that 
mechanical stimuli are an important regulatory factor in maintaining a fully 
functioning joint.
The aim of this work was to investigate the effects of mechanical strain on HA 
metabolism of synovial cells from OA knees. Establishing whether the synovial cells 
from OA knees are still able to respond to short periods of mechanical strain or 
whether due to age or disease they have become non-responsive to mechanical stimuli 
would result in a better understanding of mechanical stimuli and the regulation of HA 
synthesis in the functioning of the adult joint.
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3.2 Materials and Methods
3.2.1 Synovium Samples
Synovium samples were obtained as in Chapter 2 (2.2.1). Normal synovial samples 
were obtained within 24 hours post-mortem, again with the relevant ethical approval. 
Details of the samples are listed below.
Sample Type Sex Age (years)
OA1 OA Female 57
OA2 OA Male 64
OA3 OA Female 74
OA4 OA Female 79
OA5 OA Male 77
OA8 OA Male 79
N1 normal Female 67
N2 normal Unknown 71
Table 3.2.1 Details of synovium samples obtained at knee joint replacement surgery.
3.2.2 Cell Isolation & Culture
Cells were isolated from the synovium as described in Chapter 2 (2.2.2). Briefly, 
diced tissue was digested in 295IU mg m l'1 type I collagenase (Sigma, Poole, UK) for 
3 hours at 37°C. Cells were centrifuged at 1000 x g for 5 minutes, resuspended then 
centrifuged at 1000 x g for 5 minutes. Cells were counted and seeded as required in 
DMEM/F12 containing 1% penicillin-streptomycin (104IU ml'VloVg ml"1; Sigma), 
L-glutamine (200mM; Life Technologies, Paisley, UK), hydrocortisone (4mg m l'1; 
Sigma)[40mg hydrocortisone powder dissolved in 5ml 100% ethanol and 5ml sterile 
PBS], insulin-transferrin-selenium (200mM; Life Technologies) and 20% foetal calf 
serum (FCS;Sigma) and incubated at 37°C.
3.2.3 Mechanical Strain
Cells were used at passage 1, 2 and 3. The cells were trypsinised (Appendix 2.1), 
counted and plated at a density of 0.25 x 106 cells ml'1. One ml of cell suspension 
was placed into a well of the four-well strain plate (fig.3.2.1).
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The confluent cells were serum deprived for 18 hours, and fresh serum-free media 
(DMEM/F12 containing 1% penicillin-streptamycin (104IU ml'VloVg ml'1; Sigma), 
L-glutamine (200mM; Life Technologies), hydrocortisone (4mgml1; Sigma)[40mg 
hydrocortisone powder dissolved in 5ml 100% ethanol and 5ml sterile PBS], and 1% 
Insulin-Transferrin-Selenium (200MM; Life Technologies) [DMEM/F12-] added 30 
minutes prior to strain.
The four-point bending mechanical loading jig (fig.3.2.2) was calibrated accordingly 
(Appendix.3.1) so reproducible uniaxial strains could be applied to the cells. Cells 
were strained at 4000ps, 6000pe or lOOOOpe at a frequency of 1 Hz for 10 minutes 
(figure.3.2.3.). Controls comprised cells that did not undergo strain, static controls and 
cells that did not undergo strain but were subjected to media perturbation using a 
platform shaker set at 60 rev/min for 10 minutes, flow controls.
3.2.4 Cell Viability
To determine the effect of strain on the viability of the synovial cells a tiypan blue 
assay was used. Cells were strained as described then at 1 hour, 6 hours and 24 hours 
media was removed and 1ml trypsin (Sigma) added to each well for 5 minutes at 
37°C. The cell/trypsin solution was removed then 1ml DMEM/F12+ was added to 
wash the wells of remaining cells and the contents centrifuged at 1000 x g for 3 
minutes. The supernatant was removed and 1ml fresh DMEM/F12+ added. A 20pl 
aliquot of cell suspension was added to 20pl of trypan blue (Sigma), mixed and left 
for a few minutes before counting both live and dead cells with a haemocyto meter.
Images of cells were also taken prior to trypsinisation to assess gross morphology of 
strained and static control cells.
3.2.5 Hyaluronan ELISA
Duplicate samples of media collected from each of the strain, static control and flow 
control plates at 1 hour, 6 hours and 24 hours were assessed for HA concentration 
using a competitive ELISA plate-based assay (Fosang, Hey et al. 1990).
54
A Ninety six well plate was coated with lOOpl/well of lOOpg ml'1 HA (Calbiochem, 
San Diego, CA, USA) in 20mM sodium carbonate (Sigma-Aldrich), pH9.6 and left 
overnight on a shaker. The plate was washed 3 times in PBS-Tween 0.1% (PBS-T) 
and the plate blocked with 1% bovine serum albumin (Sigma-Aldrich)/PBS for 1 hour 
at 37°C.
The plate was washed 3 times in PBS-T. Fifty pi of sample (run in duplicate) or 
standard was added to the plate. A standard series of 10-0.00976pg ml"1 of HA was 
run in triplicate and diluted in PBS-T. A max well contained 50pl of PBS-T. Next 
50pl of biotinylated HA binding protein (Seikagaku Coorporation, Chuo-ku, Japan) 
was added at 1:1000 (0.22pg ml'1) to all wells except the blank which consisted of 
lOOpl PBS-T. The plate was incubated overnight on a shaker at room temperature.
The plate was washed 3 times in PBS-T then lOOpl of 1:500 streptavidin-biotinylated 
HRP complex (Amersham Pharmacia Biotech, Buckinghamshire, UK) diluted in 
PBS-T was applied. The plate was incubated at 37°C for 40 minutes on a shaker. The 
plate was then washed 4 times in PBS-T and lOOpl ABTS substrate (2,2'Azino-bis (3- 
ethylbenzthiazoline-6 sulfonic acid; Sigma) was added for 30-45 minutes and the 
absorbance read at 405nm.
Statistical Analysis
A set of three plates were subjected to strain, static control and flow control giving an 
n number of 3. Each plate consisted of 4 wells and statistical analysis showed HA 
media concentrations from 4 wells from the same plate did not show statistical 
difference. Data from the 3 plates subjected to either strain, control or flow control 
were combined for statistical analysis. All statistical analysis for changes in HA 
media concentrations between normal and OA patients, control and flow, control and 
strained cells were analysed using one-way analysis of variance (ANOVA) with 
Tukey post-hoc tests.
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Sample Number
The human tissue samples obtained for these experiments often varied in size and 
type. As a result, mechanical strain experiments could not be performed from each 
patient at all passages and at the 3 magnitudes of strain.
3.2.6 UDPGD Activity
UDPGD activity was assessed using a previously described cytochemical method 
(Mehdizadeh et al, 1991). Briefly, twenty four hours after strain media was removed 
and the cells were washed in PBS. Cells were then incubated for 3 hours at 37°C in 
nitrogen saturated medium containing 5.5mM UDP-glucose (Sigma), 1.5mM NAD 
(BDH Lab Supplies, Poole, UK) and 3.7mM nitrotetrazolium blue chloride (NBT) 
(Sigma-Aldrich) in 30% solution polyvinyl alcohol (Sigma) in 0.05%M glycylglycein 
buffer, pH7.8 (BDH Lab Supplies). Controls comprised cells incubated in medium 
without the UDP-glucose substrate. Once colour development occurred the cells were 
washed in distilled water and mounted in aquamount (BDH Lab Supplies).
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Figure 3.2.1 Strain plate consisting of four separate silicon wells on a polycarbonate 
base.
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Figure 3.3.2 Mechanical loading jig.
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Figure 3.2.3 Plates under mechanical loading go from a straight (A) to flexed (B) 
position.
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3.3 Results
3.3.1 Effects of Mechanical Strain on Synovial Cells
No differences in the gross morphology between the control cells and the cells 
subjected to strain were evident at 24 hours post treatment (fig.3.3.1). Cell viability 
assays on the control cells and cells subjected to the 3 magnitudes of strain showed 
over 90% viability in both the control and strained cells 24 hours post-treatment.
33.2 Static and Flow Controls
The HA concentration of the media from static and flow control normal synovial cells 
displayed no significant differences in media HA concentration at 1 hour, 6 hours or 
24 hours (fig.3.3.2A).
During the initial hour post-treatment media obtained from OA synovial cells 
subjected to flow alone and from static controls showed increases in HA 
concentrations. However, no significant difference between flow control and static 
control media HA concentrations were observed at the 1 hour time point (fig.3.3.2B). 
Although the Media HA concentration decreased in both the flow and static controls 
at 6 hours, no significant differences in HA concentrations between flow and static 
controls were evident. At 24 hours an increase in media HA concentration was 
observed in both the flow and static controls, compared to the 6 hour time point. 
However, there was no significant difference between flow and static control media 
HA concentration at 24 hours.
3.3.3 Patient Variability 
Variability with passage
The media from control cells from patient OA2 showed increasing media HA 
concentration with time at each passage. A significant difference (P<0.05) in media 
HA concentration between passages occurred at the 6 hour time point (fig.3.3.3A). 
OA3 control cells exhibited an increase in media HA concentration at passage 1 and 
passage 3 but at passage 2, media HA concentration decreased with time. Media HA
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concentration from the passage 1 cells at 6 and 24 hours were significantly higher 
(P<0.05) than the media HA concentrations obtained from passage 2 and passage 3 
cells (fig3.3.3B). Control media from patient OA4 showed an overall increase in HA 
concentration at 24 hours with each passage with both passage 1 and passage 2 cells 
containing significantly less HA in their media compared to passage 3 cells 
(fig.3.3.3C). Overall, significant differences in media HA concentration between 
each passage and at each time point were observed. As a result, the data from each 
patient at the 3 passages could not be accumulated for statistical analysis.
Cross patient variability
Synovial cell media HA concentration from normal patients ranged from 0.32pg ml*1 
to 3.8pg ml*1 at the 1 hour time point, 0.26pg ml*1 to 6.23jig ml*1 at the 6 hour time 
point and 0.99pg ml*1 to 26pg ml*1 at the 24 hour time point (Appendix.3.4). The HA 
concentration of media from synovial cells of OA patients ranged from 0.74pg ml*1 to 
5.11 pg ml*1 at the 1 hour time point, 0.14pg ml*1 to 16.55jig ml*1 at the 6 hour time 
point and 0.20pg ml*1 to 9.88pg ml*1 at the 24 hour time point (Appendix.3.5). The 
concentration of media HA from each of the individual patients at the same time point 
and passage showed significant differences. As a result media HA concentrations, 
from separate patients at each time point and at each passage, could not be combined 
for statistical analysis (fig.3.3.4).
3.3.4 Normal Patient Response to Mechanical Strain 
Patient N1
Normal control cells at passage 1 and 2 exhibited an initial increase in media HA 
concentration which was followed by a decrease at 6 hours and an increase at 24 
hours. The control cells at passage 3 had an increase in their media HA concentration 
at 1 hour that continued to increase up to 6 hours but decreased at 24 hours (fig.3.3.5 
A-C).
Subjecting normal cells to 4000pe increased media HA concentration at 1 hour 
followed by a decrease at 6 hours, then an increase at 24 hours in media from all 3
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passages. The strained cells followed the same trend in media HA concentration with 
time as the control cells. However, significantly less HA was seen in the passage 1 
cells at 1 hour after 4000p£ (PO.OOOl; fig.3.3.5A). In the passage 2 cells 
significantly less HA was seen at all time points (P<0.05; fig.3.3.5B).
The effect of applying strain at 6000ps was to increase media HA at 1 hour followed 
by a decrease at 6 hours then an increase at 24 hours in both passage 2 and passage 3 
cells. When compared to control cell media HA concentration the passage 2 strained 
cells showed significantly less media HA at the 6 hour time point (P<0.05; 
fig.3.3.5B).
At lOOOOps an initial increase at 1 hour in media HA continued to increase up to 6 
hours in the passage 1 and 3 cells. In the passage 2 cells, a decrease in media HA 
concentration was apparent at 6 hours post strain compared to 1 hour (f.ig.3.3.5A). 
Elevated media HA concentration was seen at 24 hours compared to 6 hours in 
strained cells from the 3 passages. The effect of straining the cells was reduced media 
HA concentrations in the strained cells with a significant decrease observed at the 6 
hour time point in the passage 2 cells (fig.3.3.5B). However, passage 3 cells showed 
a significant increase (PO.Ol) in media HA concentration at 24 hours compared to 
the control cells media HA concentration (fig.3.3.5C).
Patient N2
The control cells at passage 1 exhibited an initial increase in media HA at 1 hour, 
which then decreased at 6 hours, but increased at 24 hours (fig.3.3.6).
The cells subjected to 6000pe showed an initial increase at 1 hour in their media HA 
concentration which was followed by a decrease at 6 hours and then an increase at the 
24 hour time point. The strained cells showed a similar trend in media HA synthesis 
with time as the control cells, with a significant increase (P<0.05) observed at the 6 
hour time point.
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3.3.5 Summary: Changes in Media HA Concentrations from 
Normal Synovial Cells
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Table 3.3.1 Changes in media HA concentrations from normal synovial cells.
At 4000(ie the cells at passage 1 responded with a significant decrease in media HA at 
the one hour time point. The passage 2 cells responded with significant increases in 
media HA at all time points. Passage 3 cells showed no significant response at 
4000pe.
In response to 6000pe the passage 1 cells showed a significant increase at 6 hours 
whereas the passage 2 cells showed a significant decrease in media HA concentrations 
compared to the control cells. Passage 3 cells showed no significant response at 
6000pe.
The effect of straining passage 2 cells at lOOOOpe revealed a significant decrease in 
media HA at the 1 hour compared with control cell media HA concentration. At 
passage 3, cells responded with significant increases in media HA concentration at 
both 1 hour and 24 hours when subjected to lOOOOpe.
3.3.6 OA Response to Mechanical Strain 
Patient OA1
One hour after strain, passage 1 control cells gave an initial increase in their media 
concentration, which decreased at 6 hours but then increased at 24 hours (fig3.3.7).
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The cells strained at 6000pe showed an initial increase in media HA concentration 
which continued to increase up to 24 hours. When compared to control cells media 
HA concentration the strained cells showed no significant differences (/><().05) in 
media HA concentration at any time point after strain.
Patient OA2
Control cells at all passages showed an initial increase in media HA concentration and 
media HA concentration continued to increase up to the 24 hour time point (fig.3.3.8).
The effect of6000pe on the cells resulted in an increase in media HA up to the 6 hour 
time point in media from all passages. Media HA continued to increase up to the 24 
hour time point in passage 2 cells whereas passage 3 cells showed a decrease in media 
HA concentration at 24 hours. Passage 1 cells showed significantly higher (PO.05) 
levels of HA within the media of strained cells at the 1 hour time point whereas 
passage 3 cells showed a significant decrease in media HA concentration 1 hour after 
being subjected to 6000pe.
Patient OA3
Passage 1 and passage 3 control cells had increasing media HA concentration with 
time post strain (fig.3.3.9A & C). At passage 2 the control cells, after an initial 
increase at 1 hour showed a decrease in their media HA concentrations at 6 hours and 
a further decrease was observed at 24 hours (fig.3.3.9B).
Cells strained at 4000pe showed increasing media HA concentration with time at both 
passage 1 and passage 3. The effect of strain on the cells resulted in a significant 
increase CP<0.01) in HA concentration within the media compared to the control cells 
in passage 1 cells at 24 hours (fig.3.3.9A).
Applying lOOOOpe to passage 1 cells resulted in an increase in media HA 
concentration at 1 hour which fell at the 6 hour time point yet continued to increase in 
the passage 2 and 3 cells. At 24 hours, media HA concentration increased in the cells 
from all passages. When compared with control cells, passage 1 cells showed 
significantly less (P<0.1) HA within the media at the 6 hour time point whereas
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passage 3 cells showed a significant increase (P<0.1) in media HA at 1 hour and 24 
hours compared with control cells (fig.3.3.9C).
Patient OA4
Media from control passage 1 and passage 2 cells showed an initial increase in HA 
concentration which then decreased at 6 hours (fig.3.3.10A & B). At 24 hours, media 
HA concentration increased. Passage 3 control cells showed an increase in media HA 
up to 6 hours which was then decreased at 24 hours (fig.3.3.10C).
The cells strained at 4000pe gave an initial increase in media HA concentration which 
decreased at the 6 hour time point in passage 1 and 2 cells but continued to increase in 
passage 3 cells. At the 24 hour time point media HA concentration decreased in 
passage 1 cells yet increased in passage 2 and 3 cells. Passage 3 cells showed 
significantly higher (P<0.05) media HA concentration compared to the control cells at 
24 hour time point (fig.3.3.10C).
Application of 6000pe to the cells gave an increase in media HA concentration up to 6 
hours in passage 1 and 3 cells. This was followed by a decrease in media HA 
concentration at the 24 hours time point in passage 1 cells whereas an increase in 
media HA in passage 3 cells was seen. Passage 2 cells showed increased media HA 
at 1 hour which then decreased at 6 hours but increased at the 24 hour time point. 
Passage 1 cells showed significantly higher media HA compared to the control cells at 
the 1 hour time point whereas passage 2 cells showed a significant decrease CP<0.05) 
in media HA at the 24 hour time point (fig.3.3.10A & B).
HA accumulated in the media of cells subjected to lOOOOpe at 1 hour at all passages. 
At 6 hours, passage 1 and 3 cells’ media HA concentration continued to increase 
whereas passage 2 cells showed a decrease. At 24 hours, passage 1 and 2 cells 
showed an increase in media HA concentration yet passage 3 cells showed a decrease. 
Passage 1 cells showed significant increases (P<0.1) in media HA at the 6 hour and 
24 hour time point compared to the control cells whereas the passage 3 cells showed 
significantly reduced (P<0.05) media HA concentration compared with control cells 
(fig.3.3.10A&C).
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Patient OA5
Control passage 3 cells exhibited an initial increase in their media HA concentration 
at 1 hour which increased up to 6 hours but a decrease in media HA concentration was 
observed at 24 hours (fig.3.3.11).
The effect of straining the cells at 6000pe resulted in an increase in media HA 
concentration at 1 hour which continued to increase with time. The cells response to 
6000pe however, was significantly less (P<0.05) media HA at all time points when 
compared to the control cells.
3.3.7 Summary: Changes in Media HA Concentrations from OA 
Synovial Cells
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Table 3.3.2 Changes in media HA concentration from OA synovial cells.
At 4000pe the cells responded in passage 1 and 3, with an increase in HA 
concentration within the media of the strained cells compared to the control cells. A 
significant decrease in media HA concentration was observed in OA3 passage 1 cells 
at 1 hour although by 24 hours media HA concentration was significantly higher in 
the strained cells compared with the control cells (fig.3.3.9A).
In response to 6000pe, passage 1 cells exhibited an increase in media HA 
concentration, with significant increases observed in OA2 and OA4 at the 1 hour time 
point (fig.3 3.8A, 3.3.8C & 3.3.9A). The effect of straining passage 2 cells was a 
general reduction in HA accumulated in the media from the strained cells compared to 
the control cells and a significant decrease (P<0.05) was observed in OA4 at the 24 
hour time point (fig.3.3.8B & 3.3.10B). Passage 3 cells when subjected to strain
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showed significant decreases (PO.05) in media HA compared to the control cells 
(fig.3.3.8C & 3.3.IOC & 3.3.11).
The effect of straining passage 1 at lOOOOpe was to either significantly increase 
(PO .l) media HA concentration as in patient OA4 (fig.3.3.10A) or to significantly 
decrease (P<0.05) media HA as in patient OA3 (fig.3.3.9A). Passage 3 cells post­
strain showed significantly reduced (P<0.05) HA in the media of cells from patient 
OA4 at the 1 hour time point whereas patient OA3 showed significantly increased 
CP<0.1) HA in the media compared to the control cells (fig.3.3.10C & 3.3.9C).
3.3.8 Effects of Mechanical Strain on Normal and OA Synovial Cells
Normal cells produced the highest concentration of media HA at passage 3 whilst 
patient OA4 showed the same trend, the other OA patients showed higher HA 
concentrations in media produced by passage 1 cells. Subjecting OA and normal cells 
to strain resulted in higher concentrations of media HA at the 24 hour time point 
compared with the 1 hour time point. An increase in strain magnitude resulted in a 
lower Media HA concentration at each passage in the normal cells. This was not 
observed in OA synovial cells.
Subjecting normal cells to 4000pe and 6000pe resulted in the same trend in media HA 
concentration at all 3 passages, ie. increase at 1 hour followed by a decrease at 6 hours 
and then an increase at 24 hours. The effect of strain on O A cells produced a different 
response to that of normal cells. An increase in media HA concentration was 
observed with increasing time when the cells were strained at 4000ps. At 6000pe, 
OA cells either showed continued increase in media HA concentration with time or an 
increase up to 6 hours followed by a decrease at 24 hours. Patient OA4, passage 2 
cells were the only sample to show the same response as the normal cells. The 
response of normal cells to lOOOOpe was different depending on the passage, and the 
same was evident in the OA cells. Each patient at the different passages showed 
differing trends in media HA concentration with time.
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3.3.9 Comparison of Media HA Concentration from a Normal and 
an OA Patient
To allow a comparison between strain magnitude and passage number, data for 1 
normal patient (Nl) and 1 OA patient (OA4) were converted to percentage change in 
media HA concentration relative to unstrained controls. Here media HA 
concentrations from strained cells at each time point were converted to percentage 
increase or decrease over the static control cells media HA concentrations (Appendix 
3.6).
Changes in media HA concentration in passage 1 cells
The effect of mechanical strain on passage 1 normal synovial cells was a decrease in 
percentage HA release in the strained synovial cells compared to the control cells at 
all magnitudes of strain and at each time point except for the lOOOOpe cells at 24 
hours where a percentage increase was observed (fig.3.3.12A). In contrast, the effect 
of strain on the OA cells was a percentage increase in HA release at all strain 
magnitudes and at all time points (fig.3.3.12B).
Changes in media HA concentration in passage 2 cells
Normal passage 2 cells showed a percentage decrease in HA release when the cells 
were subjected to 4000pe. The effect of lOOOOpe on normal cells was a percentage 
decrease in HA release at 1 hour and 6 hours and at 24 hours (fig.3.3.12C). 
Application of strain to the OA synovial cells showed the opposite effect, with a 
percentage increase in HA release observed at 4000pe, 6000pe and lOOOOpe 
(fig.3.3.12D). However, as in the normal cells, the OA cells followed the same trend 
with time at each of the 3 magnitudes of strain.
Changes in media HA concentration in passage 3 cells
Normal cells subjected to 4000pe and 6000pe showed greater percentage increases in 
Media HA concentrations than the strained OA cells at passage 3 (fig.3.3.12E & F). 
OA cells also showed the same trend as normal cells, with an increase in media HA 
concentration at the 1 hour time point, which decreased at 6 hours then increased at 24 
hours. The effect of lOOOOpe on normal cells was to reduce percentage HA release 
compared with control cells at 1 hour and 6 hours. At the 24 hour time point an
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increase was seen. The OA cells when strained gave an initial percentage increase at 
1 hour which then decreased. As a result less HA was seen in the media of strained 
cells compared to control cells at 6 hours and 24 hours at 10000 pe.
Summary
In summary, mechanical strain of 4000pe, 6000pe and lOOOOpe produced significant 
changes in media HA concentration in normal synovial cells. The increases or 
decreases observed depended on strain and passage number of the cells. For example 
at 4000pe, decreases in media HA concentration were observed at all passages 
whereas 6000pe and lOOOOpe produced both increases and decreases.
In OA synovial cells when mechanical strain was applied to the cells a significant 
change in media HA concentration occurred at all magnitudes o f strain. Applying 
4000pe and lOOOOpe to the cells resulted in both increases and decreases in media HA 
but this depended on cell passage number. Application of 6000pe resulted in a 
decrease in media HA concentration at all passages.
The response to mechanical strain between normal and OA cells differed. At 4000pe 
normal synovial cells showed significant decreases in media HA concentration 
whereas OA cells showed both increases and decreases. At 6000pe and lOOOOpe both 
increases and decreases were observed in both OA and normal cells. It was however, 
the lOOOOpe at 24 hours which produced an increase in both normal and OA patients.
3.3.10 UDPGD Activity in OA Synovial Cells
OA synovial cells were assayed for UDPGD activity 24 hours after the application of 
strain. In strained samples, intense activity (as indicated by dark blue reaction 
product) was observed relative to unstrained controls (fig.3.3.13B & fig.3.3.14B). 
Additionally, background UDPGD activity was observed in control cells by 
comparison with assay controls (fig.3.3.13A & D & fig.3.3.14A & D). This increase 
in UDPGD activity was apparent in all samples subjected to strain.
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Figure 3.3.1 Gross morphology of a representative OA synovial cell culture 24 hows 
post-treatment. Patient OA3 cells were subjected to 10 minutes of mechanical straw 
(6000pe) or remained as static controls.
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!Figure 3.3.2 Media HA concentrations from A) normal synovial cells and B) OA 
synovial cells. Cells were serum deprived for 24 hours, then fresh serum free media 
added. The cells remained static (control) or were subjected to media perturbation 
(flow) for 10 minutes and the media sampled at 1 hour, 6 hours and 24 hours. Error 
bars represent standard deviations.
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Figure 3.3.3 Media HA concentrations from synovial cells at three passages for three 
separate samples. Cells were serum deprived for 24 hours, then fresh serum free 
media added and the media sampled at 1 hour, 6 hours and 24 hours. Error bars 
represent standard deviations. A) patient OA2 B) patient OA3 C) patient OA4. 
*P<0.05 compared with passage 2. +/,<0.05 compared with passage 3.
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fFigure 3.3.4 Media HA concentrations from synovial cells from five OA patients. 
Cells were serum deprived for 24 hours, then fresh serum free media added and the 
media sampled at 1 hour, 6 hours and 24 hours. Error bars represent standanl 
deviations. A) passage 1 cells; B) passage 2 cells; C) passage 3 cells. *P<0.05 
compared with OA1; #P<0.05 compared with OA3; +/?<0.05 compared with OA4.
79
Time 
(hours)
media HA (ug/ml) O media HA (ug/ml)
00
o>
NJA
3
(0
media HA (ug/ml)
-»■ IO  IO  o  cn o  cn o  cn
O)
ro
lh
l :
ih
□  DD ■  □ DD ■  □ □  B  □  □
o  o  o  o O  O  O o  o  o  o
>  !> !> >  
cn A  O) K) >  >  >w  Fo
>  >  >  >  A  U  M J
Figure 3.3.5 Media HA concentrations from patient Nl. Normal synovial cells were 
subjected to 10 minutes of mechanical strain and the media sampled at 1 hour, 6 hours 
and 24 hours. Control synovial cells did not undergo strain. Error bars represent the 
standard deviations. A) passage 1 cells; B) passage 2 cells; C) passage 3 cells. 
***P<0.001 compared to control cells. **P<0.05 compared to control cells. N=3 for 
control and strain data points.
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Figure 3.3.6 Media HA concentrations from patient N2. Normal synovial cells were 
subjected to 10 minutes of mechanical strain and the media sampled at 1 hour, 6 hours 
and 24 hours. Control synovial cells did not undergo strain. Error bars represent the 
standard deviations. **P<0.05 compared to control cells. N=3 for control and strain 
data points.
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Figure 3.3.7 Media HA concentrations from patient OA1. Passage 1 OA synovial 
cells were subjected to 10 minutes of mechanical strain and the media sampled at 1 
hour, 6 hours and 24 hours. Control synovial cells did not undergo strain. Error bars 
represent the standard deviations. N=3 for control and strain data points.
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Figure 3.3.8 Media HA concentrations from patient OA2. OA synovial cells were 
subjected to 10 minutes of mechanical strain and the media sampled at 1 hour, 6 hours 
and 24 hours. Control synovial cells did not undergo strain. Error bars represent the 
standard deviations. A) passage 1 cells; B) passage 2 cells; C) passage 3 cells. 
*P<0.05 compared to control cells. N=3 for control and strain data points.
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Figure 3.3.9 Media HA concentrations from patient OA3. OA synovial cells were 
subjected to 10 minutes of mechanical strain and the media sampled at 1 hour, 6 hours 
and 24 hours. Control synovial cells did not undergo strain. Error bars represent the 
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Figure 3 .3 .10  Media HA concentrations from patient OA4. OA synovial cells were 
subjected to 10 minutes of mechanical strain and the media sampled at 1 hour, 6 hours 
and 24 hours. Control synovial cells did not undergo strain. Error bars represent the 
standard deviations. A) passage 1 cells; B) passage 2 cells; C) passage 3 cells. 
*P<0.05 compared to control cells. N=3 for control and strain data points.
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Figure 3.3.13 UDPGD activity of cultured synovial cells from patient OA8. A&C 
shows static cells while B&D shows strained cells. C&D show the control reactions. 
Note the deeper blue reaction product in strained cells (B) when compared to static 
cells (A).
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i
Figure 3.3.14 UDPGD activity of cultured synovial cells from patient OA3. 
shows static cells while B&D shows strained cells. C&D show the control reactions. 
Note control cells are lighter blue.
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3.4 Discussion
The data presented here demonstrates that cells derived from both normal and OA 
synovium respond to mechanical strain by altering HA release into the surrounding 
media. Hyaluronan synthesis during joint development has been attributed in part to 
mechanical stimuli and, studies showing increased HA synthesis in vitro when cells 
from the developing joint were subjected to mechanical stimuli support this 
hypothesis (Dowthwaite et al., 1998; Dowthwaite et al., 2003; Dowthwaite et al., 
1999; Edwards et al., 1994; Pitsillides et al., 1995). The continued synthesis of HA is 
thought a necessary requirement for maintaining a fully functioning adult joint and 
this current work supports the data that mechanical stimuli are vital for maintaining 
joint function. Synovial cells responded to a brief period of mechanical strain and 
maintained their response in altered HA synthesis. It is clear from this work however, 
that normal and OA cells respond differently to mechanical strain.
The general trend observed in normal synovial cell cultures in response to mechanical 
strain was an initial increase in media HA followed by a decrease at 6 hours then an 
increase at 24 hours post-strain. The increase in media HA at the 1 hour time point 
could be due to newly synthesised HA secreted into the media or from HA released 
from the pericellular coat either as a result of mechanical stimuli or due to the 
decreased levels of HA in the media at the start of the experiment. Previous work has 
shown that HA can signal through negative and positive feedback mechanisms which 
could explain the increase in HA (Lamier et al., 1989; Philipson and Schwartz, 1984; 
Philipson et al., 1985). These feedback mechanisms could also be responsible for the 
decrease in media HA concentration at the six hour time point, yet this decrease in 
media HA could occur in different ways. Firstly, the cessation of HA synthesis, 
explained by a reduction in HAS mRNA expression, HAS synthesis or in HAS 
activity. Internalisation of HA could occur via HABPs, reducing HA concentration 
within the media. Indeed, CD44 has been established as the principle cell surface HA 
receptor and is present on synovial cells (Aruffo et al., 1990; Edwards et al., 1993; 
Henderson et al., 1994; Henderson et al., 1993). Internalisation of HA via its CD44 
receptor has previously been demonstrated and the addition of exogenous HA to the
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cell cultures decreases HA synthesis, the mechanisms of which are likely to be 
saturation of CD44 (Collis et al., 1998; Dowthwaite et al., 1998; Edwards et al., 
1994). The decrease in HA secretion into the media could also be attributed to the 
loss of nascent HA within the pericellular coat. As a result, the cell would continue to 
synthesise HA yet it would be retained within the pericellular coat so would not be 
detected. Previous work has shown the effect of digestion of the pericellular coat is to 
increase levels of HA synthesis and CD44 expression (Dowthwaite et al., 2003).
Lastly, the loss of HA within the media could also be a result of hyaluronidase 
digestion of the HA molecules. Hyaluronidases are present in mammalian cells and 
are responsible for cleaving the HA molecule (Afify et al., 1993; Flannery et al., 
1998; Laurent and Fraser, 1992; Meyer, 1971). In different tissues, HA has different 
turnover rates and this is, in part, due to hyaluronidases (Stem, 2003). Treatment of 
cell cultures with hyaluronidases stimulates HA synthesis and high levels of 
hyaluronidase can modulate CD44 expression (Lamier et al., 1989; Philipson and 
Schwartz, 1984; Stem, 2003; Tanabe et al., 1993). The hyaluronidases are able to 
generate different sized disaccharides from the HA chain and these molecules are able 
to interact within the environment producing different effects (Afify et al., 1993; 
Lepperdinger et al., 2001; Noble, 2002).
The increased concentrations of HA at 24 hours suggests the HA levels within the 
surrounding media have reached a minimum level or that the levels of HA within the 
pericellular coat are at a maximum and so HA is secreted into the surrounding media. 
HA synthesis could be switched on again via increased expression of HAS mRNA or 
increased activity of HAS. If the pericellular coat has retained enough HA, then HA 
intended for the pericellular coat could simply be secreted into the media from the 
pericellular coat. Again, these data suggest a feedback mechanism exists that enables 
the synovial cells to sense the levels of HA that have been synthesised. More 
intriguingly, despite the presence of a HA pericellular coat, the cells seem to sense 
concentrations of HA distant and beyond this coat.
The response of the OA cells with time either showed a gradual increase in HA 
synthesis over the 24 hour period or an increase up to 6 hours then a decrease at 24 
hours. Both these trends could be due to a breakdown in the HA synthesis feedback
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pathway. The cells response to HA concentrations within the surrounding media 
could be hampered due to the disease and so the cells could take longer to respond to 
the stimuli. If the HA media concentrations could have been monitored over a longer 
period of time, then this might give a better insight into the response to mechanical 
stimuli. The fact that the OA control cells and OA strained cells respond differently 
with time suggests that the response to mechanical stimuli is altered perhaps as part of 
the disease process, but it can be seen that the OA synovial cell cultures are capable of 
synthesising HA.
Although the cells were subjected to 10 minutes of mechanical strain, the alterations 
in HA synthesis are evident 24 hours later. The results, however, indicate a difference 
in the synovial cell cultures from normal and OA tissues, in response to the three 
magnitudes of strain. Normal synovial cell cultures at 24 hours showed a decrease in 
media HA synthesis when subjected to 4000pe whereas at lOOOOpe an increase in 
media HA concentration was observed. In contrast, the OA synovial cell cultures 
showed an increase in media HA concentration at 4000pe and a decrease at both 
6000j l i b  and lOOOOpe. Whilst the exact mechanical strain to which cells in the 
synovium are subjected to are at present unknown we do know that the lowest strain 
magnitude of 4000p8 applied to the cells in this investigation is physiological in a 
wide range of bones from a number of different species (Lanyon, 1996). Thus, it is 
the lowest strain of 4000pe that is able to increase and maintain HA synthesis in OA 
synovial cell cultures. The normal cells, however, showed a decrease in media HA 
concentration when subjected to 4000pe. Previous work has shown that HA synthesis 
can be controlled by the amount of HA present in the surrounding milieu and could 
explain the reduction in HA synthesis in the normal cell cultures post strain 
(Dowthwaite et al., 2003; Lamier et al., 1989; Philipson et al., 1985). The responses 
to lOOOOpe by normal and OA synovial cell cultures is different and the increase in 
HA synthesis by the normal cells might be considered more advantageous. An 
increase in media HA concentration would lead to a more viscous synovial fluid 
allowing greater loads to be applied and preventing synovial fluid leaking from the 
cavity (Coleman et al., 1999; Coleman et al., 2000).
The differences in media HA concentrations between normal and OA synovial cells 
seen in response to strain was highlighted in the different passages. At passage 1 and
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2, normal cells showed decreases in media HA concentration when subjected to 
4000pe whereas passage 3 cells showed no changes in media HA concentration in 
response to strain. When the cells were subjected to lOOOOpe an increase in media 
HA concentration was observed only in the passage 3 cells. The OA synovial passage 
1 cells gave an increase in media HA concentration at the three magnitudes of strain 
whereas passage 3 cells showed an increase only when strained at 4000pe and 
lOOOOpe. These results might suggest that the cells become less mechano-sensitive 
with passage as they do not receive mechanical cues in vitro. Further explanation of 
the response to mechanical strain by the cells at the different passages could be the 
result of alterations in cell cultures due to in vitro growth. It has previously been 
shown that synovial cell cultures alter in both cell population and cell characteristics 
with the length of time in culture (Clarris and Fraser, 1968; Marsh et al., 1978; Smith 
and Hamerman, 1969; Zimmerman et al., 2001). As a result, a loss of macrophage 
and other infiltrating cells with repeated passage can be observed. This prevents the 
cell-cell interactions between the SFBs and SMPs which occur in vivo and which 
might be needed for transduction of mechanical stimuli in vitro (Edwards, 1999). The 
development of a more fibroblastic cell line has also been suggested to occur with 
repeated passage and could result in a different response to mechanical stimuli in vitro 
(Marsh et al., 1978; Zimmerman et al., 2001).
The loss of mobility within the OA joint is one of the main symptoms associated with 
OA and this has often been attributed in part to the loss of hyaluronan from the 
synovial fluid and synovium. Whether the synovial cells are unable to synthesise HA 
due to the disease or whether the loss of HA synthesis observed in the synovium is 
due to the reduction in mechanical stimuli or is a combination of both of these factors 
is not clear. From this work, however, it can be established that OA synovial cell 
cultures are able to respond to mechanical stimuli. In particular, the lowest magnitude 
of strain increased HA synthesis in OA synovial cell cultures. Whether this would 
transfer to an in vivo situation remains to be researched. Previous work of controlled 
exercise based studies as a treatment for OA have been shown to reduce joint pain and 
increase joint mobility and this could be due to the increase in HA synthesis as a 
result of mechanical stimuli (Fisher et al., 1993; Minor et al., 1989; Penninx et al., 
2001; Rejeski et al., 1998; Sullivan et al., 1998). It seems that HA does indeed play 
an important role in joint mobility and mechanical stimuli are necessary to maintain
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the HA synthesis within the synovial joint. Thus, development of exercise based 
therapies could prove beneficial as a treatment for OA.
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Chapter 4
Effects of Mechanical Strain on 
Hyaluronan Synthase mRNA 
Expression in Synovial Cells
4.1 Introduction
Since the discovery of hyaluronan (HA) in 1934 (Meyer and Palmer, 1934), this 
polysaccharide has generated a great amount of interest, due to the variety of physical 
and biochemical properties it exhibits that are able to influence cell behaviour. HA 
has been shown to modulate cellular migration and differentiation, regulate the 
organisation and metabolism of the ECM and be an important factor in metastasis, 
wound healing and inflammation (Hall and Turley, 1995; Ichikawa et al., 1999; 
Kozaci et al., 1997; Laurent and Fraser, 1992; Lee et al., 2000; Lesley et al., 1993; 
Toole, 1990). The variety of functions HA is able to perform is partly due to the 
nature of its synthesis and the sizes of the polymer chain and the concentrations at 
which it is synthesised leads to differing biological and physical characteristics.
HA synthesis begins with conversion of UDP-glucose to UDP-glucuronate by the 
enzyme uridine-diphosphoglucose dehydrogenase (UDPGD) and this has been shown 
to be the rate-limiting step of HA synthesis (McGarry and Gahan, 1985; Molz and 
Danishefsky, 1971). UDPGD activity provides the precursors for the next step in HA 
synthesis that involves the enzyme hyaluronan synthase (HAS). HAS is responsible 
for extending the HA polymer at the reducing end of the HA chain (Prehm, 1984). 
Here UDP-glucuronate (UDP-glc) or UDP-N-acetlyglucosamine (UDP-glcNAc) are 
transferred onto the reducing end sugar of the HA chain, with displacement of the 
terminal UDP (fig. 1.1). This is in contrast to the synthesis of GAGs, which are 
synthesised in processes involving elongation of the sugar chains bound to core 
proteins (Mason et al., 1982). Simultaneously, the HA chain is extruded in to the 
ECM while still being extended in the cell. This process of synthesis allows the 
formation of large chains of HA as they are not restricted in size by modifications in 
the Golgi compartment, or vesicular transport to the cell surface, as in the synthesis of 
other macromolecules (Kjellen and Lindahl, 1991).
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Site 1: UDP-glc UA-4,1 -[glcNAc-3,1 -glcUA-4,1 -]„
Site 2: UDP-glcNAc
■ i
Site 1: UDP-glcUA * UDP released
Site 2: UDP-glcNAc-3,1 -glcUA-4,1 -[glcNAc-4,1 -glcUA-4,1-]n
Figure 4.4.1 Example o f proposed HA chain polymerisation
HAS resides on the plasma membrane and consists of seven putative membrane- 
spanning domains, two of which are located at the N-terminal end of the molecule 
while the other five are located at the C-terminal end (Prehm, 1984). HAS is unusual 
because of the large number of functions that are required for the overall 
polymerisation of the HA chain. It has been suggested that vertebrate HAS is part of 
a multicomponent enzyme complex comprising of 2 binding sites for the 2 different 
sugar nucleotides, 2 different glycosyltransferase activities, 1 or more binding sites 
that can anchor the HA polymer to the enzyme and a ratchet-like transfer reaction site 
that moves the growing polymer one sugar at a time (Mian, 1986; Weigel et al., 
1997).
Research into the bacterial HAS genes lead to the discovery of a multigene family 
encoding distinct isoenzymes (DeAngelis, 1996; Itano et al., 1999; Watanabe and 
Yamaguchi, 1996). As research progressed to eukaryotic organisms three mammalian 
enzymes, HAS1, HAS2 and HAS3, encoded by three HAS genes on different 
chromosomes were discovered and have contributed to a greater understanding of HA 
synthesis (Spicer and McDonald, 1998). The 3 HAS genes show similar homology 
yet in vitro have been shown to be responsible for the synthesis of three distinct HAS 
enzymes capable of synthesising HA of different chain lengths and at different rates 
(Itano et al., 1999). If the same were to occur in vivo, then this would provide some 
answers to the many biological and physical properties of HA. The regulation of HAS 
gene expression remains obscure. Levels of media HA concentrations have been 
shown to correlate with HAS mRNA levels in some studies whilst in others this is not 
the case (Jacobson et al., 2000; Recklies et al., 2001). Growth factors and cytokines 
have been shown to act as stimuli in HA synthesis but alterations in HA detected in
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response to these stimuli can vary from 4 hours to 24 hours depending on cell type 
(Heldin et al., 1992; Suzuki et al., 1995). There is also evidence to suggest negative 
feedback mechanisms occur, as in vitro depletion of HA by hyaluronidase treatment 
results in an upregulation of HA (Dowthwaite et al., 2003; Lamier et al., 1989). The 
low turnover exhibited by the HAS enzymes and the variation in half-life, which can 
range from one day to three weeks depending on cell type, adds to the complexity of 
understanding HAS regulation and subsequent HA synthesis (Morales and Hascall, 
1988; Tammi et al., 1991).
Synovial fibroblasts within the adult joint are responsible for synthesising HA 
(Pitsillides and Blake, 1992; Wilkinson et al., 1992). The HA is either retained in the 
synovium or secreted into the synovial fluid, maintaining a constant volume and level 
of viscosity necessary for frictionless movement of the joint (Levick, 1991; Levick, 
1996). Low abundance of HAS gene expression in cultured synovial cells has caused 
some difficulties in detecting the three HAS genes but Recklies et al., (2001) 
demonstrated that HAS1 and HAS2 are in similar abundance whereas HAS3 is the least 
abundant. The differential expression of the three HAS genes suggest each plays an 
important role in maintaining joint function. As the genes are responsible for HAS 
expression and, as the three HAS proteins are each able to synthesise different sized 
HA polymers at different rates, this could allow the cells the flexibility to synthesise 
the necessary HA polymers required to maintain synovial fluid viscosity and to 
prevent synovial fluid leaking out from the cavity when the joint is flexed.
In OA synovium, there is evidence of a decrease in HA synthesis by the synovial 
fibroblasts and a consequent decrease in HA concentration of the synovial fluid, 
leading to a reduction in joint mobility (Pitsillides et al., 1994; Yamada et al., 2000). 
At present, little research exists on differential HAS gene expression within OA joints 
but alterations in HA synthesis occurring in OA joints would suggest regulation of 
HAS gene expression is involved. It is interesting to note that OA patients show high 
HA serum levels and this could be due to increased HAS3 message levels (Miyaguchi 
et al., 2003). HAS3 synthesises the smallest HA molecule in vitro, if the same were to 
occur in vivo then the HA molecule could more easily be lost to the lymphatic system 
than larger HA molecules (Miyaguchi et al., 2001). If HA is not retained within the 
synovial fluid then this will affect synovial fluid viscosity and volume.
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As OA progresses, the OA joint becomes painful to move and the observed decrease 
in HA synthesis could be attributed in part, to the reduction in mechanical stimuli. 
HA synthesis within the developing joint cavity is involved in cell separation of the 
cartilage anlagen and the stimuli for HA synthesis here could well be mechanical 
since cavitation only occurs after the musculature becomes functional (Craig et al., 
1990). Indeed, mechanical stimuli has been shown to induce HAS3 expression in 
developing chick fibrocartilage cells whereas HAS2 expression remained constitutive 
(Dowthwaite et al., 2003; Dowthwaite et al., 1999). Thus, reduction in HA synthesis 
in the OA joint could be due partly, to the reduction or loss of mechanical stimuli on 
the three HAS genes. The ability to regulate HAS expression through mechanical 
stimuli could prove beneficial in treating OA patients by increasing HA concentration 
within the synovial fluid and so improving joint mobility.
The aim of this work was to try and establish a greater understanding of HAS 
regulation in the synovial cells from OA knees. The previous chapter has 
demonstrated the effect of mechanical strain on HA synthesis. An increase in media 
HA concentration was observed when the cells were subjected to 4000pe whereas 
6000p£ and lOOOOpe gave variable results depending on the patient. Investigation of 
the differential expression of the three HAS genes in synovial cells and subsequent 
alterations in gene expression when synovial cells are subjected to mechanical stimuli 
should provide a more indepth understanding of the regulation of HA synthesis.
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4.2 Materials and Methods
4.2.1 Synovium Samples
Synovium samples were obtained as in Chapter 2 (2.2.1). Details of the samples are 
listed below.
Sample Type Sex Age (years)
OA1 OA Female 57
OA2 OA Male 64
OA3 OA Female 74
OA4 OA Female 79
OA5 OA Male 77
OA6 OA Male 79
OA7 OA Male 79
N1 normal Female 67
N2 normal Unknown 71
Table 4.2.1 Details of synovium samples obtained a t knee jo in t replacem ent surgery.
4.2.2 Cell Isolation & Culture
Cells were isolated from the synovium as described in Chapter 2 (2.2.2). Briefly, 
diced tissue was digested in 295IU mg ml'1 type I collagenase (Sigma, Poole, UK) for 
3 hours at 37°C. Cells were centrifuged at 1000 x g for 5 minutes, resuspended then 
centrifuged at 1000 x g for 5 minutes. Cells were counted and seeded as required in 
DMEM/F12 containing 1% penicillin-streptamycin (104IU mTVl04pg ml"1; Sigma), 
L-glutamine (200mM; Life Technologies, Paisley, UK), hydrocortisone (4mg ml"1; 
Sigma)[40mg hydrocortisone powder dissolved in 5ml 100% ethanol and 5ml sterile 
PBS], Insulin-Transferrin-Selenium (200mM; Life Technologies) and 20% foetal calf 
serum (Sigma) and incubated at 37°C.
4.2.3 Mechanical Strain
The cells were subjected to mechanical strain as described in Chapter 3 (3.2.3). 
Briefly, cells were serum deprived for 18 hours then fresh serum free media was 
added. The cells were strained at 4000pe, 6000pe and 10000pe for 10 minutes using
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a four-point bending loading jig. Control cells remained static for 10 minutes and 
flow control cells remained static but were subjected to media perturbation for 10 
minutes.
4.2.4 RNA Isolation
RNA from the strained, static control and flow control cells were isolated 24 hours 
post-strain using the Qiagen RNeasy Mini kit (Qiagen Ltd, West Sussex, UK) 
following manufacturers instructions. RNA was stored in solution at -80°C until 
required.
The quality of extraction was verified by 1% (w/v) agarose (Helena Biosciences, 
Europe)/ Tris-Borate EDTA buffer (TBE, Sigma-Aldrich) gel and by measuring light 
absorbance at 260nm and 280nm. The concentration of RNA in the extraction was 
calculated using the equation:
[RNA] = A260 x D x 40ug/ml
where D = the final dilution factor, and A26o = the absorbance of the solution at
260nm.
4.2.5 Real-Time PCR
Reverse transcription polymerase chain reaction was used to establish HAS 
expression by the strained, static control and flow control cells. A reverse 
transcription reaction was performed to transcribe the RNA to cDNA using the 
following reaction mix.
Product Volume
RNA (1 Mg/ml) 10|jl
5X MMLV RT buffer (Promega, Southampton, UK) 10mI
MMLV Reverse Transcriptase (200U/ul, Promega) 0.5(jI
dNTP (25mM each, Promega) 1pl
Random Hexamer (500pg/ml, Promega) 1(j|
Rnasin (400U/pl, Promega) 1.25|jl
Distilled Rnase & Dnase free H20 26.25(j|
Total 50pl
Table 4.2.2 Reagents for cDNA synthesis.
I l l
The reaction mix was incubated at 25°C for 10 minutes, followed by 48°C for 60 
minutes then a 95°C step for 10 minutes to denature the reverse transcriptase enzyme. 
All cDNA was synthesised using a Perkin Elmer cDNA thermal cycler. The RT 
products were used immediately or stored at -20°C.
The PCR primers in table 4.2.3 were designed using Bio/Oligo Primer Design 
software and supplied by Invitrogen (Paisley, UK).
Sequence (5’-3’) Primer
Annealing
Temperature
°C
Product
(bp)
CAT CGC TGC CTA TCA AGA AGA Forward human HAS2
65 454
CCC AAC ACC TCC AAC CAT Reverse human HAS2
TCA TCT CTG CCC CCT CTG CTG Forward human GAPDH
53 444
CCT CCG ACG CCT GCT TCA C Reverse human GAPDH
CGG CCT GTT CCC CTT CTT CGT Forward human HAS1
62 347
CGT GTG CTA CGC TGC GGA CCA Reverse human HAS1
CAG CCT CCT CCA GCA GTT CC Forward human HAS3
55 317
TAA CCG TGG CAA TGA GGA G Reverse human HAS3
Table 4.2.3 Oligonucleotide prim ers for RT-PCR analysis.
PCR for HAS2 was then performed on a Gene AMP PCR system 9700 (PE Applied 
Biosystems) using the above primers and the following reaction products. The PCR 
mix consisted of the reagents described in table 4.2.4.
The PCR reaction started at 95°C for 30 seconds, then cycled at 95°C for 30 seconds, 
the annealing temperature (listed in table.4.2.3) for 60 seconds, then 72°C for 60 
seconds for 35 cycles, followed by an elongation step of 72°C for 6 minutes. The 
product was stored at 4°C until required.
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Product Volume
Forward primer (50pm, Invitrogen) 1 pi
Reverse primer (50pm, Invitrogen) 1 pi
RT product 1 pi
dNTPs (10mM each, Promega) 1 pi
Taq DNA polymerase (95U/pl, Promega) 0.25pl
10X buffer (Promega) 5pl
MgCI2 (25mM, Promega) 3pl
dH20 37.75pl
Total 50pl
Table 4.2.4 Reagents for HAS2 P C R
PCR for HAS1 and HAS 3 was performed using the published primer sequences 
(Recklies et al., 2001) shown in table 4.2.3. The PCR mix was as follows.
Product Volume
Forward primer (50pm, Invitrogen) 1 pi
Reverse primer (50pm, Invitrogen) 1 pi
RT product 1 pi
dNTPs (10mM each, Promega) 1 pi
Amplitaq Gold (5U/pl, Applied Biosciences, CA, USA) 0.3pl
10X PCR X10 Gold buffer (Applied Biosciences) 5pl
MgCI2 (25mM, Applied Biosciences) 3pl
dH20 37.75pl
Total 50pl
Table 4.2.5 Reagents for HAS1 and HAS3 P C R  
The PCR reaction was the same as above with the cycle number increased to 45.
Positive controls of human tendon fibroblast cDNA were run with each reaction to 
ensure the PCR was effective.
Gel Electrophoresis
Eighteen pi of the PCR product was run on a 2.0% (w/v) agarose/ TBE gel at 70 V for 
35 minutes along with phiX DNA///ae III marker (Promega). The gel was stained 
with ethidium bromide (Sigma) at lpg/ml for 20 minutes and the excess washed off
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with tap water. The bands were visualised on an ultraviolet light box and the gel 
documented using Quantitiy One software (BioRads Labs, Hertfordshire, UK).
Analysis of PCR products
To determine that the bands visualised on the gel were the gene of interest, each PCR 
product was purified, using the QIAquick PCR purification kit (Qiagen) following the 
manufacturers instructions. The purification products were then sequenced using the 
ABI PRISM Big Dye Terminator Cycle Sequencing Ready Reaction kit (Applied 
Biosciences) following manufacturers instructions.
4.2.6 Quantitative Real-Time PCR
The relative expression levels of HAS 1, HAS2 and HAS3 in strained and unstrained 
synovial cells from OA patients and normal patients were determined using the ABI 
Prism 7700 TaqMan quantitative polymerase chain reaction system (Applied 
Biosystems, CA, USA).
Primers and dual-labelled probes were designed using Oligo Primer Design software 
to detect HAS1, HAS2 and HAS3 and purchased from Invitrogen and Sigma 
respectively. The relative expression levels of each HAS gene from control and 
strained cells were all normalised to 18S rRNA (Applied Biosystems, CA, USA).
Forward Prim er R everse  Prim er TaqMan Probe
HAS 1
Acc. NM_001523
911-GCG GGC TTG  
TCA GAG CTA-931
995-AAC TGC TGC  
AAG AGG TTA TTC  
CTA TAT-968
ACTGTGTATCCTG
CATCAGCGGTCCT
CTA
HAS 2
Acc. U54804
45-GCA GCT CAT 
TGA ACC AGA GA- 
65
130-AAG ACT CAG 
CAG AAC CCA GGA 
A-108
CCCCAGCCAAAGA 
C l l l l  CTCCCAATT 
CT
HAS 3
Acc.Af232772
3445-GGT AAG ACT 
GCT GGT TGA CAT 
CAG-3469
3547-CAG AAT GAT 
TGC CTG GAT CA- 
3527
CCCAACCCATT GA 
AGGCTGGAAGG
Table 4.2.6 Q uantitative PCR  prim er and probe sequences.
The probe reporter dye used for detection of the HAS amplicons was 6- 
carboxyfluorescein (FAM), quenched by 6-carboxy-tetramethyl-rhodamine
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(TAMRA). The rRNA reagents were purchased as a kit (Applied Biosystems). The 
probe reporter dye was VIC (proprietary dye, Applied Biosystems), quenched by 
TAMRA
I
Amplification of both HAS and 18S rRNA was performed in a 96 well plate prepared 
as per the manufacturers instructions (Eurogentec Ltd, Hampshire, UK) with a total 
reaction volume of 25pi. Primer and probe concentrations were optimised and are 
indicated in table.4.2.7. Each reaction used 0.5pl of cDNA template. All reactions 
were performed in triplicate and to certify reactions were not contaminated negative 
controls replacing cDNA with water were run in parallel.
T arget Prim er Probe
18S rRNA (Applied Biosciences) 50nM 200nM
HAS 1 50nM 100nM
HAS 2 300nM 100nM
HAS 3 50nM 100nM
Table 4.2.7 Q uantitative PCR prim er and probe reaction concentrations.
Reactions were run on the ABI Prism 7700 Sequence Detection System (Applied 
Biosystems) with cycling conditions set at 95°C, 10 minutes, then 40 cycles of 95°C 
for 15 seconds followed by 60°C for 1 minute.
Before conducting the experiment on the samples a validation plate was run. This was 
to establish the efficiencies of the gene interest and the 18S rRNA to determine 
whether the standard curve or comparative Ct method was needed.
For HASl and HAS2, the comparative Ct method could be applied. The efficiencies 
of the HAS and 18S rRNA amplicons were shown to be equal, so eliminating the need 
for a standard curve (Appendix 4.2).
For HAS3, a dilution series o f control synovial cDNA was run in triplicate for both 
the gene of interest (HAS3) and the standard (18S rRNA) on the same 96 well plate as 
the samples (Appendix 4.4). Thus, Ct (cycle threshold; AppliedBiosystems, 1997)
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values and total RNA quantities were used to generate a relative standard curve 
(Appendix 4.4).
Statistical Analysis
The mean Ct values and standard deviation values were determined as per Applied 
Biosystems instructions (Appendix 4.2 & 4.4). Thus data are presented as relative 
levels of mRNA for each gene of interest normalised to either control normal or 
control OA synovial cells. Changes in mRNA quantities were analysed using one­
way analysis of variance (ANOVA) of normalised Ct values for pairwise contrasts 
with Tukey error protection at a 95% confidence interval.
Sample Number
As a result of low cell number, cells from some patients could not be subjected to the 
three magnitudes of strain at each passage. Therefore, subsequent QPCR analysis of 
HAS expression could not be performed for each patient at all passages and at the 
three magnitudes of strain.
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4.3 Results
4.3.1 HAS1, HAS2 and HAS3 Gene Expression
Sequence analysis of PCR products generated using HAS1, HAS2 and HAS3 gene- 
specific primers each produced a positive match to the published gene sequences for 
HAS1, HAS2 and HAS3 in mRNA extracted from cultured synovial fibroblasts.
HAS Gene Expression in Normal Synovial Cells
Subjecting the cells to 4000pe HAS1 revealed mRNA expression in strained cells 
whereas HAS1 mRNA expression was not detected in control cells at passage 1 
(fig.4.3.1). At passage 3, HAS1 expression was detected in both strained and control 
cells. HAS2 mRNA expression was detected in strain and control cells at all 
passages. The expression of HAS3 mRNA was not detected in control or strain cells 
at any passage.
Analysis of HAS 1 mRNA expression post-6000pe revealed variable results. Strained 
and control cells from patient N2 at passage 1 and 2 did not express HAS1 whereas 
HAS1 expression was detected in strained and control cells at passage 3. HAS2 
expression was detectable in strained and control cells from both normal patients and 
in cells from all passages. HAS3 mRNA expression was not detected in cells from 
patient N1 subjected to strain or in control cells but was detected in patient N2 in both 
strained and control cells.
HAS1 mRNA expression was detected in both strained and control cells when the 
cells were strained at lOOOOpe. Strained and control cells were both seen to express 
HAS2 mRNA in cells from the 3 passages. HAS3 mRNA was expressed in both 
strained and control cells at passage 1 but was not detected at passage 3 when cells 
were subjected to lOOOOpe.
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HAS Gene Expression in OA Synovial Cells
Analysis of synovial fibroblast HAS1 mRNA expression by PCR at 24 hours post- 
4000 pe revealed no differences in expression patterns between the strained and 
control cells, with both sets of cells expressing HAS1 mRNA, except for Patient OA3 
at passage 3 which did not express HAS1 mRNA (fig.4.3.2). HAS2 mRNA was 
expressed in both strained and control cells in all patients and at all passages 
regardless of strain. HAS3 mRNA was absent in both strained and control synovial 
fibroblasts except Patient OA3 passage 3 cells which expressed HAS3 mRNA in both 
strain and control cells.
When cells were subjected to 6000p£, HAS1 mRNA expression was detected in both 
strained and control cells at all passages except in Patient OA7, passage 1 cells. 
HAS2 mRNA expression was expressed in both strained and control cells in all 
patients and at all passages regardless of strain. HAS3 mRNA expression could not 
be detected in over half of patients. Patients OA1 and OA7 passage 1 cells however, 
expressed HAS3 mRNA expression in control cells but not in strained cells.
Analysis of HAS1 mRNA expression in the cells subjected to lOOOOpe showed 
expression in strained and control cells, except for patient OA3 passage 3 cells and 
OA4 passage 1 cells which showed no expression in both strain and control cells. 
HAS2 mRNA expression was detectable in both strained and control cells in all 
patients and at all passages. HAS3 mRNA expression was detected in patient OA3 in 
all but the control passage 3 cells, in the strained passage 3 cells from patient OA5 
and in the strained passage 1 cells from patient OA4. HAS3 mRNA expression was 
not detected in the remainder of the patients sampled, either in control or strained 
cells.
4.3.2 QPCR data: Normal Patient Response to Mechanical Strain 
Patient N1
HAS1 mRNA expression. At passage 1, HAS1 mRNA expression was significantly 
decreased (PO.Ol) relative to the control cells when the cells were strained at 4000pe 
(fig.4.3.3A). The effect of lOOOOpe on HAS1 mRNA expression was not
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significantly different in the strained cells relative to the control cells (fig.4.3.3A). At 
passage 2 and 3, no significant differences in HAS1 expression were observed in the 
cells subjected to 4000pe, 6000pe and lOOOOpe relative to the control cells (fig.4.3.3B 
& C).
HAS2 mRNA expression. At passage 1, a significant decrease (7^0.001) in HAS2 
mRNA expression was seen at 4000ps relative to the control cells (fig.4.3.4A). At 
passage 2, a significant increase (PO.OOOl) in HAS2 mRNA expression was detected 
at 6000 and lOOOOpe, with the greatest increase in HAS2 mRNA expression at 
6000pe (fig.4.3.4B). At passage 3, no significant differences in HAS2 mRNA 
expression were observed at the 3 magnitudes of strain relative to the control cells 
(fig.4.3.4C).
HAS3 mRNA expression. At passage 1, no significant differences in HAS3 mRNA 
expression in the strained cells relative to the control cells were apparent when the 
cells were subjected to 4000ps and lOOOOpe (fig.4.3.5A). At passage 2 and 3, 
significant increases in HAS3 mRNA expression relative to the control cells resulted 
when the cells were subjected to 4000pe (fig.4.3.5B & C). At 6000pe no significant 
differences were observed between the strained and control cells. Significant 
decreases (PO.OOl) in HAS3 mRNA expression were observed when the passage 2 
and 3 cells were strained at lOOOOpe, relative to the control cells (fig.4.3.5B 8c C).
Patient N2
HAS2 mRNA expression. At passage 1, no significant differences in HAS2 mRNA 
expression relative to the control cells was observed when the cells were strained at 
6000pe (fig.4.3.6A).
HAS3 mRNA expression. At passage 1, no significant differences in HAS3 mRNA 
expression in the strained cells relative to the control cells was observed when the 
cells were subjected to 6000pe (fig.4.3.6B).
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4.3.3 OA Patient Response to Mechanical Strain
Patient OA2
HAS1 mRNA exoressioa At passage 1 and 3 no significant differences in HAS1 
mRNA expression were observed when the cells were subjected to 6000pe, relative to 
HAS1 mRNA expression in the control cells (fig.4.3.7A & B).
HAS2 mRNA expression. At passage 1, a significant decrease (P<0.001) in HAS2 
mRNA expression was observed in the cells that were strained at 6000pe relative to 
the control cells (fig.4.3.7C).
Patient OA3
HAS1 mRNA expression. At passage 1 and 2, no significant differences in HAS1 
mRNA expression relative to the control cell HAS1 mRNA expression were detected 
when the cells were subjected to 4000pe, 6000pe and lOOOOpe (fig.4.3.8A & B). At 
passage 3, a significant increase (7^0.001) in HAS1 mRNA expression relative to 
control cells could be seen at 4000pe (fig.4.3.8C). At lOOOOpe, a significant increase 
(7*<0.001) in HAS1 mRNA expression was seen in the passage 3 strained cells 
relative to control cells.
HAS2 mRNA expression. At passage 2, no significant differences in HAS2 mRNA 
expression in the strained cells relative to the control cells were observed when the 
cells were subjected to 4000ps (fig.4.3.9A). At lOOOOpe, a significant increase 
(PO.Ol) in HAS2 mRNA expression in the strained cells relative to the control cells 
was detected. At passage 3 significant increases (P<0.01) in HAS2 mRNA 
expression was observed at4000pe and lOOOOpe relative to control cells (fig.4.3.9B).
Patient OA4
HAS1 mRNA expression. At passage 1, no significant differences were observed in 
HAS1 mRNA expression relative to the control cells HAS1 mRNA expression when 
the cells were subjected to 4000pe. The effect of 6000pe resulted in a significant 
increase (P0.001) in HAS1 mRNA expression in the strained cells relative to the 
control cells whereas lOOOOpe resulted in a significant decrease (7*<0.001) in HAS1
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mRNA expression (fig.4.3.10A). At passage 2, a significant increase (/*<0.01) in 
HAS1 mRNA expression in strained cells relative to control cells was observed in the 
cells subjected to 4000pe and 6000pe (fig.4.3.10B & C). The effect of 6000pe on 
passage 3 cells HAS1 mRNA expression resulted in a significant increase (P<0.01) 
relative to the control cells. At 4000pe and lOOOOpe no changes in HAS1 expression 
were detected.
HAS2 mRNA expression At passage 1, cells subjected to 6000ps showed a 
significant increase (PO.OOl) in HAS2 mRNA expression (fig.4.11A). There was no 
significant difference between HAS2 mRNA expression in the cells subjected to 
4000pe and lOOOOpe relative to the control cells. At passage 2, no significant 
differences in HAS2 mRNA expression were observed in the strained cells relative to 
the control cells when the cells were subjected to 4000pe and 6000pe (fig.4.3.11B). 
At lOOOOpe, a significant decrease (J°<0.001) in HAS2 mRNA expression in the 
strained cells was apparent (fig.4.3.11B). At passage 3, no significant effects in 
HAS2 mRNA expression were observed when the cells were subjected to strain 
regardless of magnitude (fig.4.3.11C).
HAS3 mRNA expression At passage 1, no significant effects in HAS3 mRNA 
expression were observed in the cells subjected to 4000pe and lOOOOpe (fig.4.3.12A). 
At 6000pe a significant increase (PO.OOl) in HAS3 mRNA expression in the strained 
cells relative to the control cells HAS3 mRNA expression was detected (fig.4.3.12A). 
Passage 2 cells showed significant increases fP<0.001) in HAS3 mRNA expression in 
the cells subjected to 4000ps and 6000ps relative to the control cells (fig.4.3.12B). 
No significant difference in HAS3 mRNA expression was seen when the cells were 
subjected to lOOOOpe. The effect of 4000pe on HAS3 mRNA expression in passage 3 
cells was a significant increase fP<0.001) relative to the control cells (fig.4.3.12C). 
Straining the cells at 6000pe and lOOOOpe resulted in no significant differences in 
HAS3 mRNA expression relative to the control cells (fig.4.3.12B & C).
Patient OA6
HAS1 mRNA expression At passage 1, no significant differences in HAS1 mRNA 
expression in the strained cells relative to the control cells were seen at 4000ps and
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lOOOOpe (fig.4.3.13A). Cells at passage 2 showed a significant increase (.P<0.01) in 
HAS1 mRNA expression relative to control cells when subjected to 4000ps 
(fig.4.3.13B). The cells subjected to 6000 and lOOOOpe showed no significant 
differences in HAS1 mRNA expression relative to control cells. At passage 3, HAS1 
mRNA expression in strained cells was significantly increased (PO.Ol) relative to 
control cells at 6000pe (fig.4.3.13C). At 4000pe and lOOOOpe, no significant 
differences between HAS1 expression in the strained cells relative to the control cells 
was observed (fig.4.3.13C).
HAS2 mRNA expression At passage 1, no significant effects of strain on HAS2 
mRNA expression was observed when the cells were subjected to 4000pe or lOOOOpe 
relative to control cells (fig.4.3.14A). At passage 2, significant increases (PO.OOOl) 
in relative HAS2 mRNA expression were seen when the cells were strained at the 
4000pc, 6000ps and lOOOOpe (fig.4.3.14B). Strain resulted in a significant increase 
(P<0.0001) in HAS2 mRNA expression in the passage 3 cells subjected to 6000ps 
and lOOOOpe relative to the control cells (fig.4.3.13C). When 4000pe was applied to 
the cells no significant difference was observed in HAS2 mRNA expression between 
the strained and control cells (fig.4.3.13C).
4 3 3  Summary: Normal Patient Response to Mechanical Strain
4000pc 6000|i£ 10000ns
HAS HAS HAS HAS HAS HAS HAS HAS HAS
1 2 3 1 2 3 1 2 3
Passagel 4 4 — — — 4 — - —
Passage2 — — — — 4 — — 4 4
Passage3 — — 4 — — — 4
Table.43.1 Expression o f HAS mRNA in normal synovial cells.
When passage 1 cells were subjected to 4000ps HAS1 and HAS2 mRNA expression 
could be seen to significantly decrease (Z^O.Ol) relative to the control cells. At
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passage 3, the effect of 4000pe on HAS3 mRNA expression resulted in a significant 
increase in expression (PO.OOl) relative to the control cells.
Passage 1 cells showed a significant increase in HAS3 mRNA expression relative to 
control cells when 6000pe was applied. The effect of strain on passage 2 cells was a 
significant increase (P0.0001) in HAS2 mRNA expression in the strained cells 
relative to the control cells.
The cells at passage 2, when subjected to lOOOOpe showed a significant increase 
(PO.OOl) in HAS2 mRNA expression as a result of strain whereas a significant 
decrease (PO.OOl) was observed in HAS3 mRNA expression relative to control cells. 
The effect of strain on HAS3 mRNA expression in the passage 3 cells was a 
significant decrease (PO.OOl) in expression relative to control cells.
4.3.4 Summary: OA Patient Response to Mechanical Strain
4000p8 6000|i8 10000(18
HAS HAS HAS HAS HAS HAS HAS HAS HAS
1 2 3 1 2 3 1 2 3
Passagel — — — t 1 t t 1 — —
Passage2 t t t t t t
— t  1 —
Passage3 t t t t t
— t t —
Table 4.3.2 Expression of HAS mRNA in OA synovial cells.
Cells at passage 2 and passage 3 showed significant increases (PO.OOl) in HAS1, 
HAS2 and HAS3 mRNA expression in strained cells relative to control cells.
Passage 1 cells when subjected to 6000pe showed a significant increase (PO.OOl) in 
HAS1 mRNA expression relative to the control cells. The effect of strain on HAS2 
and HAS3 mRNA expression was a significant increase (PO.OOl) relative to the 
control cells, yet one patient showed a significant decrease in HAS2 mRNA 
expression. Passage 2 cells showed significant increases in HAS1, HAS2 and HAS3
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mRNA expression in cells that underwent strain relative to control cells. Passage 3 
cells showed a significant increase (P<0.001) in both HAS1 and HAS2 expression 
when they were subjected to strain relative to the control cells HAS1 and HAS2 
expression and there was no detectable change in HAS3 expression.
Passage 1 cells showed a significant decrease (P<0.001) in HAS1 mRNA expression 
relative to control cells when they were subjected to lOOOOpe whilst HAS2 and HAS3 
remained unchanged. The effect of strain on passage 2 cells was a significant 
increase in HAS2 mRNA expression in the strained cells relative to the control cells 
in one patient whereas another patient showed a significant decrease (PO.OOOl). 
Passage 3 cells, when strained, showed a significant increase (P<0.001) in HAS1 
mRNA expression whereas HAS2 mRNA expression showed both a significant 
increase and a significant decrease in two different patients relative to the control 
cells.
4.3.4 Changes in HAS mRNA Expression in OA Synovial Cells 
Relative to Normal Synovial Cells
HAS mRNA expression in unstrained normal and OA synovial cells
HAS1 mRNA expression in passage 1 OA cells showed significant decreases 
(P<0.05) relative to normal cell HAS1 mRNA expression (fig.4.3.15A & C). At 
passage 2 and passage 3, the OA cells showed significant increases (P<0.1) in their 
HAS1 mRNA expression relative to the normal control cells (fig.4.3.15B & D).
At passage 1, OA cells HAS2 expression was variable compared with normal samples 
(fig.4.3.16). Patient OA2 exhibited increased (PO.Ol) HAS2 expression 
(fig.4.3.16A) whereas Patients OA3, OA4 and OA6 had decreased (P<0.05) HAS2 
mRNA expression (fig.l6.3.16B, C & D). All OA samples at passage 2 and 3 
exhibited significantly higher (PO.OOl) HAS2 mRNA expression compared to 
controls (fig.4.3.15B, C & D).
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HAS3 mRNA expression in passage 1 OA cells was significantly lower (P<0.05) than 
the normal cells (fig.4.3.17). In passage 2 and 3 cells, HAS3 mRNA expression was 
not significantly different in the OA cells relative to the normal cells (fig.4.3.17).
HAS mRNA expression in normal and OA synovial cells at 4000|t8
Passage 2 cells showed significant increases (P<0.01) in HAS1 mRNA expression in 
the OA cells relative to the normal cells (fig.4.3.18B & C.). However, passage 1 and 
passage 3 cells showed no significant differences in HAS1 mRNA expression when 
the cells were subjected to strain.
A significant decrease (P<0.1) in HAS2 mRNA expression in OA cells relative to 
normal cells was apparent in passage 1 cells (fig.4.3.19B). Passage 2 OA cells 
showed a significant decrease ( /><0.01) in HAS2 mRNA expression relative to the 
normal cells in one patient yet a significant increase (P<0.01) could be seen in 
another patient (fig.4.3.19B & C). All three OA patients at passage 3 showed 
significant increases (P<0.001) in HAS2 expression relative to normal cells 
(fig.4.3.19).
HAS3 mRNA expression in OA cells was not significantly different to the normal 
cells HAS3 mRNA expression in passage 1, 2 or 3 cells when they were subjected to 
the three magnitudes of strain (fig.4.3.20).
HAS mRNA expression in normal and OA synovial cells at 6000pc
In passage 1 OA cells there was a significant increase in HAS1 mRNA expression 
relative to the normal cells HAS1 mRNA expression (fig.4.3.21D.). In passage 2 OA 
cells, no differences in HAS1 mRNA expression were observed relative to the normal 
cells (fig.4.3.21). At passage 3, the cells showed a significant increase (R<0.01) in 
HAS1 mRNA expression relative to the normal cells (fig.4.3.21D).
HAS2 mRNA expression in passage 1 OA cells showed significant increases 
(R<0.001) in two of the patients relative to the normal cells (fig.4.3.22A & C). 
Significant decreases (P<0.0001) in HAS2 mRNA expression were seen in OA 
passage 2 strained cells relative to the normal strained cells whereas significant 
increases (/><0.0001) were observed in passage 3 OA cells (fig.4.3.22B, C & D).
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A significant increase (P<0.05) in HAS3 mRNA expression in strained OA cells 
relative to strained normal cells was observed in passage 1 and passage 3 cells 
whereas significant decrease (P<0.01) in HAS3 mRNA expression could be seen in 
the passage 2 OA cells relative to the normal cells (fig.4.3.23).
HAS mRNA expression in normal and OA synovial cells at lOOOOpe
HAS1 mRNA expression in passage 1 and passage 3 OA cells decreased significantly 
(P<0.0001) relative to normal strained cells in all patients sampled (fig.4.3.24.). At 
passage 2, OA cells showed no significant differences in HAS1 mRNA expression 
relative to normal cells (fig.4.3.24).
There was no differences in HAS2 mRNA expression in strained OA cells relative to 
strained normal cells at passage 1 (fig.4.3.25). At passage 2 and passage 3, HAS2 
mRNA expression in OA cells was significantly increased (/><0.01) relative to 
normal cells HAS2 mRNA expression (fig.4.3.25B & C).
The effect of strain on passage 1 OA cells was a significant decrease (/^<0.05) in 
HAS3 mRNA expression relative to normal cells at passage 1 (fig.4.3.26). In passage 
2 cells, OA cells showed significantly increased (^<0.01) HAS3 mRNA expression in 
the strained cells relative to the normal cells (fig.4.3.26). HAS3 mRNA expression 
was no different in the OA strained cells relative to the normal strained cells.
Summary
In summary, the majority of OA synovial cells subjected to the 3 magnitudes of strain 
showed an increase in HAS1, HAS2 and HAS3 mRNA expression. It was lOOOOpe 
which produced the most variable results in HAS mRNA expression between passage 
number and magnitude of strain. In normal synovial cells, mechanical strain both 
induced and decreased HAS mRNA expression at 4000pe and lOOOOpe while 
increases in HAS mRNA expression were observed at 6000pe. The expression of 
HAS mRNA was different between OA and normal synovial cells at each of the 3 
strains with observed changes in expression of HAS1, HAS2 and HAS3 mRNA 
occurring more frequently in the OA synovial cells compared to the normal synovial 
cells.
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Figure 43.1 Changes in HAS mRNA expression from a represented 
passage 3 synovial fibroblast cell culture. Cells were subjected to 10 nr 
and RT-PCR performed 24 hours post-strain as described in materials and 
HAS 1 and HAS2 mRNA is expressed in strained and control cells at 4 
and lOOOOpe. HAS3 mRNA was not expressed in the strained or 
4000pe, 6000pe and lOOOOpe.
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Figure 43.2 Changes in HAS mRNA expression from a representative passage 3 OA 
synovial fibroblast cell culture. Cells were subjected to 10 minutes of strain and RT- 
PCR performed 24 hours post-strain as described in materials and methods. HASl 
and HAS2 mRNA is expressed in strained and control cells at 4000pe, 6000pe and 
lOOOOpe. Control and strained cells were positive for HAS3 mRNA at 4000pe and 
6000pe whereas control and strained cells at lOOOOpe were negative for HAS3 
expression. Typical results from one of the patients sampled.
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Figure 4.3.3 HAS1 mRNA expression in normal synovial cells from Patient 
RNA was purified from cells that had been subjected to mechanical strain * 
minutes and from control cells, 24 hours post-treatment. Strained cell HAS1 
expression has been normalised to control cell HAS 1 mRNA expression as 
in materials and methods. A) passage 1 cells; B) passage 2 cells; C) passage 3 
*P<0.01 relative to control cells.
control 
4000(j.e 
6000fis 
10000^8
Relative HAS1 mRNA expression Relative HAS1 mRNA expression Relative HAS1 mRNA expression
N1 
P1
Figure 4.3.4 HAS2 mRNA expression in normal synovial cells from Pati 
RNA was purified from cells that had been subjected to mechanical strain 
minutes and from control cells, 24 hours post-treatment. Strained cell HAS2 
expression has been normalised to control cell HAS2 mRNA expression as d 
in materials and methods. A) passage 1 cells; B) passage 2 cells; C) passage 3 
*P<0.001 relative to control cells. **P<0.0001 relative to control cells.
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Figure 4.3.5 HAS3 mRNA expression in normal synovial cells from 
RNA was purified from cells that had been subjected to mechanical strain 
minutes and from control cells, 24 hours post-treatment. Strained cell HAS3 
expression has been normalised to control cell HAS3 mRNA expression as 
in materials and methods. A) passage 1 cells; B) passage 2 cells; C) passage 
*P<0.01 relative to control cells. **P<0.001 relative to control cells.
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Figure 4.3.6 A) HAS2 m RN A  expression and B) HAS3 expression in normal 
1 synovial cells from Patient N2. RN A  was purified from cells that had 
subjected to mechanical strain  for 10 m inutes and from control cells, 24 hours 
treatment. Strained cell HAS mRNA expression has been normalised to cotf 
HAS mRNA expression as described in materials and methods.
137
Relative HAS3 mRNA expression Relative HAS2 mRNA expression
zN>
TJ
N2 
P1
Figure 4.3.7 A) HAS1 mRNA expression in passage 1 in OA synovial cells from 
Patient OA2; B) HAS1 expression in passage 3 cells from Patient OA2; C) HA# 
expression in passage 1 cells from OA2. RNA was purified from cells that had been 
subjected to mechanical strain for 10 minutes and from control cells, 24 hours po& 
treatment. Strained cell HAS mRNA expression has been normalised to control cel 
HAS mRNA expression as described in materials and methods. *P<0.001 relative to 
control cells.
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Figure 4.3.8 HAS1 mRNA expression in OA synovial cells from Patient OA3. RNA 
was purified from cells that had been subjected to mechanical strain for 10 minutes 
and from control cells, 24 hours post-treatment. Strained cell HAS1 mRNA 
expression has been normalised to control cell HAS 1 mRNA expression as described 
in materials and methods. A) passage 1 cells; B) passage 2 cells; C) passage 3 cells. 
VO.OOl relative to control cells.
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Figure 4.3.9 HAS2 mRNA expression in OA synovial cells from Patient 0 
was purified from cells that had been subjected to mechanical strain for 10 
and from control cells, 24 hours post-treatment. Strained cell HAS2 
expression has been normalised to control cell HAS2 mRNA expression as 
in materials and methods. A) passage 2 cells; B) passage 3 cells. */><0.01 
control cells.
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Figure 4.3.10 HAS1 mRNA expression in OA synovial cells from Patient 
RNA was purified from cells that had been subjected to mechanical strain 
minutes and from control cells, 24 hours post-treatment. Strained cell HAS1 
expression has been normalised to control cell HAS 1 mRNA expression as d 
in materials and methods. A) passage 1 cells; B) passage 2 cells; C) passage 3 
*P<0.01 relative to control cells. **P<0.001 relative to control cells.
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Figure 4.3.11 HAS2 mRNA expression in OA synovial cells from Patient 0A4. 
RNA was purified from cells that had been subjected to mechanical strain for 10 
minutes and from control cells, 24 hours post-treatment. Strained cell HAS2 mRNA 
expression has been normalised to control cell HAS2 mRNA expression as described 
in materials and methods. A) passage 1 cells; B) passage 2 cells; C) passage 3 cells. 
*/><0.001 relative to control cells. **P<0.0001 relative to control cells.
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Figure 4.3.12 HAS3 mRNA expression in OA synovial cells from Patient 0A4. 
RNA was purified from cells that had been subjected to mechanical strain for 10 
minutes and from control cells, 24 hours post-treatment. Strained cell HAS3 mRNA 
expression has been normalised to control cell HAS3 mRNA expression as described 
in materials and methods. A) passage 1 cells; B) passage 2 cells; C) passage 3 cells. 
*P<0.001 relative to control cells. **/><0.0001 relative to control cell.
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Figure 4.3.13 HAS1 mRNA expression in OA synovial cells from Patient 0A£, 
RNA was purified from cells that had been subjected to mechanical strain for IQ 
minutes or from control cells, 24 hours post-treatment. Strained cell HAS1 mRNA 
expression has been normalised to control cell HAS 1 mRNA expression as desofted 
in materials and methods. A) passage 1 cells; B) passage 2 cells; C) passage 3 cells. 
*P<0.01 relative to control cells. **P<0.0001 relative to control cell.
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Figure 4.3.14 HAS2 mRNA expression in OA synovial cells from Patient 0A6. 
RNA was purified from cells that had been subjected to mechanical strain for 10 
minutes and from control cells, 24 hours post-treatment. Strained cell HAS2 mRNA 
expression has been normalised to control cell HAS2 mRNA expression as described 
in materials and methods. A) passage 1 cells; B) passage 2 cells; C) passage 3 cells. 
VO.OOOl relative to control cells.
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wFigure 4.3.15 HAS1 mRNA expression from A) Patient OA2; B) Patient 0A3;C) 
Patient OA4; D) Patient OA6. RNA was purified from control cells 24 hours post­
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Figure 4.3.16 HAS2 mRNA expression from A) Patient OA2; B) Patient 0 
Patient OA4; D) Patient OA6. RNA was purified from control cells 24 hours 
treatment. OA control cell HAS2 mRNA expression was normalised to 
control cell HAS2 mRNA expression as described in materials and methods. *. 
relative to normal strained cells; **/*<0.01 relative to normal strained 
***7^0.001 relative to normal strained cells.
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Figure 4.3.18 HAS1 mRNA expression from A) Patient OA3; B) Patient OA4; C) 
Patient OA6. RNA was purified from cells subjected to 4000pe for 10 minutes, 24 
hours post treatment. OA and strained cell HAS1 mRNA expression was normalised 
to normal strained cell HAS1 mRNA expression as described in materials and 
methods section. */*<0.01 relative to normal strained cells.
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Figure 4.3.19 HAS2 mRNA expression from A) Patient OA3; B) Patient 0A4; jj[ 
Patient OA6. RNA was purified from cells subjected to 4000pe for 10 minutes, jj 
hours post treatment. OA strained cell HAS2 mRNA expression was normalised| 
normal strained cell HAS2 mRNA expression as described in materials and method 
*/*<0.1 relative to normal strained cells. **7*<0.01 relative to normal strained cdfc 
***7^0.001 relative to normal strained cells.
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cells subjected to 4000pe for 10 minutes 24 hours post-treatment. OA strained cell 
HAS3 mRNA expression was normalised to normal strained cell HAS3 mRNA 
expression as described in materials and methods section.
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Figure 4.3.21 HAS1 mRNA expression from A) Patient OA2; B) Patient OA3; C) 
Patient OA4; D) Patient OA6. RNA was purified from cells subjected to 6000pe for 
10 minutes 24 hours post-treatment. OA strained cell HAS1 mRNA expression was 
normalised to normal strained cell HAS 1 mRNA expression as described in materials 
and methods. */*<0.1 relative to normal strained cells. **/*<0.01 relative to normal 
strained cells.
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Figure 4.3.22 HAS2 mRNA expression from A) Patient OA2; B) Patient OA3; C) 
Patient OA4; D) Patient OA6. RNA was purified from cells subjected to 6000pe for 
10 minutes 24 hours post-treatment. OA strained cell HAS2 mRNA expression was 
normalised to normal strained cell HAS2 mRNA expression as described in materials 
and methods section. */*<0.01 relative to normal strained cells. **7^0.001 relative to 
normal strained cells. ***7^0.0001 relative to normal strained cells.
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Figure 4.3.23 HAS3 mRNA expression from Patient OA4. RNA was purified fin 
cells subjected to 6000pe for 10 minutes 24 hours post-treatment. OA strained o | 
HAS3 mRNA expression was normalised to normal strained cell HAS3 mRNA 
expression as described in materials and methods. */*<0.1 relative to normal strained 
cells. **/*<0.01 relative to normal strained cells.
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Figure 4.3.24 HAS1 mRNA expression from A) Patient OA3; B) Patient OA4; C) 
Patient OA6. RNA was purified from cells subjected to lOOOOpE for 10 minutes 24 
hours post-treatment. OA strained cell HAS1 mRNA expression was normalised to 
normal strained cell HAS1 mRNA expression as described in materials and methods. 
*/J<0.001 relative to normal strained cells. **/*<0.0001 relative to normal strained 
cells.
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Figure 4.3.25 HAS2 mRNA expression from A) Patient OA3; B) Patient OA4; C) 
Patient OA6. RNA was purified from cells subjected to lOOOOpe for 10 minutes 24 
hours post-treatment. OA strained cell HAS2 mRNA expression was normalised to 
normal strained cell HAS2 mRNA expression as described in materials and methods. 
*/*<0.01 relative to normal strained cells.
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cells subjected to 1 OOOOpe for 10 minutes 24 hours post-treatment. OA strained cell 
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expression as described in materials and methods. */*<0.05 relative to normal strained 
cells. **/^0.01 relative to normal strained cells.
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4.4 Discussion
Results from this work show that synovial cells cultured from normal and OA 
synovium differentially express 3 HAS genes in vitro. Previous work has shown the 
regulation of the HAS genes to be controlled by physiological stimuli including 
cytokines and growth factors (Jacobson et al., 2000; Recklies et al., 2001). Data from 
this current study demonstrate that mechanical stimuli can also regulate HAS 
expression in synovial cells derived from normal and OA donors. The importance of 
HA and mechanical stimuli during joint development has been detailed. The removal 
of mechanical stimuli during joint development prevents the separation of the 
cartilage anlagen and this is linked to alterations in HA synthesis (Drachmann and 
Sokoloff, 1966; Edwards et al., 1994; Fell and Canti, 1934; Osborne et al., 2002; 
Pitsillides, 1999; Pitsillides et al., 1995). Indeed, mechanical strain applied to 
fibrocartilage cells from the developing joint resulted in induction of HA S3 gene 
expression (Dowthwaite et al., 1999). Thus, the regulation of HAS and subsequent 
HA synthesis by mechanical stimuli is a necessary component of joint development 
and also necessary for continued HAS gene regulation and HA synthesis to maintain 
frictionless movement within the adult joint.
There are 3 HAS genes responsible for the generation of 3 HAS enzymes capable of 
synthesising HA molecules at different rates and of different sizes (Itano et al., 1999; 
Spicer and McDonald, 1998). From this current work it can be seen that all 3 HAS 
genes show differential expression when synovial cells were subjected to mechanical 
stimuli. If the same were to occur in vivo, then this would provide the cell with some 
control over its biological functions. The HA molecules provide different functional 
roles within the cell and surrounding environment depending on size (Rooney et al., 
1995; West and Kumar, 1989). For example, within the synovial joint, the larger HA 
molecules are able to prevent synovial fluid loss from the synovial cavity more so 
than the smaller HA molecules (Coleman et al., 1999).
The response to the three magnitudes of strain (4000pe, 6000pe and lOOOOpe) was 
different between the normal and OA cells. 4000pe is the physiological strain applied
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to cells in vivo based on measurements from bone surfaces during normal activity and 
in vitro 4000pe resulted in an increase in all three of the HAS genes in the OA 
synovial cell cultures (Lanyon, 1996). Conversely, a decrease in HAS1 and HAS2 
mRNA expression was seen in normal cells. Although the normal synovial cell 
cultures showed an increase in HAS2 and HAS3 mRNA expression at 6000pe this did 
not occur at each passage. The OA synovial cell cultures however, showed increases 
in all three HAS mRNA expression relative to the control cells at each passage when 
subjected to 6000pe. Application of lOOOOps to the normal synovial cell cultures 
resulted in alterations in HAS2 and HAS 3 mRNA expression whereas HAS1 and 
HAS2 expression could be seen to alter in the OA synovial cells. Thus, the normal 
cells showed fewer alterations in HAS gene expression in response to strain compared 
to the OA cells. Whether this is because the normal synovial cells are able to 
synthesise the necessary amounts of HA without mechanical stimuli cannot be 
confirmed from this study. It has been shown that feedback mechanisms are involved 
in HA synthesis, so, if there is an adequate concentration of HA being synthesised, 
further synthesis could be switched off via a reduction in HAS mRNA expression 
(Philipson and Schwartz, 1984; Philipson et al., 1985; Stem, 2003).
HA concentrations decrease within the synovial fluid of OA patients and this could be 
attributed to the loss of response to mechanical stimuli by the cells due to the disease. 
These results however, demonstrate that OA synovial cells constitutively express the 
three HAS genes and differential expression occurs as a result of mechanical stimuli. 
The observed increase in mRNA expression of the 3 HAS genes in response to 4000p£ 
and 6000ps suggests the cell needs to increase it’s HA synthesis and also needs to 
synthesise the 3 differently sized HA molecules. The synthesis of the larger HA 
chains in the synovial joint as a result of HAS1 and HAS2 synthesis, would allow 
buffering outflow preventing the synovial fluid decreasing in volume and viscosity as 
a result of joint flexion. The larger HA molecules interact forming a network above 
the synovium controlling interstitial fluid flow into and out of the synovial cavity 
(Coleman et al., 1999). The role of the smaller HA molecule, synthesised by HAS3 in 
vitro, is less clear. High levels of this smaller HA molecule can be seen in the 
synovial fluid and plasma of OA patients (Miyaguchi et al., 2001). The smaller HA 
molecule is able to buffer synovial outflow but to a lesser extent than the larger HA 
molecules (Coleman et al., 2000). The role of this smaller HA molecule could be in
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cell signalling as a variety of genes have been shown to be expressed in response to 
lower molecular mass HA allowing the regulation of biological properties within the 
cell (Oertli et al., 1998; Slevin et al., 1998). The low molecular weight HA chains 
might also stimulate macrophage responses during inflammatory situations (McKee et 
al., 1996; Termeer et al., 2000). Thus, the expression of HAS3 mRNA upon the 
application of mechanical strain could be to generate HA molecules of smaller 
molecular weights that could be involved in the inflammatory process. The 
generation of this smaller HA might, in contrast, simply act to increase the levels of 
HA within the synovial fluid in a shorter time sequence.
Response at lOOOOps in HAS expression resulted in an increase in HAS1 and HAS2 
mRNA expression in the OA synovial cultures. The requirement to synthesise HA 
molecules with a high molecular weight could be a reflection of the exceedingly high 
load applied to the cells. A greater viscosity in synovial fluid would be required 
compared to the lower magnitudes of strain and greater fluid outflow buffering would 
also be needed.
The effect of passage number on the synovial cell cultures needs to be taken into 
consideration when assessing the results. As this study and others have shown there 
is a difference between low and high passage cell cultures (Clarris and Fraser, 1968; 
Marsh et al., 1978; Zimmerman et al., 2001). Here, it can be seen that normal 
synovial cell cultures each showed a different response to the three magnitudes of 
strain depending on the passage number. A significant difference between control 
and strained cell HAS mRNA expression was not observed in the three genes 
simultaneously at any passage. In contrast, the OA synovial cell cultures’ HAS 
mRNA response at each passage at the low magnitudes of strain was an increase in 
each of the 3 HAS genes. At lOOOOpe the response at each passage was different.
Although it must be taken into consideration that changes in mRNA expression do not 
always correspond to protein synthesis and subsequent HA synthesis, the observations 
obtained from this study suggest that mechanical stimuli do influence the regulation 
of the three HAS genes allowing the cell to synthesise the required size of HA 
molecule, with the response dependent on disease state and passage number.
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Chapter 5
Effects of Mechanical Strain on 
Cytokine Synthesis by Synovial Cells
5.1 Introduction
The cytokine family compromises a diverse group of soluble proteins and peptides 
that modulate the functional activities of individual cells and tissues and are involved 
in inflammatory processes (Firestein, 2003; Fortunato and Menon, 2003; Grooten et 
al., 1993; Kaden et al., 2003; Kawano et al., 1988; Tsuyama et al., 2003; Warner et 
al., 1987). Almost all cytokines detected are pleiotropic effectors showing multiple 
biological activities depending on the cell signalling pathway stimulated by the 
cytokine. The circumstance of the cell -  its growth state, type of neighbouring cells, 
cytokine concentration and presence of other cytokines will influence the effect of a 
single cytokine thus allowing the transmission of diverse signals to different subsets 
of cells. Response to cytokine stimulation is rapid. Once the cytokine has bound to 
its receptor, the receptor undergoes oligomerisation. Kinases are activated, 
phosphorylating cytoplasmic transcription factors which are able to translocate to the 
nucleus where they bind to unique DNA sequences in the promoter regions of 
cytokine responsive genes. The translation of these genes leads to protein synthesis 
and an appropriate response. Once released, the cytokine concentrations are controlled 
through soluble receptors and specific or unspecific binding proteins. Further release 
is controlled by positive and negative feedback mechanisms or by other cytokines 
(Feldmann et al., 1996b; Nishimoto et al., 2000; Silacci et al., 1998).
Regulation of matrix synthesis and degradation is an integral requirement for 
maintenance of a healthy joint. During RA and OA however, impaired matrix 
turnover occurs involving an imbalance between synthesis of pro-inflammatory and 
anti-inflammatory cytokines (Feldmann et al., 1996a; Firestein, 2003). The synovium 
contributes to disease progression releasing pro-inflammatory cytokines yet also 
attempting to restore the damaged matrix with the release of anti-inflammatory 
cytokines. The cytokine network in OA and RA has been extensively studied at both 
the mRNA and protein level in an attempt to understand the complex interactions 
occurring during disease progression and to develop treatments that block pro- 
inflammatory processes (Feldmann et al., 1996a; Moreland, 1999).
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Tumour necrosis factor alpha (TNFa) and interleukin-1 (IL-1) have been considered 
the main pro-inflammatory cytokines involved in arthritis (Firestein, 2003; Firestein et 
al., 1992; Fukui et al., 2001; Hedbom and Hauselmann, 2002). Both of these 
cytokines are synthesised and secreted by synovial cells and chondrocytes and have 
been shown to inhibit or induce their own synthesis and are controlled by complex 
feedback mechanisms depending on cell type (Alsalameh et al., 1999). Enhanced 
synthesis of both TNFa and IL-1 have been observed in RA and OA synovium and 
cartilage, inducing pro-inflammatory processes such as proteinase synthesis, 
inhibition of new matrix synthesis and increasing matrix catabolism (Goldring et al., 
1988; Goldring et al., 1990; Hauptmann et al., 1991; Hollander et aL, 1994; 
Hutchinson et al., 1992; Ismaiel et al., 1992; Miyasaka et al., 1988; Westacott et al., 
1990; Yoshida et al., 1992). Intact and degraded matrix molecules within the synovial 
fluid also contribute to proteinase synthesis and cytokine release, as well as 
synoviocyte activation, potentiating disease progression (Biswas and Dayer, 1979; 
Chu et al., 1991; Deleuran et al., 1994; Gurr et al., 1990; Saito et al., 2002; Wurster 
and Lust, 1984). In response to these catabolic signals, the joints response is an 
attempt to diminish disease activity. Increased levels of soluble cytokine receptors 
such as p55 tumor necrosis factor-receptor (TNF-R), p75 TNF-R and soluble 
interleukin-1-receptor (sIL-lR) are present in the synovial fluid of RA and OA 
patients and within the chondrocytes themselves (Butler et al., 1994; Firestein et al., 
1992; Malyak et al., 1993; Martel-Pelletier et al., 1992; Pelletier and Martel-Pelletier, 
2002; Roux-Lombard and Steiner, 1992; Smith et al., 1997; Symons et al., 1991). The 
TNF-Rs are able to bind to TNFa and inactivate TNFa whereas sIL-l-R prevents 
processing of the IL-1 protein so acting as inhibitors (Symons et al., 1995). Although 
these inhibitors can be detected at elevated concentrations, (in the case of TNF-R four 
fold), this is not enough to inactivate the enhanced levels of TNFa and IL-1 
synthesised during disease (Brennan et al., 1989; Cope et al., 1992; Roux-Lombard et 
al, 1993).
The cytokine interleukin-6  (IL-6 ) is involved in the inflammatory process in RA and 
OA and is synthesised by the both synovial cells and chondrocytes (Gueme et al., 
1989; Rosenbaum et al., 1992). The physiological stimuli for IL-6 includes both IL-1 
and TNFa and as with both of these pro-inflammatory cytokines, IL-6 concentration is 
elevated in the synovial fluid of patients with RA and OA and in media from synovial
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cell cultures from inflamed tissues (Bucala et al., 1991; Hirano et al., 1988; Mihara et 
aL, 1995; Nishimoto et al., 2000; Okamoto et al., 1997; Ritchlin, 2000). Stimulation 
of synovial fibroblasts with IL-6  does not induce collagenase or prostaglandin E2 
(PGE2) synthesis, suggesting an anti-inflammatory or mediating role (Hauptmann et 
al., 1991; Lotz and Gueme, 1991). IL-6  has a glycosylated membrane protein receptor 
as well as soluble receptor that act as physiological regulators of IL-6  activity (Mihara 
et al., 1995; Nishimoto et al., 2000). The concentration of the soluble IL-6  receptor 
(sIL-6R) has been shown to be elevated 2.5 fold in the synovial fluid of inflamed 
joints and in combination with IL-6 , the soluble receptor is capable of increasing 
TIMP expression 3 fold. Since tissue inhibitors of metalloproteases (TIMP) are 
responsible for blocking MMP activity, this adds credence to the role of IL-6 in 
mediating anti-inflammatory responses (Silacci et al., 1998).
Synovial cells are one of the many cell types that synthesise the chemokine 
interleukin-8 (IL-8) and both OA and RA tissues exhibit increased synthesis of this 
chemokine (Brennan et al., 1990; Koch et al., 1991; Koch et al., 1992b; Loetscher et 
al., 1994; Rampart et al., 1992; Seitz et al., 1991). IL-8 is a low molecular weight 
pro-inflammatory chemokine frequently found at high concentrations in diseases 
associated with neutrophil influx such as cystic fibrosis, gastroduodenal disease, 
psoriasis and respiratory disease (Alaaeddine et al., 1999; Brennan et al., 1990; 
Crabtree and Lindley, 1994; Dean et al., 1993; Kulke et al., 1996; Mahida et al., 1992; 
Oppenheim et al., 1991). As IL-8  is a potent chemoattractant for neutrophils, it plays 
a role in inducing neutrophil activation and recruitment involving the regulation of 
adhesion molecules on the neutrophil cell surface (Koch et al., 1992a; Nanki et al., 
2001). In OA and RA, IL-8 has been shown to enhance inflammatory cell migration 
and is often found at very high concentrations within the cells of the cartilage-pannus 
junction (Deleuran et al., 1994). The pro-inflammatory cytokines TNFa and IL-1 
have both been shown to induce mRNA expression and subsequent protein synthesis 
of IL-8 , which during RA and OA could be associated with the increase in 
inflammatory cells seen in the synovial membrane (Bedard and Golds, 1993; Koch et 
al., 1991; Rathanaswami et al., 1993; Tobe et al., 2002; Wang et al., 1997).
The therapeutic effects of physiotherapy as a treatment for OA has already been 
discussed in terms of HA synthesis and the beneficial effects this has on joint function
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(Chapter 3). Nevertheless, it is clear that during OA and RA, the equilibrium that 
exists between the cytokines and their inhibitors is disrupted and this needs to be 
taken into consideration if mechanical strain is to be used as a treatment for OA.
The effects of mechanical strain on chondrocytes has been more widely studied than 
the effects of strain on synovial fibroblasts, the results of these studies however, are 
contradictory. Mechanical strain has been shown to reduce IL-1 and TNFa induced 
expression of pro-inflammatory mediators in vitro, down-regulate nitric oxide 
expression and synthesis and increase proteoglycan and collagen synthesis 
augmenting the reparative process of the cartilage matrix (Deschner et al., 2003; Long 
et al., 2001) (Gassner et al., 2000; Xu et al., 2000). The induction of interleukin-4 
synthesis is also observed leading to anti-inflammatory signals (Lee et al., 2000). 
Conversly, mechanical strain has also been shown to increase mRNA expression of 
the pro-inflammatory cytokines and matrix metalloproteinases (MMP) (Deschner et 
al., 2003; Honda et al., 2000). It must be bom in mind that these pro-inflammatory 
responses were detected when chondrocytes were subjected to high levels of cyclic 
strain.
The effect of mechanical strain on RA synovial cells resulted in a reduction of mRNA 
expression, protein synthesis and activity of MMP-1 and MMP-13 even when the 
cells had been subjected to IL-1 and TNFa stimulation (Sun and Yokota, 2001a; Sun 
and Yokota, 2001b). The anti-inflammatory effect of strain is further supported by 
data showing that TIMP-1 and TIMP-2 are up regulated after synovial cells have been 
subjected to strain (Sun et al., 2003). An exercise based study also showed the 
beneficial effects of strain, with observed reductions in IL-1 concentration in the 
synovial fluid (Messier et al., 2000). IL-8  synthesis has been shown to increase in 
bronchial epithelial cells that were subjected to mechanical stimuli and if the same 
were to occur in synovial cells then this would facilitate disease progression (Oudin 
and Pugin, 2002).
The aim of this work was to determine the effects of mechanical strain on IL-1, IL-6 , 
IL-8 and TNFa synthesis from synovial cells derived from the synovium of normal 
and OA donors.
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5.2 Materials and Methods
5.2.1 Synovium Sam ples
Synovium samples were obtained as in Chapter 2 (2.2.1). Details of the samples are 
listed below.
Sam ple Type Sex Age (years)
OA3 OA Female 74
OA4 OA Female 79
OA6 OA Male 79
N1 normal Female 67
Table 5.2.1 Details of synovium sam ples obtained a t knee jo in t replacem ent surgery.
5.2.2 Cell Isolation & Culture
Cells were isolated from the synovium as described in Chapter 2 (2.2.2). Briefly, 
diced tissue was digested in 295IU mg ml'1 type I collagenase (Sigma, Poole, UK) for 
3 hours at 37°C. Cells were centrifuged at 1000 x g for 5 minutes, resuspended and 
centrifuged at 1000 x g for 5 minutes. Cells were counted and seeded as required in 
DMEM/F12 containing 1% penicillin-streptomycin (104IU ml'Vl04pg ml'1; Sigma), 
L-glutamine (200mM; Life Technologies, Paisley, UK), hydrocortisone (4mg ml'1; 
Sigma)[40mg hydrocortisone powder dissolved in 5ml 100% ethanol and 5ml sterile 
PBS], insulin-transferrin-selenium (200mM; Life Technologies) and 20% foetal calf 
serum (FCS) (Sigma) and incubated at 37°C.
5.2.3 Mechanical Strain
The cells were subjected to mechanical strain as described in Chapter 3 (3.2.3). 
Briefly, cells were serum deprived for 18 hours and fresh serum free media was 
added. The cells were strained at 4000ps, 6000ps and lOOOOps for 10 minutes using 
a four-point bending loading jig. Control cells remained static for 10 minutes and 
flow control cells remained static but were subjected to media perturbation for 10 
minutes.
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5.2.4 Cytokine ELISA
Samples of media collected from the strain and control plates at 24 hours were 
assayed for interleukin-1 (IL-1), interleukin-6  (IL-6 ), interleukin-8 (IL-8) and tumour 
necrosis factor-a (TNFa) concentration using an ELISA plate-based assay developed 
by Biosource Int. Inc. (Ca, USA).
Plates were coated with lOOpl per well o f lOpl coating antibody (IL-1, IL-6 , IL-8 or 
TNFa) diluted in 10.5ml phosphate buffered saline (PBS, Sigma, Poole, UK). These 
were incubated overnight at 4°C. The coating was removed and plates washed in PBS 
then blocked with 300pl 1% bovine serum albumin (BSA; Sigma) in PBS. The plates 
were incubated for 2 hours at room temperature and then washed in PBS-Tween 
(PBS-T) three times. One hundred pi o f sample or standard was added. A standard 
series ranging from 15 to lOOOpg ml"1 was run on each plate in triplicate. Samples 
and standards were diluted in DMEM/F12 when necessary and duplicate samples 
were assayed. Fifty pi biotin-detection antibody diluted 1:1375 in PBS was added to 
the plates and incubated for 2 hours at room temperature. The plates were washed 
thoroughly in PBS-T and lOOpl strepavidin-HRP conjugate (Biosource Int Inc, CA, 
USA) added at a dilution of 1:1000. This was incubated for 30 minutes at RT. Plates 
were washed in PBS-T and lOOpl developing buffer added. The developing buffer 
consisted of 10ml citrate buffer (Sigma), lOpl hydrogen peroxide (Sigma), and lOOpl 
tetramethyl benzidine (TMB; Sigma) and was prepared immediately before use. 
Plates were gently shaken for 20-30 minutes and once colour had developed the 
reaction was quenched with 50pl H2SO4 (12.5%). The absorbencies were read at 
405nm.
Statistical Analysis
All statistical analysis for changes in cytokine concentrations between normal and OA 
patients and control and strained cells were analysed using one-way analysis of 
variance (ANOVA) with Tukey post-hoc tests. This statistical test was applied in 
order to compare more than 2 sets o f data.
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Sample Number
As a result of low cell number, cells from some patients could not be subjected to the 
three magnitudes of strain at each passage. Media was retained for HA analysis and 
this also reduced the sample number available for cytokine analysis.
%
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5.3 Results
5.3.1 Patient Variability 
Variability with passage
Media IL-6 and IL-8 concentrations from the three passages of the normal synovial 
cells showed significant differences (PcO.05) and as a result, the data from each 
passage could not be combined for statistical analysis (fig.5.3.1). Media cytokine 
concentrations from the three passages of OA synovial cells showed no significant 
differences, except for IL-8 concentrations, so the data from each passage could be 
combined for statistical analysis (fig.5.3.2).
Cross patient variability
Media cytokine concentrations from the separate patients showed significant 
differences (P<0.05) so the data from separate patients could not be combined for 
statistical analysis (fig.5.3.3).
5.3.2 Normal Patient Response to Strain 
TNFa
No significant differences between the cells subjected to the three magnitudes of 
strain and the control cells were observed in media TNFa concentrations (fig.5.3.4A).
Interleukin-1
No significant differences in media IL-1 concentrations in the media from cells 
subjected to the three magnitudes of strain compared to the control cells were seen 
(fig.5.3.4B).
Interleukin-6
The cells subjected to 4000|xe and 6000pe at passage 1 ,2  and 3 showed no significant 
differences in their media IL-6 concentrations compared to the control cells 
(fig.5.3.5). When cells were subjected to lOOOOps, a significant increase (P<0.05) in
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media IL-6  concentration was observed in the passage 1 cells (fig.5.3.5A) but no 
significant differences were observed in the passage 2 and passage 3 cells (fig.5.3.5B 
&C).
Interleukin-8
Cells at passage 1, 2 and 3 showed no significant differences in media IL-8 
concentration compared with the control cells when they were subjected to 4000jii8 
and 6000pe (fig.5.3.6). The passage 1 cells, when subjected to lOOOOpe showed a 
significant increase (P<0.05) in media IL-8  concentration (fig.5.3.6A). Passage 2 and 
3 cells showed no significant differences in media IL-8  concentration when subjected 
to lOOOOpe.
Summary: Cytokine Media Concentrations from Normal Synovial Cells
Passage 4000pe 6000ps lOOOOpe
P1 IL-6 increase IL-8 increase
P2
P3
Table 5.3.1 Changes in cytokine media concentration from normal cells.
5.3.3 OA Patient Response to Strain 
TNFa
The passage 3 cells showed no significant differences in media TNFa concentration 
compared to the control cells, when subjected to the three magnitudes of strain 
(fig.5.3.7A).
Interleukin-1
The passage 3 cells showed no significant differences in media IL-1 concentrations 
compared to the control cells, when subjected to the three magnitudes of strain 
(fig.5.3.7B).
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Interleukin-6
Passage 3 cells from three different patients, when subjected to the three magnitudes 
of strain, showed no significant differences in media IL-6 concentrations compared to 
the control cells (fig.5.3.8).
Interleukin-8
Passage 1 cells showed a significant increase (P<0.05) in media IL-8 concentration 
when subjected to lOOOOpe whereas subjecting the cells to 4000ps and 6000pe 
resulted in no significant differences in media IL-8 concentrations compared to the 
control cells (fig.5.3.9). Passage 2 and 3 cells showed no significant differences in 
media IL-8 concentrations compared to the control cells when they were subjected to 
4000ps, 6000pa and lOOOOpe (fig.5.3.10).
Summary: Cytokine Media Concentrations from OA Synovial Cells
P assage 4000pe 6000|i£ 10000p£
P1 IL-8 increase
P2
P3
Table S. 3.2 Changes in cytokine media concentration from OA cells
5.3.4 Effects of Mechanical Strain on Normal and OA Cells 
TNFa
No significant differences in TNFa media concentrations from normal control cells 
compared to the OA control cells were observed. When the cells were subjected to 
the three magnitudes of strain no significant differences in media TNFa 
concentrations were seen in the normal strained cells compared to the OA strained 
cells (fig-5.3.11).
Interleukin-1
No significant differences in the IL-1 media concentrations from normal control cells 
compared to the OA control cells were observed. When the cells were subjected to 
the three magnitudes of strain, 4000ps resulted in an increase in the media IL-1
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concentrations in the normal cells whereas the OA cells showed a decrease in IL-1 
concentration which was significantly less (/><().0 0 0 1 ) than the response of the 
normal cells (fig.5.3.12). No significant differences in the IL-1 media concentrations 
were observed when the normal and OA cells were subjected to 6000pe and lOOOOpe 
(fig.5.3.12).
Interleukin-6
Passage 1 and 3 control cells from normal and OA patients showed significant 
differences in media IL-6  concentrations whereas passage 2 cells showed no 
significant differences. When the cells were subjected to 4000pe, the passage 1 
normal cells responded with significantly higher (PO .05) media IL-6 concentration 
compared to the OA cells (fig.5.3.13A). Passage 2 OA cells showed significantly less 
(P<0.05) media IL-6 compared to the normal cells IL-6  response when normal and 
OA cells were strained at 6000pe (fig.5.3.13B). Passage 3 cells showed no significant 
differences in IL-6 media concentration between normal and OA cells when subjected 
to the three magnitudes of strain (fig.5.3.13C).
Interleu kin-8
Control cells from the three passages from control normal and OA patients showed 
significant differences in media IL-6  concentrations (P<0.05). When the cells were 
subjected to lOOOOpe, the passage 1 cells responded with media IL-8  concentrations 
significantly less than media IL-8  concentrations synthesised by normal cells in 
response to strain (fig.5.3.14A). Passage 2 cells showed significantly less media IL-8 
compared to the normal cells when the cells were strained at 6000pe (fig.5.3.14B). 
No significant differences between OA and normal cells IL-8  media concentration 
were observed in cells response to 4000pe and lOOOOpe at passage 2 (fig.5.3.14B). 
Passage 3 cells showed no significant differences between normal and OA cells when 
subjected to the three magnitudes of strain (fig.5.3.14C).
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Figure 5.3.1 A) Media interleukin-6  and B) media interleukin-8  concentrations from 
synovial cells at passage 1 and passage 3 from Patient N l. Cells were serum deprived 
for 24 hours, then fresh serum free media added and the media sampled at 24 hours. 
Error bars represent standard deviations. *P<0.05.
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Figure 5.3.2 A) Media tumour-necrosis factor a ; B) media interleukin-1; C) media 
interleukin-6 and D) media interleukin-8 concentrations from synovial cells at passage 
1 and passage 3 from an OA patient. Cells were serum deprived for 24 hours, then 
fresh serum free media added and the media sampled at 24 hours. Error bars 
represent standard deviations. *P<0.05.
Passage 1 Passage 3
Figure 5.3.3 A) Media interleukin-6  and B) media interleukin-8 concentrations from 
synovial cells from two different OA patients. Cells were serum deprived for 24 
hours, then fresh serum free media added and the media sampled at 24 hours. Error 
bars represent standard deviations. *P<0.05.
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Figure 5.3.4 A) Media tumour-necrosis factor a  and B) media interleukin-1 
concentrations. Normal passage 3 synovial cells were subjected to mechanical strain 
and the media sampled at 24 hours. Control synovial cells did not undergo strain. 
Error bars represent standard deviations.
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Figure 5.3.5 Media interleukin-6 concentrations from Patient N l. Normal synovial 
cells were subjected to mechanical strain and the media sampled at 24 hours. Control 
synovial cells did not undergo strain. Error bars represent standard deviations. A) 
passage 1 cells; B) passage 2 cells; C) passage 3 cells. *P<0.05 compared to control 
cells.
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Figure 5.3.6 Media interleukin-8 concentrations from Patient N l. Normal synovial 
cells were subjected to mechanical strain and the media sampled at 24 hours. Control 
synovial cells did not undergo strain. Error bars represent standard deviations. A) 
passage 1 cells; B) passage 2 cells; C) passage 3 cells. *P<0.05 compared to control 
cells.
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Figure 5.3.7 A) Media tumour-necrosis factor a  and B) media interleukin-1 
concentrations. OA passage 3 synovial cells were subjected to mechanical strain and 
the media sampled at 24 hours. Control synovial cells did not undergo strain. Error 
bars represent standard deviations.
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Figure 5.3.8 Media interleukin-6  concentrations from A) patient OA3; B) patient 
OA4 and C) patient OA6 . OA synovial cells were subjected to mechanical strain and 
the media sampled at 24 hours. Control synovial cells did not undergo strain. Error 
bars represent standard deviations.
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Figure 5.3.9 Media interleukin-8 concentrations from Patient OA4. Passage 1 OA 
synovial cells were subjected to mechanical strain and the media sampled at 24 hours. 
Control synovial cells did not undergo strain. Error bars represent standard 
deviations. *P<0.05 compared to control cells.
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Figure 5.3.10 Media interleukin-8 concentrations from A) patient OA4 and B) 
patient OA6 at passage 2; C) patient OA3 and D) patient OA6 at passage 3. OA 
synovial cells were subjected to mechanical strain and the media sampled at 24 hours. 
Control synovial cells did not undergo strain. Error bars represent standard 
deviations.
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Figure 5.3.11 Media TNFa concentrations from normal and OA synovial cells. Cells 
were subjected to mechanical strain, the media sampled at 24 hours and the 
percentage differences between the control and strained cells calculated. Error bars 
represent standard deviations.
213
3T
,00
0(
H 
3r
i0
00
9 
3r
l0
00
fr
% increase TNFa
Figure 5.3.12 Media interleukin-1 concentrations from normal and OA synovial 
cells. Cells were subjected to mechanical strain, the media sampled at 24 hours and 
the percentage differences between the control and strained cells calculated. Error 
bars represent standard deviations. */><0.0001 compared to normal cells.
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Figure 5.3.13 Media interleukin-6 concentrations from normal and OA synovial. 
Cells were subjected to mechanical strain, the media sampled at 24 hours and the 
percentage differences between the control and strained cells calculated. A) passage 1 
cells; B) passage 2 cells; C) passage 3 cells. Error bars represent standard deviations. 
♦PO.OS compared to normal cells.
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Figure 5.3.14 Media interleukin-8 concentrations from normal and OA synovial. 
Cells were subjected to mechanical strain, the media sampled at 24 hours and the 
percentage differences between the control and strained cells calculated. A) passage 1 
cells; B) passage 2 cells; C) passage 3 cells. Error bars represent standard deviations. 
*P<0.05 compared to normal cells.
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5.4 D iscussion
This study investigated the synthesis o f cytokines from synovial cultures from OA 
and normal synovium The spontaneous synthesis o f  the cytokines IL-1, TNFa, IL-6 
and the chemokine IL-8 were observed. Synthesis o f  the pro-inflammatory cytokines 
IL-1 and TNFa were not significantly different in the normal and OA cells. The low 
levels of cytokines synthesised could be attributed to the low numbers of SMPs in the 
cultures which contribute to IL-1 and TNFa synthesis (Alsalameh et al., 1999; Chu et 
al., 1991; Okamoto et al., 1997). The SMPs interact with SFBs and loss of this 
interaction could lead to a withdrawal o f cytokine stimulation in vitro and subsequent 
alterations in SFBs (Edwards, 1999).
Higher concentrations of IL-6 were observed in the cultures from OA synovium 
compared to the synovial cultures from normal tissues. This has previously been 
shown in synovial fluid and in cell cultures yet, lower concentrations of IL-6 were 
synthesised in this investigation than those already reported.(Bucala et al., 1991;
Hirano et al., 1988; Hirth et al., 2002; Mihara et al., 1995; Okamoto et al., 1997) In
some of these previous studies, however, IL-1 and TNFa were used to stimulate IL-6 
synthesis in vitro. The lower concentrations o f IL-6 synthesised in this study shows 
the ability of the cells to constitutively secrete IL-6 (Gueme et al., 1989; Okamoto et 
al., 1997). As with IL-6, IL-8 is detected in the synovial fluid of normal patients at 
lower concentrations than in patients with joint disease and the same trend was 
observed in the synovial cultures from normal and OA tissues (Brennan et al., 1990;
Koch et al., 1992; Rampart et al., 1992; Seitz et al., 1991).
Investigation into the effects of mechanical strain on cytokine synthesis from normal 
and OA synovial cell cultures gave varied results. Application of mechanical strain to 
normal synovial cells did not produce a significant response in cytokine synthesis 
when the cells were subjected to 4000ps and 6000^18 and the same trend was observed 
in cells from OA synovium. However, when the cells were subjected to lOOOOpe, the 
normal cells showed an increase in IL-8 synthesis whereas the OA cells showed a 
decrease. IL-8 is considered a potent chemoattractant involved in the process of
2 2 1
inflammation, so a decrease in this chemokine could reduce disease progression, 
although it must be taken into consideration that it is unlikely that one cytokine alone 
will be able to halt the disease (Deleuran et al., 1994; Koch et al., 1992). Mechanical 
strain of lOOOOps did not alter the synthesis of IL-1, TNFa or IL-6 in either the 
normal or the OA synovial cells.
A recent exercise based study has shown a reduction in IL-1 concentration within the 
synovial fluid, with reported decrease in joint pain (Messier et al., 2000). Indeed, 
IL-1 concentration was significantly decreased in OA cells compared to the normal 
cells when cells were subjected to 4000p£. The higher magnitudes of strain showed 
no differences between IL-1 concentrations from normal or OA cells in response to 
strain Lower concentrations of IL-6 were synthesised by the OA cells whereas 
normal cells showed higher IL-6 concentrations when subjected to the lower 
magnitudes of strain (4000ps, 6000pe). It is also interesting to note that it was the 
passage 1 and 2 cells that showed a response to strain, indicating that higher passage 
cells may not be able to respond to strain due to the length of time in culture or the 
loss of cytokine stimuli provided by the SMPs which reduce in number with passage 
(Hirth et al., 2002; Zimmerman et al., 2001). A difference between IL-8 synthesis 
from normal and OA cells was also observed in the lower passage cells. Here, higher 
levels of IL-8 were seen in the normal cells compared to the OA cells in response to 
both 6000p£ and 10000p£. A decrease in IL-8 synthesis within the synovium and a 
loss of subsequent secretion into the OA joint could reduce the inflammatory effects 
associated with disease. Overall, the OA cells have responded to mechanical strain 
synthesising lower concentrations of cytokine compared to the normal cells.
Studies have shown the effects of strain on chondrocytes and tendon cells and these 
have shown strain does not induce or abrogate cytokine synthesis unless cells are 
stimulated with cytokines (Archambault et al., 2002; Gassner et al., 2000; Long et al., 
2002). The low levels of cytokines synthesised by the synovial cells and the lack of 
response to strain may indicate that cytokine stimulation is needed for synovial cells 
to respond to mechanical strain. Previous work used cells from RA tissue which 
shows more of an inflammatory response than OA tissues. Consequently, synthesis of 
higher levels of cytokines are observed in vivo in RA tissues compared to OA tissues
2 2 2
which might explain the low levels o f cytokines synthesised by the OA cells in this 
study.
The effect of passage number on cytokine synthesis also needs to be taken into 
consideration. Previous work has concentrated on the effects of MMP 
activity/synthesis in synovial cells and has shown these increase with strain (Sun and 
Yokota, 2002). These studies, however, used cells at passages 8 and greater whereas 
this investigation used cells at passage three or lower and could explain the 
differences in response to strain. Alterations in in vitro features of the synovial cells 
could be responsible for the differences in cytokine response to mechanical strain. It 
has been shown that infiltrating cells such as macrophages decrease with increasing 
passage number and the loss of the SFB and SMP interaction and subsequent loss of 
cytokine stimulation may be reflected in synovial cell response (Chomarat et al., 
1995; Hirth et al., 2002; Marsh et al., 1978; Zimmerman et al., 2001).
Current treatments for OA and RA involve the blockade of the cytokine pathways 
however, the aim of this work was to investigate the effects o f strain on cytokine 
synthesis in order to develop exercise based therapies as an alternative treatment for 
OA. This investigation was hampered by the low number o f synovial samples used 
and needs to be taken into consideration when assessing the results. Overall, it can be 
seen that the synovial cells from both OA and normal synovium respond to the 
greatest magnitude of strain, which is higher than the physiological strains the joint 
undergoes during flexion (Lanyon, 1996). Mechanical strain does not however, affect 
all of the cytokines and chemokines investigated. At present, this work does not 
provide enough evidence necessary to show that cytokine production can be 
modulated by mechanical strain but does show OA and normal cells are responsive to 
mechanical strain and both respond differently. Whether mechanical strain can be 
used to modulate cytokine synthesis will require further studies on a greater number 
of synovial samples.
Chapter 6
Effects of hTERT Infection on Synovial
Cells
6.0 Introduction
A two stage model for the control o f cellular growth has been proposed by Shay et al., 
(1991). The first, or Ml (mortality stage 1) represents the onset of senescence in 
normal cells. Replicative cell senescence is characterised by continued cell viability 
without further cell division yet alterations in gene expression and phenotype are 
observed and can be overridden in certain cell populations leading to an extended life 
span (Allsopp et al., 1995; Allsopp and Harley, 1995; Bodnar et al., 1998; Martin et 
al., 2002; Wei and Sedivy, 1999). Eventually, however, cell proliferation will be 
stopped in a stage initially defined as crisis or M2 (mortality stage 2). Here, 
karyotypic instability and widespread apoptosis occurs (Maser and DePinho, 2002; 
Wei and Sedivy, 1999). Cells that survive M2 are considered immortal in that they 
can divide infinitely.
Replication of linear eukaryotic chromosomes during cell proliferation poses a 
problem as DNA polymerase is unable to synthesise DNA in 3'- 5* direction or start 
DNA chain synthesis de novo. The presence of telomerase, a functional 
ribonucleoprotein complex consisting of an integral RNA telomeric template 
(hTERC) and a reverse transcriptase subunit (hTERT) however, allows chromosome 
replication (Feng et al., 1995; Nakamura and Cech, 1998). Telomerase exists at the 
ends of chromosomes and in humans telomeres consist of hundreds and thousands of 
tandem repeats, which are simple, repetitive DNA sequences. The hexanucleotide 
telomeric sequence in humans is TTAGGG and it is this sequence that acts as an RNA 
template for telomerase. The RNA template o f the telomerase complex binds to the 
telomere and the reverse transcriptase subunit allows elongation of the DNA, 
beginning with the telomere. This mechanism of chromosome elongation during cell 
proliferation ensures the maintenance of chromosome length. The loss of telomeres 
leads to end-to-end chromosomal fusions, facilitates increased genetic recombination 
and triggers cell death through apoptosis, as can be seen to occur in the Ml stage of 
growth. (Blasco et al., 1997; Counter et al., 1992; Knauper et al., 1996). The ability 
of the cells to escape M2 is thought due to the restoration and/or stabilisation of 
telomere length.
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Loss of between 50-200 nucleotides o f the telomeric sequence at each cell division 
results in the progressive shortening o f telomere length and it is this shortening of the 
telomere that is thought to control entry into senescence leading to genetic instability. 
(Chang and Harley, 1995; Harley, 1997; Hastie et al., 1990; Lee et al., 1998). Once 
the telomere reaches a critical length, the cell will no longer be able to undergo 
replicative proliferation and so becomes senescent (Kipling and Faragher, 1999; 
Reddel, 1998). The disruption of telomerase activity has been shown to cause 
telomere shortening and cell senescence (Yu et al., 1990) whereas the activation of 
telomerase can result in telomere lengthening and cell immortilisation (Bodnar et al., 
1998; Counter, 1998). These data suggest that there is a critical telomere length 
necessary to prevent senescence and that telomerase activity is involved in controlling 
cell senescence.
Normal human somatic tissues have been shown to lack telomerase activity and in 
these cell types, telomere shortening is thought to act as a molecular counting device, 
indicating the number of times a cell has divided, triggering proliferative arrest when 
the telomeres become too short (Harley et al., 1990; Kim et al., 1994; Wright and 
Shay, 2002). Telomere length can be seen to decrease with age and is considered a 
mechanism controlling cellular aging by limiting cell proliferation (Harley et al., 
1990; Prowse and Greider, 1995). Hayflick et a l, (1961) showed cell growth arrest 
was entered to in vitro after a characteristic number of cell doublings and this 
depended on cell type. For example, human fibroblasts undergo on average 60 
population doublings whereas chondrocytes undergo between 30-35 population 
doublings before becoming senescent (Allsopp and Harley, 1995; Kolettas et al., 
1995). In addition to time in culture, the age of the donor seems to affect cellular 
senescence. Hayflick (1965) and Campsi (2000) both demonstrated that cells cultured 
from older individuals exhibited a lower proliferative lifespan than those from 
younger individuals and a relationship between number of population doublings and 
the life span of the organism in chondrocyte cultures was demonstrated by Adolphe 
(1983). Indeed, in vivo age related changes in phenotype such as decreased response 
to growth factors, decreased production o f extracellular matrix components and 
increased apoptosis occurs in relation to accumulating senescent cells (Adams and 
Horton, 1998; Gueme et al., 1995; Price et al., 2002). A decrease in telomere length 
in vitro occurs in human fibroblasts and chondrocytes with increasing passage number
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and if the same occurs in vivo, this could be the mechanism controlling cellular ageing 
by limiting cell proliferation (Harley et al., 1990; Parsch et al., 2003; Prowse and 
Greider, 1995). Further research however, disputes the relationship of donor age and 
cellular senescence. Cells from old and young donors were shown to senesce at the 
same point in vitro suggesting cell proliferation in vitro is not simply related to age 
(Cristofalo et al., 1998). The influence o f many genetic and epigenetic factors 
involved in cell proliferation are thought to affect telomerase activity and, as a result, 
telomeres have been shown to be longer in an older donor compared to that of a 
younger donor (Harley, 1997; Reddel, 1998). Additional work demonstrating that 
although humans have a longer life span than rodents, it is rodents that have the 
longest telomeres (Kakuo et al., 1999). Thus, the length of the telomere might not be 
the critical factor in cell senescence. As long as telomerase maintains a stable 
telomere length during cell proliferation then cell senescence is prevented (Allsopp et 
al., 1992; Greider, 1990; Harley et al., 1990; Prescott and Blackburn, 1997; Roy et al., 
1998). Furthermore, telomerase length may have a protective effect on short 
telomeres by preventing further shortening once a critical telomere size has been 
achieved, above this critical size telomerase activity is not required (Yang et al., 1999; 
Zhu et al., 1999).
The ability to maintain cellular life span while preserving the diploid status o f growth 
characteristics, gene expression patterns and phenotype of primary cells has important 
implications for biological research. Access to cells usually limited by life span in 
vitro or availability would be a useful tool to the researcher. As a result, 
immortalisation of cell types is a rapidly expanding area of research. Extension of the 
life spans of human somatic cell types including endothelial cells, bone marrow 
stromal cells, retinal pigment cells and skin fibroblasts has been increased by the 
transfection of telomerase cDNA (hTERT) (Bodnar et al., 1998; Jiang et al., 1999; 
Morales et al., 1999; Simonsen et al., 2002; Steinert et al., 2000; Yang et al., 1999). 
Normal cells showed a limited proliferative potential in vitro with characteristics of a 
senescent phenotype. The ectopic expression of telomerase reverse transcriptase 
hTERT however, inhibited replicative senescence and the cells maintained a normal 
differentiation potential in vitro (Simonsen et al., 2002). Phenotypic markers were 
maintained and often resembled those o f a younger phenotype and the cells did not 
acquire transformed or malignant characteristics (Jiang et al., 1999; Morales et al.,
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1999; Simonsen et al., 2002; Young et al., 2003). The increase in population 
doubling (PD) number varied between cell type. An increase of 10 PD was observed 
in chondrocytes whereas a 6 fold increase was seen in human mesenchymal stem cells 
from bone (Simonsen et al., 2002). The PD rate also equalled that of young cells. 
The reason for this increase in replicative capacity is thought to be because of the 
stabilisation in telomere length or an actual increase in telomere length by the 
introduction of ectopic hTERT (Bodnar et al., 1998; Wood, 2001).
Conclusions drawn for previous work on synovial cells suggest that cultures from the 
same passage should be used for experimentation as synovial cell cultures in long­
term in vitro studies showed alterations in cell type, cell morphology and growth rates 
(Lories et al., 2003; Marsh et al., 1978; Zimmerman et al., 2001). Rapid proliferation 
of cells occurs in lower passage cells yet this is seen to decrease in cells from higher 
passage cultures (beyond passage 15) (Clarris and Fraser, 1968; Saksela, 1962). The 
change in morphological features and growth rates is associated with chromosomal 
deviations and also the loss of individual cell populations (Castor, 1960; Clarris and 
Fraser, 1968; Saksela, 1962). The synovial cultures have a finite lifespan in vitro and 
long-term cultures show detrimental morphological alterations which result in cell 
senescence and eventual cell death (Bartfeld, 1965; Hayflick, 1965; Martin et al., 
1970). Establishment of an immortalised cell line providing a limitless supply of 
heterogeneous synovial cells would aid greatly in overcoming the problems associated 
with primary synovial cell culture.
A rabbit synovial fibroblast cell line, HIG-82 has been established (Georgescu et al., 
1988). This cell line however, was produced by spontaneous transformation of an 
ageing late-passage population of primary cells. The HIG-82 cell line can be 
activated by a number of stimuli, such as phorbol myristate acetate (PMA) and can 
express similar SFB cell markers as primary synovial cells, for example CD44 
(Galea-Lauri et al., 1993; Georgescu et al., 1988). The HIG-82 cells do not respond 
to IL-1 in exactly the same manner as SFBs, the responsiveness to IL-1 is lost 
probably as a consequence of repeated-passage (Gouze et al., 2003; Lin et al., 1996). 
The HIG-82 cells do however, synthesise factors capable of inducing synthesis of 
PGE2 and collagenase by chondrocytes (Watanabe et al., 1986). Synovial fibroblasts 
(SFBs) usually synthesise no or little nitric oxide (NO) and HIG-82 cells show the
227
same trend in vitro (Stefanovic-Racic et al., 1994). When both SFBs and HIG-82 
cells are exposed to IL-1 and TNFa, SFBs increase NO synthesis whereas HIG-82 
cells show no change in NO synthesis. Thus, synovial cells have the potential to be 
immortalised but there exists a difference between these cells and the SFBs that needs 
to be considered during experimentation.
The aim of this work was to immortalise human synovial fibroblasts from normal, OA 
and RA donors. At present, limited availability and the variability between donors is 
disadvantageous when using SFBs for research. Generation of an immortalised SFB 
cell line with an extended life span and that maintains characteristics of an early 
culture would benefit research, allowing study o f the disease at the cellular level.
6.2 Materials and Methods
6.2.1 Synovium Samples
Synovium samples were obtained as in Chapter 2 (2.2.1). Details of the samples are 
listed below.
Sample Type Sex Age (years)
OA1 OA Female 57
OA3 OA Female 74
OA2 OA Male 64
OA16 OA Male 55
OA17 OA Female 75
RA1 RA Male 56
N2 normal Unknown 71
N3 normal Female 89
N4 normal Female 55
N5 normal Unknown Unknown
Table 6.2.1 Details of synovium sam ples obtained at knee jo in t replacem ent surgery.
6.2.2 Cell Isolation & Culture
Cells were isolated from the synovium as described in Chapter 2 (2.2.2). Briefly, 
diced tissue was digested in 295IU mg ml*1 type I collagenase (Sigma, Poole, UK) for 
3 hours at 37°C. Cells were centrifuged at 1000 x g for 5 minutes, resuspended in 
DMEM/F12+, then centrifuged at 1000 x g for 5 minutes. Cells were counted and 
seeded as required in DMEM/F12 containing 1% penicillin-streptamycin (104IU m l1 
/104pg ml'1; Sigma), L-glutamine (200mM; Life Technologies, Paisley, UK), 
hydrocortisone (4mg ml’1; Sigma)[40mg hydrocortisone powder dissolved in 5ml 
100% ethanol and 5ml sterile PBS], Insulin-Transferrin-Selenium (200mM; Life 
Technologies) and 20% foetal calf serum (Sigma) and incubated at 37°C.
6.2.3 Construction of Vector
The human telomerase cDNA was provided by Geron Corporation (Menlo Park, Ca, 
USA). The telomerase retroviral expression plasmid was constructed by inserting the 
human telomerase cDNA into the pBABEpuro vector from Clontech (Palo Alto, Ca, 
USA) (appendix 6.1). A control plasmid consisting of the puro resistant gene with no 
telomerase cDNA was also constructed. Briefly, 5jig of either control vector plasmid 
or telomerase construct was transfected into the \pCRlP packaging cell line using the 
Profection Calcium phosphate kit as per manufacturers instructions (Promega UK, 
Southamton, UK). Cells that had taken up the vector were then selected by culturing 
for 10 days in the presence of 350pg ml'1 of G418. Retrovirus was pooled from the 
supernatant of stably transfected yjCRIP producing cells.
6.2.4 Infection & Selection of Synovial Cells
Infection was carried out by incubating monolayer synovial cells with 0.45pm-filtered 
supernatants of retroviral producing cells in the presence of 8pg ml'1 of polybrene 
(Sigma). The infection medium was in contact with the synovial cells for 48 hours 
then cells were expanded with non-selective medium (DMEM/F12+). Cells were re­
fed 48 hours later. Infected cells were submitted to selection for 14 days in the 
presence of l.Opg ml'1 puromycin (Sigma) before reverting to non-selective media.
Cells from three samples, (normal (N2), OA (OA1) and RA (RA1)) were infected at 
passage 9. In each case the cell lines were infected with pBABEpuro-telomerase 
retrovirus or with pBABEpuro retrovirus as a control. Cells were labelled as shown in 
table 6.2.2.
Parent Cell 
Sample
pBABEpuro- 0 . or_None __a ' pBABE-purotelomerase
N2 Normal N-hTERT N-chTERT
OA1 OA OA-hTERT OA-chTERT
RA1 RA RA-hTERT RA-chTERT
Table 6.2.2 Labelling of retroviral cell lines and non-infected cell lines.
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6.2.5 Telomeric Repeat Amplification Protocol (TRAP Assay)
Cells at selected passages were allowed to reach confluence, trypsinised (appendix
2.1) and then washed in PBS before being frozen at 100,000 cells per pellet in liquid 
nitrogen. These cell pellets were .stored at -80°C until needed.
Cell pellets were defrosted at room temperature and lysis buffer (appendix 6.2) added 
proportional to the cell count (in most cases 5000 cells per pi). The samples were 
incubated at 4°C for 30 minutes then centrifuged at 100000 x g at 4°C. The 
supernatant was removed, divided into 2 separate samples and frozen at -80°C prior to 
the TRAP assay.
The first step of the TRAP assay uses nascent telomerase to extend the TS primer 
sequence (5'-AATCCGTCGAGCAGAGTT-3'). Cells were diluted 1:5 in lysis buffer 
(appendix 6.2) and each extract was split into 2 aliquots, one aliquot was incubated at 
85°C for 10 minutes to destroy nascent telomerase activity (negative control). Human 
293 kidney cells (CACCS) at 5000 cells pi'1 were used as positive controls. Fifty pi 
of premix (appendix 6.1) consisting o f reaction buffer (appendix 6.2), lOOng TS 
primer (MWG biotech Ltd, Milton Keynes, UK), and lpg T4 gene 32 protein 
(Amersham Pharmacia Biotech, Buckinghamshire, UK) was added to lpl of prepared 
cell extract. After capping with mineral oil, this mixture was incubated for 30 
minutes at 30°C, followed by a soak at 92°C using a DNA Thermal cycler (Perkin 
Elmer).
The second step of the TRAP assay involves extension of the nascent telomerase 
products created in the above step using the polymerase chain reaction (PCR). Two 
pi of final mix (appendix 6.2) containing lOOng CX primer (5- 
CCCTTACCCTTACCCTT ACCCT AA-3') (MWG biotech Ltd), 2.5U Taq 
Polymerase (Promega, Southampton, UK) and 0.5 x 10'18 of internal standard was 
added to each extract. The PCR was run for 31 cycles of 92°C for 30s; 50°C for 30s 
and 72°C for 90s with a final soak at 4°C.
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Detection of the TRAP assay products involved loading 30jil of the samples onto a 
10% polyacrylamide (19:1) 20cm Protean II gel containing 1.5 X tris borate EDTA 
(TBE) that was run at 300V for 3 hours. The gel was stained with Sybr Gold (Sigma) 
at a 1:10,000 dilution in H2O for 10 minutes. Excess stain was washed off and the gel 
destained for 3 minutes in dH20 . Bands were visualized on a STORM ultraviolet 
light box (Amersham Biosciences) and the gel documented using Image Quant 
software (Molecular Dynamics).
6.2.6 Immunohistochemistry
Cells were fixed in cold 95% ethanol (Sigma) for 10 minutes or 0.4% 
paraformaldehyde (Sigma) depending on the antibody used and the cells washed in 
PBS. Labelling for collagen IV required enzymatic pre-treatment. The cells were 
equilibrated in 0.1M tris-acetate (Sigma) for 5 minutes, and then incubated in 
chondroitinase (0.25U/ml in tris-acetate pH7.8; Sigma) and hyaluronidase (lU/ml in 
tris-acetate pH7.8; Sigma) for 2 hours at 37°C. Cells were washed for 3 times (5 
minutes each) in PBS-T and primary antibody applied.
Nante of 
done
Antigen
Specificity Subclass Source Reference
BRIC 128 CD55 IgM
IBGRL
Research
Products,
Bristol.
Mushens R & 
Scott M (1990) 
J.Immunol.Meth. 
131:83-89
COL-94 Collagen Type IV IgM
Sigma, Poole, 
UK
Sanes JR et al 
(1990) Journal 
Cell Biology 
111:1685
HM-2 MAP-2 IgG Sigma, Poole, UK
Huber G & 
Matus A (1984) 
J.Neuroscience 
4:151-160
Table 6.2.3 List of synovial fibroblast markers.
Cells were labelled with a variety of synovial fibroblast markers (table 6.2.3) and the 
immunohistochemistry was performed as described in Chapter 2 (2.2.3). Briefly, 
cells were incubated with blocking serum to prevent unspecific binding of primary 
antibody. Excess serum was removed and the primary antibody diluted (table 6.2.4) 
in PBS-T, applied to the cells and incubated overnight at 4 C. The cells were washed 
and incubated with secondary antibody. Alexa fluor 488 (Molecular Probes Europe,
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The Netherlands) used depended on the primary antibody (table 6.2.4). The
secondary antibody was diluted to lOpg ml'1 in 1% blocking serum in PBS for 60 
minutes at room temperature. Cells were washed in PBS and mounted in Vectashield 
containing lpg ml'1 propidium iodide (Vector Labs, UK).
Negative controls consisted of PBS-T instead of primary antibody or Mouse/Rabbit 
IgGs. Positive controls used were frozen sections of synovium due to the lack of 
human cell cultures available.
Antigen
Specificity Fix
Blocking
Serum
Dilution of 
Antibody
Alexa 
Fluor 488
CD55 95% EtOH Goat 1:10 Goat a  mouse
Collagen
TypelV 95% EtOH Goat 1:500 Goat a  mouse
MAP-2 4%paraformaldehyde Goat 1:800 Goat a  mouse
PGP9.5 95% EtOH Goat 1:400 Goat a  rabbit
Table 6.2.4 Protocol for antibody labelling.
6.2.7 Population Doublings
Confluent cultures were subjected to enzymatic dissociation with trypsin (appendix
2.1) and cell numbers determined by counting 2 aliquots o f the resulting suspension in 
a haemocytometer. Cells were re-seeded at 50,000 cells per T25 flask. The 
population doublings were calculated using the following equation:
PD = Logio (N/N0) X 3.33
where N is the number of cells at trypsinisation and No is the number of cells initially 
seeded (Cristofalo et al., 1998).
Remaining cells were seeded into 35mm dishes for cell senescence assays, 
immunohisochemistry or RNA isolation, or were frozen and stored at -80°C.
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w6.2.8 Senescence Associated P-Galactosidase Staining
Cells were washed in PBS and fixed in 0.4% formaldehyde for 3 minutes at room 
temperature then washed in PBS. Fresh senescence associated p-Gal stain solution 
(SA-P-Gal) was made immediately before use and consisted of lmg of 5-bromo-4- 
chloro-3-indolyl p-D-galactoside (p-Gal;Sigma) dissolved in 1ml dimethylformamide. 
B-gal was then added to 100ml 40mM citric acid (Sigma) / 40mM sodium phosphate 
(Sigma), pH6.0 / 5 mM potassium ferrocyanide (Sigma) / 5 mM potassium 
ferricyanide (Sigma) / 150 mM sodium chloride (Sigma)/ 2 mM magnesium chloride 
(Sigma). Cells were incubated with the SA-P-Gal solution at 37°C for 16 hours. Cells 
were washed with dHiO, then counterstained in haematoxylin for 1 minute. Cells 
were thoroughly washed in PBS and mounted with Vectashield (Vectorlabs). Young 
bovine chondrocytes were used as a negative control and late passage bovine 
chondrocytes were used as a positive control.
Three dishes from each sample were counted for total cell number and number of 
cells labelled for SA-p-gal senescent activity. A total o f one hundred cells were 
counted in three random areas of each dish using a x20 objective lens. One-way 
ANOVA, wih Tukey post hoc analysis was used to calculate differences between 
infected and control synovial cells. This particular statistical test was used as it 
allowed the comparasion of more than 2 sets o f data.
6.2.9 Gene Expression
RT-PCR for hyaluronan synthase 2 (HAS2) mRNA expression was performed as 
described in Chapter 4 (4.2.4 & 5). Briefly, 10,000 cells were seeded in 35mm dishes 
and allowed to reach confluence, and RNA isolated using an RNeasy minikit (Qiagen 
Ltd, UK). The RNA was reverse transcribed to cDNA and the cDNA generated was 
amplified using the reverse transcriptase polymerase chain reaction and HAS2 
specific primers as described in Chapter 4 (table 4.2.3). PCR products were run on a 
1.5% (w/v) agarose/TBE gel and visualised using Quantity One software (Bio-Rad 
Labs).
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6.3 Results
6.3.1 TRAP Assay
The TRAP assay demonstrated that there was no telomerase activity in synovial cells 
from normal, OA and RA cell samples (fig.6.3.1). The same normal, OA and RA cell 
samples when infected with the hTERT construct were positive for telomerase 
activity at passage 11 (fig.6.3.2).
6.3.2 Cell Morphology
The morphologies of N-hTERT and N-chTERT infected cells resembled that of the 
uninfected parent cell sample (N^(fig.6.3.3A-D). All samples contained thin, spindle- 
shaped cells during growth \yhist spindle-shaped and stellate cells were present in 
confluent cultures (fig.6.3.3B). In addition, no obvious differences in cell 
morphology between early and late passage normal cells were apparent regardless of 
mfection with of hTERT (fig.6.3.F & G).
The morphologies of OA-hTERT and OA-chTERT synovial cells were similar in 
appearance to that of the OA synovial cells at passage 11 (fig.6.3.4A-C). As passage 
number increased in both the infected and parent OA synovial cell cultures, a reduced 
proliferative capacity was accompanied by an increase in the larger stellate shaped 
cells (fig.6.3.4D & E).
Cells from RA-hTERT and RA-chTERT cultures showed similar morphology to each 
other at passage 11 (fig.6.3.5A & B). With an increase in passage number, an 
increase in cell size was noted (fig.6.3.5C).
6.3.3 Immunohistochemistry
Collagen type IV was used as a marker o f synovial fibroblast phenotype. Normal 
synovial cell cultures showed collagen type IV labelling in both early and late passage
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cultures (fig.6.3.6A & B). N-hTERT cells exhibited collagen type IV labelling in late 
passage cultures (fig.6.3.6E).
Positive labelling for collagen type IV was seen in OA cultures at both early and late 
passages (fig.6.3.7A & B). The infected OA and RA synovial cells, (OA-hTERT and 
RA-hTERT) showed collagen type IV expression in late passage cultures (fig.6.3.7C 
&D).
CD55 was expressed in early OA synovial cell cultures (fig.6.3.8A) but was not 
observed in late passage cultures (fig.6.3.8B). OA-hTERT cells did not express CD55 
at late passages (fig.6.3.8E). Expression o f CD55 was seen in cultures from the 
RA-hTERT cells in late passage cultures (fig.6.3.8G).
With time in culture cells morphology became neuronal-like. As a result MAP-2 
labelling was performed. Cultured synovial cells from both normal and OA cultures 
at early and late passage exhibited MAP-2 labelling (fig.6.3.9A-C). The infected N 
cells, N-hTERT showed MAP-2 labelling in late passage cells (fig.6.3.9E & F).
6.3.3 Population Doublings
Synovial cells were grown in monolayer culture over a period of a year to determine 
the effects of hTERT infection on population doublings (PD). PD was calculated 
each time the cultures were trypsinised and passed to new flasks. Accumulated PDs 
were plotted as a function of time to show changes in population growth rates that 
occurred with successive passage.
Normal synovial cells exhibited the greatest PD of 18 at 270 days in culture 
(fig.6.3.10A). The normal synovial cells infected with hTERT and chTERT showed 
lower population doublings at this time point. N-hTERT cells had reached a PD of 13 
whereas the cells infected with chTERT reached a PD o f 8 when the experiment was 
terminated (fig.6.3.10A). The parental normal cells, (N) were infected with chTERT 
and hTERT during its growth phase. The growth rate o f parental normal cells was 
similar to the growth rate o f synovial cells from other normal donors (fig.6.3.10B).
The OA synovial cells exhibited 10 PD in 249 days of culture and similar results were 
obtained with the hTERT infected OA cells, which exhibited 11 PD at the same 
number of days in culture (fig.6.3.10C). OA-chTERT cells exhibited a much lower 
number of PDs, with only 4 PD observed (fig.6.3.10C). The OA parental cells (OA) 
were infected with chTERT and hTERT during the growth phase (fig.6.3.10D). The 
growth rate of parental OA cells was similar to the growth rate of other OA synovial 
cells (fig.6.3.10D).
The RA synovial cells showed similar population doubling times to the hTERT 
infected RA cells (fig.6.3.10E). The RA-hTERT cells exhibited a higher PD of 11 in 
200 days in culture whereas the chTERT cells reached a PD of 7 in the same number 
of days (fig.6.3.10E).
6.3.4 Cell Senescence
In normal synovial cell cultures, the percentage of cells labelled for P-Gal activity 
increased with passage number (fig.6.3.1 IE). Normal cells infected with hTERT and 
ch-TERT showed (3-gal activity (fig.6.3.11C & D). A significant increase (P<0.05) in 
percentage of senescent cells compared to the normal parental cells (N) at the same 
number late passage culture was observed in the N-hTERT cells (fig.6.3.1 IE). A 
significant increase (P<0.05) in the number of senescent cells in N-chTERT cultures 
at passage 23 was observed compared to the N cells (fig.6.3.1 IE). N-chTERT cells 
showed no significant differences in the number of senescent cells compared to the 
N-hTERT cells in late passage cultures (fig.6.3.1 IE).
OA synovial cells showed p-Gal activity in both early and late passage cultures 
(fig.6.3.12A). No significant differences in the numbers of senescent cells in the early 
passage compared to the late passage cells were observed (fig.6.3.12E). The 
OA-hTERT cells showed p-Gal activity (fig.6.3.12B) and did not show a significant 
difference in the number of senescent cells compared to parental OA cells, at the same 
passage (fig.6.3.12E).
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6.3.5 Gene Expression
Hyaluronan synthase 2 expression was seen in cultures from the synovial cells and 
infected cells from normal, OA and RA donors (fig.6.3.13). HAS 2 expression was 
maintained in all late passage cultures until each cell culture was terminated 
(fig.6.3.13).
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Figure.6.3.1 TRAP assay for telomerase activity in synovial cells from normal (N), 
OA and RA donors. Cell extracts from parental cell samples were subjected to the 
TRAP assay. Telomerase activity is demonstrated by multiple bands as telomerase 
extension products have been amplified by PCR. Telomerase positive human 293 
kidney cells were used as a positive control (293 lane). The absence o f bands in the 
negative control lanes (-ve) are a result o f heated-treated cell extracts in which 
nascent telomerase activity has been destroyed.
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Figure.6.3.2 TRAP assay for telomerase activity in telomerase infected (hTERT) and 
telomerase control infected (chTERT) normal (N), OA and RA synovial cells. Cell 
extracts from infected parental cells were subjected to the TRAP assay. Telomerase 
activity is demonstrated by multiple bands as telomerase extension products have been 
amplified by PCR. Telomerase positive human 293 kidney cells were used as a positive 
control (293 lane). The absence o f bands in the negative control lanes (-ve) are a result 
of heated-treated cell extracts in which nascent telomerase activity has been destroyed.
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Figure.6.3.3 Morphology o f synovial cell cultures from normal tissue. Parental cells
from a normal donor and infected normal cells were monitored from early to late
passage. The similarities between infected and non-infected cells were noted. Scale
bars, 100pm.
A) N-hTERT non-confluent synovial cell culture at passage 14.
B) N-hTERT synovial cell culture at passage 14. A stellate-shaped cell (st) and 
spindle-shaped cells (sp) are present within the culture.
C) N-chTERT synovial cell culture at passage 13.
D) Normal synovial cell culture at passage 14.
E) Normal non-confluent synovial cell culture at passage 20.
F) Normal synovial cell culture at passage 20. Spindle-shaped cells are present 
within the culture (sp).
G) N-hTERT synovial cell culture at passage 24. Spindle-shaped cells are present 
within the culture (sp).
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Figure.6.3.4 Morphology of synovial cell cultures from osteoarthritic synovium. 
Parental cells from an OA donor and infected OA cells were monitored from early to 
late passage. The similarities between infected and non-infected cells were noted. 
Scale bars, 1 00pm.
A) OA-hTERT synovial cell culture at passage 11.
B) OA-chTERT synovial cell culture at passage 11.
C) OA synovial cell culture at passage 11.
D) OA synovial cell culture at passage 19. Stellate-shaped cells are present within
the culture (st).
E) OA-hTERT synovial cell culture at passage 20. Stellate-shaped cells are
present within the culture (st).
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Figure.6.3.5 Morphology of synovial cell cultures from rheumatoid tissue. Infected 
RA parental cells were monitored in culture. The similarities between infected and 
non-infected cells were noted. Scale bars. 100pm.
A) RA-hTERT synovial cell culture at passage 11.
B) RA-chTERT synovial cell culture at passage 11.
C) RA-hTERT synovial cell culture at passage 20.
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Figure.6.3.6 Immunolabelling o f normal synovial cell cultures for collagen type IV. 
Cells from parental or hTERT infected normal cells were labelled for collagen type 
IV in early and late passage cultures. Scale bars, 100pm.
A) Representative early passage normal parental cells (N4, P4). Cells that show 
labelling for collagen IV are indicated (arrow).
B) Late passage normal parental cells (N, P20). Cells that show labelling for 
collagen IV are indicated (arrow).
C) Negative control o f early passage normal parental cells (without anti-collagen 
type IV) (N4, P4).
D) Negative control o f early passage normal parental cells (without anti-collagen 
type IV antibody) (N4, P4).
E) N-hTERT cells at P20. Note the positive label for collagen IV within the cell 
cluster.
F) Negative control o f N-hTERT cells at P20 (antibody replaced with IgGs) (OA. 
P20).
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Figure.6.3.7 Immunolabelling o f OA and RA synovial cell cultures for collagen type
IV. Scale bars. 100p.m.
A) Representative early passage parental OA cells (OA3, P4). Cells labelled for 
collagen type IV are indicated (arrow).
B) Late passage parental OA cells (OA, P20). Cells labelled for collagen type IV 
are indicated (arrow).
C) OA-hTERT cells at P20. The cell at the centre of the image displays collagen 
type IV expression.
D) RA-hTERT cells at P I6. Cells labelled for collagen IV are indicated (arrow).
E) Negative control o f early passage OA cells (without anti-collagen type 
IV)(OA3, P4).
F) Negative control o f early passage parental OA cells (antibody replaced with 
IgGs) (OA3, P4).
G) Negative control o f late passage parental OA cells (without anti-collagen type 
IV)(OA, P20).
H) Negative control o f early passage parental OA cells (antibody replaced with 
IgGs) (OA, P20).
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Figure 6.3.8 Immunolabelling o f OA and RA synovial cell cultures for CD55. Scale
bars, 100pm.
A) Representative early passage parental OA cells (OA17, P2). Cells labelled for 
CD55 expression are indicated (arrow).
B) Representative late passage parental OA cells (OA, P20). No positive CD55 
label was observed.
C) Negative control of early passage OA cells (without anti-collagen type 
IV)(OA17. P2).
D) Positive control; synovial section from an OA sample. The intense 
immunolabel along the edge o f the section indicates CD55 expression (arrow).
E) OA-hTERT cells at P20.
F) Negative control OA-hTERT cells at P20 (without anti-collagen type IV).
G) RA-hTERT cells at P I6. Cells labelled for CD55 expression are indicated 
(arrow).
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Figure.6.3.9 Immunolabelling o f OA and normal synovial cell cultures for MAP-2. 
Cells from parental cells and infected hTERT normal and OA cells were labelled for 
MAP-2 in early and late passage cultures. Scale bars, 100p.m.
A) Representative early passage parental OA cells (OA2, PI). Note the positive 
labelling for MAP-2 (arrow).
B) Representative late passage parental normal cells (N5. P8). Note the positive
labelling for MAP-2 (arrow).
C) Representative late passage parental OA cells (OA16, P10). Note the positive
labelling for MAP-2 (arrow).
D) Negative control o f late passage parental OA cells (without anti-collagen type 
IV)(OA16, P10).
E) N-hTERT cells at P I7. Note the positive labelling for MAP-2 (arrow).
F) N-hTERT cells at P24. Note the positive labelling for MAP-2 (arrow).
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Figure.6.3.10 Growth curves o f normal synovial cells. Cells were grown in
monolayer and subcultured when confluent. Cell number was counted at each
passage and used to calculate population doublings.
A) Growth curves of hTERT infected, chTERT infected cells and the corresponding 
parental normal synovial cells from a 71 year old donor.
B) Growth curves o f normal synovial cell cultures derived from four normal donors.
C) Growth curves o f the hTERT infected, chTERT infected OA cells and the 
corresponding parental OA synovial cells from a 57 year old donor.
D) Growth curves of OA synovial cell cultures derived from three OA donors.
E) Growth curves o f the hTERT infected, chTERT infected RA cells and the 
corresponding parental RA synovial cells from a 56 year old donor.
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Figure 6.3.11 Cell senescence associated p-gal activity in synovial cell cultures.
A) and B) P-gal staining of a representative normal synovial cell culture.
C) N-hTERT synovial cells. Scale bars, 100p.m.
D) N-chTERT synovial cells. Scale bars, 100pm.
E) Graph to show percentage o f cells labelled for P-gal activity in parental normal 
early and late passage cultures and in infected normal cells at late passage. 
*^<0.05 compared to normal late passage cultures.
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Figure.63.12 Cell senescence associated P-gal activity in OA synovial cell cultures
A) P-gal staining of a representative OA synovial cell culture Note the intense blue 
reaction product (arrow) Scale bars. 50pm
B) OA-hTERT synovial cells Scale bars. 100pm
C) Positive controls consisted of senescent chondrocytes Scale bars. 50pm
D) Negative controls were young chondrocytes Scale bars, 50pm
E) Graph to show percentage of cells labelled for P-gal activity in parental OA and in 
infected OA cells at late passage
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Figure.6.3.13 Synovial cell hyaluronan synthase 2 mRNA expression from infected 
late passage cultures o f synovial cells and the corresponding parental cell cultures. 
Nore that all samples expressed HAS2 mRNA expression. N=normal: 
OA=osteorthritic: RA=rheumatoid.
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6.1 Discussion
This study showed that normal, OA and RA synovial cells expressed telomerase 
activity when they received the hTERT construct as evaluated by the TRAP assay. 
Previous studies have shown the lack o f telomerase activity in human somatic cells 
and synovial cells from normal and OA donors are no different (Tsumuki et al., 2000; 
Yamanishi et al., 1999; Yamanishi et al., 1998; Yudoh et al., 1999). Synovial cells 
from RA donors however, showed no telomerase activity in this study but previous 
work both supports and contradicts this result (Yamanishi et al., 1999; Yudoh et al., 
1999). It has been suggested that it is the infiltrating mononuclear cells and not the 
SFBs which are responsible for the detected telomerase activity (Yamanishi et al., 
1998). The stage at which the cells were subjected to the TRAP assay in this study 
was at passage 9, by which point infiltrating cells would not be present.
The normal synovial cells reached a higher population doubling than the normal cells 
infected with the hTERT expression vector at the end of the experiment. 
Interestingly, the hTERT cells reached confluence between passages in a fewer 
number o f days than the non-infected (N) cells. The OA cells infected with the 
hTERT expression vector increased the population doubling number by 4 compared 
to the OA cells. As with the N-hTERT cells, the OA-hTERT cells reached confluence 
in less time than the non-infected cells. The RA cells, at termination of the 
experiment showed a population doubling o f 8 and if one looks at the RA-hTERT 
cells at this point, the PD is 7 yet the cells have been passed twice more than the RA 
cells. Again, this suggests that the RA-hTERT cells are able to reach confluence 
quicker than the cells from the parent RA cultures. Normal, OA and RA cells 
infected with the ch-TERT expression vector showed the least number of population 
doublings. This result suggests that the infection of the cell with the vector plasmid is 
inhibiting the growth rates and might explain why the hTERT expressing cells do not 
show a greater proliferative capacity than the non-infected cells.
Cell senescence is classified as the loss o f replicative proliferation by the cells yet the 
cells remain viable (Allsopp et al., 1995; Bodnar et al., 1998; Wei and Sedivy, 1999). 
Others have defined cell senescence as the cells taking longer than three weeks to
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reach confluence (Gire and Wynford-Thomas, 1998). The growth rates of the N- 
hTERT cells initially showed 2 weeks or less to reach confluence after passaging 
throughout the majority o f the experiment. At the last 2 passages however, cultures 
took 3 or more weeks to reach confluence. Significantly, more senescent cells were 
observed in the N-hTERT cell cultures compared to the N cell cultures which suggest 
the hTERT construct cannot prevent cell senescence. Whether hTERT expression 
would eventually allow hTERT infected cells to overcome this growth arrest stage 
was one o f the aims o f this study, but it seems the cells needed to be monitored for a 
greater period o f time to determine this outcome. The OA hTERT cells showed a 
period o f no growth that was over 3 weeks. The time required to reach confluence 
after this period decreased and this could indicate that a population of cells was able 
to overcome senescence. The decrease in time required to reach confluence could be 
the result o f ectopic hTERT expression as the non-infected OA cells shows an 
increase in the number o f days needed to reach confluence at this point which 
suggests cells might be entering growth arrest. Again the cell cultures needed to be 
maintained over a greater period o f time to draw definite conclusions.
The immortalisation o f a cell line not only requires an extended proliferative lifespan 
in vitro but the cells also need to maintain their phenotype. The expansion of synovial 
cells in vitro has been shown to lead to an increase in cell size (Marsh et al., 1978). 
This study shows similar results, the cells in late passage cultures although showing a 
spindle-like morphology characteristic o f a fibroblast cell type, an increase in cell size 
was also observed. This increase in size may account for the increasing time required 
to reach cell confluence as cell passage number increases but as the cells increase in 
size it could be argued that they should reach confluence in a shorter period of time 
than smaller sized cells. The cells expressing the hTERT or chTERT vector plasmid 
showed similar gross morphology to the corresponding non-infected normal, OA and 
RA cells. The infected and non-infected cells from normal, OA and RA donors 
expressed typical phenotype markers in both early and late passage cultures. 
Previously, expression o f fibroblast markers was lost with time in culture but this was 
not seen in cells cultured from these particular donors (Edwards et al., 1997; 
Zimmerman et al., 2001). The expression of hyaluronan synthase 2 mRNA was seen 
in infected and non-infected cultures from normal, OA and RA cells. As the enzyme
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hyaluronan synthase is required for hyaluronan synthesis, this resuh indicates that the 
cell retains its synovial fibroblast characteristics (Edwards, 1999).
Overall, the results o f this study showed that hTERT infection was not sufficient to 
extend the lifespan o f a normal, OA or RA synovial cell population under typical 
monolayer culture conditions. Although ectopic hTERT expression has been shown 
sufficient to immortalise fibroblasts, other cell types require further intervention 
(Dickenson et al., 2000; Kiyono et al., 1998). Previous work suggests that viral 
oncogenes are required for by-passing Ml growth arrest while stabilisation of 
telomere length by ectopic hTERT expression is needed to by-pass M2 growth, thus 
generating an immortal cell line (Counter, 1998). Introduction of the high-risk human 
papilloma virus 16 (HPV16) oncogene E6 and E7 allows growth beyond Ml as E7 
blocks the activity o f the pl6/pRb pathway that induces growth arrest and E6 
expression also acts to overcome growth arrest by targeting the p53 pathway (Demers 
et al., 1994; Foster and Galloway, 1996; Scheffiier et al., 1990). The requirements for 
immortalisation however, vary in different types o f cells. It has been shown that 
chondrocytes require hTERT and both E6 and E7 expression to exceed the ‘normal’ 
number o f population doublings, whilst E6 and E7 expression in endometrial cells is 
sufficient for immortalisation (Kyo et al., 2003; Martin et al., 2002). It seems 
therefore, that SFBs can not maintain an extended lifespan with ectopic hTERT 
expression alone and the expression of either one or both of the viral oncogenes is 
required. The expression o f these viral oncogenes can lead to phenotypic disruption 
in some cell types during immortalisation and needs to be considered when planning 
future work (Bodnar et al., 1998; Jiang et al., 1999; Vaziri and Benchimol, 1998). 
Certain cells including the rabbit synovial cell line HIG-82 have become immortal 
through spontaneous transformation o f late-passage cultures (Georgescu et al., 1988). 
The immortalised cell line showed similar morphology and properties to primary 
synovial cell cultures although responsiveness to some stimuli was lost (Lin et al., 
1996; Stefanovic-Racic et al., 1994). The spontaneous transformation of human 
synovial fibroblasts could prove a possibility for the immortalisation of human 
synovial cells if they were monitored and maintained in culture.
Due to the nature of the synovium, cell cultures often retain a mixed population in 
vitro. As time in culture increases these infiltrating cells are lost and the remaining
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cells show a more homogeneous phenotype (Marsh et al., 1978; Zimmerman et al., 
2001). As a result, experiments on synovial cell cultures could produce varied results 
because of the differences in cell population and morphology at the different 
passages. If experiments are to be conducted using cells at the same passage then this 
would limit cell numbers. Synovial cells in culture show an increase in the time taken 
to reach confluence as passage number increases (Clarris and Fraser, 1968; Smith and 
Hamerman, 1969). The alterations associated with time in vitro and the fact that the 
cells eventually undergo replicative senescence also limits cell numbers (Hayflick, 
1965; Hayflick and Moorhead, 1961). The immortalisation of a SFB cell line that 
maintains characteristics o f a young phenotype with an increased proliferative 
capacity would allow a limitless and available supply of cells. At present, this study 
does not provide an immortalised cell line but does show that synovial cells retain 
some o f their characteristics in long term culture yet whether this is due to ectopic 
hTERT expression requires further investigation.
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Chapter 7 
General Discussion
7.0 General Discussion
The importance o f mechanical stimuli during joint cavitation and differential HA 
synthesis at the presumptive joint line has been established (Dowthwaite et al., 1998; 
Osborne et al., 2002; Pitsillides, 1999; Pitsillides et al., 1995). Furthermore, the 
reduction o f HA concentration within the synovial fluid leads to painful and immobile 
joints, as in OA, suggesting that continued synthesis of HA, and hence continued 
mechanical stimuli is necessary for friction free articulation of the joint. At present, 
the decreases in HA concentration observed within the synovial fluid are attributed in 
part to the loss o f mechanical stimuli as the joint becomes less mobile but could also 
be the result o f a decrease in synovial cell responsiveness to mechanical stimuli 
(Pitsillides et al., 1999; Pitsillides et al., 1994). Treatments for OA include intra- 
articular HA therapies to try and increase HA within the synovial fluid, yet these have 
not always proved beneficial in reducing joint pain or immobility (Altman and 
Moskowitz, 1998; Dixon et al., 1988; Dougados et al., 1993; Petrella et al., 2002). 
Using exercise based therapies as a treatment for OA to increase the concentration of 
HA within the synovial joint could prove to be an appropriate and simple treatment 
measure If  exercise is to be considered as a method of increasing HA concentration 
within the synovial fluid to reduce pain and increase joint mobility, then the effects of 
mechanical stimuli in vitro first need to be investigated. Although mechanical stimuli 
has been shown to be important in inducing alterations in HA synthesis during joint 
development and in maintaining HA synthesis in the adult joint, it needs to be known 
whether the synovial cells from OA donors are still able to respond to mechanical 
stimuli. Observations from this study show that mechanical stimuli produces 
significant changes in HA media concentrations in synovial cell cultures.
Synovial cells derived from both normal and OA tissues were used in the study and it 
could be seen that response to mechanical strain was different between the two. 
Overall, it was the OA synovial cell cultures that gave the greatest changes in HA 
media concentration and HAS mRNA expression. These changes demonstrate that 
OA cells were able to respond to strain but this response was different to that of 
normal cells.
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The response o f the synovial cell cultures to the three magnitudes of strain in terms of 
HA media concentration was different with each strain. The OA cells however, 
showed greater increases in media HA concentration at the lowest magnitude of 
strain. This increase relates to the physiological magnitude of strain experienced 
during walking and so a simple walk would prove beneficial in reducing joint pain 
and increasing mobility (Lanyon, 1996).
HA Passage1
HAS1 HAS2 HAS3
4000|ie
6000pe
10000pe t
HA Passage2
HAS1 HAS2 HAS3
4000
6000pe t t
10000pe
HA Passage3
HAS1 HAS2 HAS3
4000 t
6000|i£
iOOOOpe t t
Table 7.1 Table to indicate media HA concentration from strained synovial OA cell cultures in 
relation to HAS mRNA expression.
Expression o f the three HAS genes was altered upon mechanical strain but this change 
was not as dependent on passage number as it was in alterations in media HA 
concentration. HAS mRNA expression does not always reflect protein and 
subsequent HA synthesis and this needs to be taken into consideration. If we 
correlate the data of HA media concentration and HAS mRNA expression in some 
patients, an increase in media HA concentration could be correlated to an increase in 
HAS mRNA expression (table 7.1). It is interesting to note that HAS1 mRNA 
expression increases at lOOOOpe whereas HAS3 mRNA expression increases at 
4000p£, both correlating to an increase in media HA concentration. The HAS genes 
are responsible for the synthesis o f differently sized HA molecules and the application
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of the different magnitudes of strain could be reflected in the size of the HA molecule 
synthesised. An increase in the larger HA molecule has been shown to buffer outflow 
so retaining synovial fluid within the cavity whereas synthesis of the smaller HA 
molecule may facilitate cell signalling as low Mr weight HA has been shown to 
induce gene expression during inflammation (Coleman et al., 1999; Coleman et al., 
2000; McKee et al., 1996; Termeer et al., 2000). The observed increase in HAS1 and 
HAS3 mRNA expression at 6000pe accompanied by a decrease in media HA 
concentration may reflect post transcriptional regulation. The concentration of HA is 
reportedly more important than the size of the HA molecule in retaining a constant 
volume and viscosity o f HA within the synovial fluid (Coleman et al., 2000; Scott et 
al., 2000) but for future work it would be interesting to determine the size of the HA 
molecules synthesised as a result o f  mechanical stimuli and investigate the correlation 
to HAS mRNA expression.
During OA, cytokine synthesis becomes unbalanced and although cells within the 
joint try and restore the equilibrium the disease progresses (Feldmann et al., 1996; 
Firestein, 2003). The use o f exercise as a treatment would prove disadvantageous if 
pro-inflammatory cytokines were to be synthesised as a result of joint movement. 
Data from this study however, show that pro-inflammatory cytokine synthesis is not 
altered by mechanical stimuli although the synthesis o f anti-inflammatory cytokines 
through mechanical strain would have proved an added advantage to exercise as a 
therapy for OA.
The use o f human cells for this study was necessary but it has produced variability in 
the data. Whether these arise from age, sex, disease state or treatment program of 
patients can not be determined from the number o f donors used in this study. The use 
of an increased number of patients might reduce the observed variability but it would 
be beneficial to develop a synovial cell line that provides a limitless supply of cells. 
This should also combat the problems of changes in cell characteristics during long­
term in vitro growth. In primary cultures there exists a mixed population of cells 
which become more homogeneous with time in culture (Clarris et al., 1977; Marsh et 
al., 1978; Zimmerman et al., 2001). The loss of macrophages and other infiltrating 
cells and the increase in a more fibroblastic like cell type might indeed alter the 
response to strain and, thus, might not reflect the response in vivo. Changes in cell
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characteristics such as cell markers and cell size were also observed and suggest cells 
are deviating from their in vivo phenotype. As a result, the use of synovial cells at the 
same passage is essential to produce reproducible and reliable results as this study has 
demonstrated. Thus, the immortalisation o f synovial cells using ectopic hTERT 
expression to develop a cell line for future experiments was investigated with the aim 
of generating an available and limitless supply of synovial cells. Data obtained from 
this study however, show that hTERT alone was not sufficient to immortalise the 
cells, although the infected OA cells did show an increased population doubling 
compared to the non-infected cells. Cells retained characteristic synovial cell markers 
and gene expression but continued to increase in size and show increased senescence 
associated p-galactosidase activity. An immortal cell line would reduce some of the 
problems associated with the use o f human tissue and so further investigation is 
definitely needed.
Further work into the effects of mechanical strain on OA synovial cells will require a 
greater number of donors to be sampled or an immortal cell line. This intum might 
show definite trends in synovial cell response to mechanical strain. A similar 
argument pertains to both normal and RA cells alike. Using an animal cell line could 
have proved worthwhile for this study as it would have provided a baseline for our 
human data to be compared against. The established HIG-82 rabbit synovial cell line 
(CRL-1832: ATCC, USA) would have been an ideal candidate. Since finishing this 
study however, I have been made aware o f a human synovial cell line (Hs 70I T: 
ATCC, USA) that could have proved even more beneficial to this study. It must be 
taken into consideration however that to date this cell line has not been characterised 
fully.
The mechanical strain that was applied to the cells reached a maximum of 1% due to 
the constraints of the mechanical loading jig. At present there are no measurements 
for the stretch the synovium undergoes within a joint due to the nature and situation of 
the tissue. Previous studies on tendon fibroblasts, periodontal ligament fibroblasts 
and dermal fibroblasts have all used stretches above 1%, in most cases starting at 5% 
and rising to 20% (Grymes and Sawyer, 1997; Neidlinger-Wilke et al., 2002; 
Sambajon et al., 2003; Skutek et al., 2003; van Griensven et al., 2003; Yamaoka et al., 
2001; Yoshino et al., 2003). The application of mechanical strain at a higher
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magnitude to that used in this study would therefore be an area of further work. The 
stretch applied to the cells was based on work by Lanyon who carried out his studies 
on bone (Lanyon, 1996). In retrospect, the stretch applied to synovial cells is likely to 
be higher than 1% especially in areas where the synovium covers a large surface area 
during joint flexion.
The ECM and cytoskeleton play significant roles in mechanotransduction with 
signalling through integrins and Ca2+ channels resulting in changes in gene expression 
(Chiquet, 2003; Itano et al., 2003; Maniotis et al., 1997; Munevar et al., 2004). 
Coating the plates with various ECM proteins could have given us some insight into 
the role the cytoskeleton plays in mechanical transduction pathway and maybe would 
have provided a more physiological environment for the cells. Previous work has 
already shown different responses to mechanical strain when cells were adhered to 
different matrices providing evidence for the role of the ECM in mechanotransduction 
and a valid area for future study (Breen, 2000; Reusch et al., 1996) .
Regulation o f HA synthesis could occur at three different levels, mRNA expression of 
the HAS genes, HAS protein expression and the activity of the HAS enzyme. 
Whether mechanical strain can directly affect HA synthesis at these three points 
remains to be seen. Evidence suggests the involvement of MAPKs (mitogen activated 
protein kinases) such as p38 in signalling to transcription factors within the cell 
nucleus controlling gene expression (Oudin and Pugin, 2002; Skutek et al., 2003). 
Indeed a study by Mascarenhas et al (2003) demonstrated the cessation of HAS3 
mRNA expression on addition of a protein tyrosine kinase inhibitor. Work by Sun et 
al (2001) has shown alterations in transcription factors when mechanical strain was 
applied to the cells and more recently, Sun’s work has shown mechanical strain 
induces post-transcriptional reduction in enzyme activity (Sun et al., 2003).
Evidence establishes that mechanical stimuli are able to signal to the cell to initiate a 
response yet it is also evident from this work and previous studies that the synovial 
cells are able to monitor HA levels within their surrounding environment and signal 
back to the cell. At present it is unclear how this process occurs but investigation into 
the HABPs, for example CD44 and RHAMM, should be considered.
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Many area still exist which will require further research in order to improve our 
understanding o f the regulation of HA metabolism via mechanical strain. 
Nevertheless, OA synovial cell cultures can be seen to increase HA synthesis upon 
mechanical stimulation.
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Appendices
Appendix 2.1
Svnovial Cell Passage
1) Remove media.
2) Wash cells in PBS.
3) Add 3ml trypsin (0.05%) per T25 flask.
4) Incubate at 37°C for 8 minutes.
5) Tap underneath of flask
6) Remove media.
7) Add 5ml DMEM/F12+ to flask. Use cell scrapper to remove remaining cells.
8) Combine with previous media.
9) Centrifuge at 1000 x g for 5 minutes.
10) Remove supernatant, flick bottom of tube to disrupt pellet.
11) Add 1ml DMEM/F12+, shake tube.
12) Count cells.
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Appendix 3.1
Four point bendine mechanical loadine jig calibration
The jig was calibrated using an Omega strain gauge SG-3/350-LY13 with CIL 870 
strain gauge amplifier (CIL Electronics, Worthing)
Jig Calibration
2000 4000 6000 8000 10000 12000
As strain is measured as a ratio between the change in length between 2 points;
s = AL 
L
strains are often referred to as a percentage. Thus 10,000 pe is equivalent to a 1% 
strain.
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Appendix 3.2
AB
38
3 0 R B A N C E S
. J UL 1 9 1 6  1 5 : 5 9 : 4 8
l 2
A 8 . 7 0 5 8 . 1 1 4 0 . 125
e 8 . 6 3 8 0 . 103 0 . 122
c
D
8 . 6 1 7
0 . 6 0 3
8 . 118  
0 . 101
0 . 1 5 5  
0 . 123
F 0 • o 4 6 0 . 1 1 2 0 . 1 2 5
p 8 . 3 7 9 0 . 113 0 . 120
0 1 . 101 
1 . 2 0 6
8 . 127  
0 . 134
0 . 1 2 3  
0 . 1 3 5H bHABP calibration curve
4 C■J 6 -2-5 4  « * -0-5 > 0.5 1
A 8 . 2 5 4 0 . 2 9 6 0 . 2 6 9
r ,D
c
ri 
F
0 . 143 
8 . 167 
8 . 134  
8 . 151 
8 . 157
8 . 178 
8 . 174  
8 . 162 
0 . 176 
8 . 165
0 . 2 1 7  
0 . 2 1 0  
8 . 2 1 1  
0 . 221  
0 . 2 2 1
■ A
■ -°A O *
0  AO ■ A .
9  a I  ~ * 0.8
-1
0
’  •  i
OA 
■ B
AC\
6 0 . 144 8 . 173 0 . 2 2 7 -1.2
u 0 . 154 8 . 179 8 . 3 8 6 Iog10 *tandard
7 O 9
A 8 . 3 1 3 8 . 3 3 9 0 . 6 0 1
g 8 . 265 8 • 34  9 0 . 5 2 6
r • j .  274 0 . 3 7 2 0 . 5 2 1
D 8 . 2 6 1 8 . 3 6 3 0 . 4 7 7
E 8 . 2 5 7 0 . 3 6 9 0 . 5 8 2
F i"“4 “i »“i 1“%8 . iO O 8 . 4 3 4 8 . 5 2 3
G
H
H
8 . 29 2  
8 . 3 1 5
10 
8 . 3 3 4
8 . 4 8 5  
8 . 4 4 6
11 
0 . 9 6 3
8 . 5 6 1
0 . 6 1 0
12 
0 . 0 9 0
B 8 . 7 8 6 8 . 9 2 5 8 . 1 2 9
L 0 . 8 1 8 9 . 9 2 7 0 . 1 0 3
8 . 6 9 2 0 . 7 4 5 0 . 168
r*C 8 .  31 3 0 . 3 5 9 0 . 135
r*r 8 . 3 1 9 0 . 3 4 5 8 . 139
b
H
8 . 7 9 9  
8 . 3 2 8
8 .  9 4 2  
0 . 8 5 6
0 .  1 0 2  
0 . 0 3 3
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bHABPA
standard 001 OD2 003
5 0 114 0.106 0.118
2 5 0 125 0.122 0.156
1 25 0 254 0 143 0 167
0 625 0.296 0.178 0.174
03125 0269 0.217 0.21
0 15625 0 313 0 266 0.274
0 078125 0 389 0.349 0 372
0 0390625 0 601 0.526 0 521
001953125 0834 0.706 0.81
0009765625 0 963 0 925 0.927
Tfl
0.113
0.188
0.216
0.284
0 370
0.549
0783
0 938
standard avg.OO loglO standard leglOOD HA HA HA avg std
5 0 113 0696970004 -0.945642338 slop# -0.337173 3.928176 4 611392 3.546264 4 029 5
2 5 0 134 0 397940009 -0 872806202 mtsrcspt -0 74275 2.989111 3.212419 1.579314 2 594 2.5
1 23 0 188 0096910013 -0.725842151 rsq 0.974546 0.364996 2.006672 1 266961 1.212 1.25
0623 0216 -0 204119963 -0 666646249 0231839 1047746 1 120806 0800 0.625
0 3125 0 232 -0 506149978 -0 634512015 0.307883 0 562206 0.641660 0.511 0.3125
0 15625 0 264 -0 806179974 -0.34668196 0196452 0.321871 0.291517 0 270 0.15625
0 078125 0 370 -1 10720997 -0 431796276 0 103102 0.142242 0.117713 0.121 0.078125
00390625 0 549 -1 406239966 -0 260164047 0.028376 0.042134 0.043345 0 038 0039063
001963125 0 783 -1 709269961 -0.106063392 0.010738 0.017601 0 01171 0013 0.019631
0 009766625 0 938 -2010299967 -0 027642866 0.007009 0 007896 0.007848 0 008 0 009766
bHABP B
standard OOI 0 0 2 00 3
5 0 101 0 112 0 118
2 5 0 123 0 125 0 12
1 25 0 134 0.151 0 157
0 625 0 162 0 176 0.166
0 3125 0 211 0221 0.221
0 15625 0261 0257 0 288
0078125 0363 0 369 0.434
00390625 0477 0 502 0.523
001963125 0692 0.818 0819
0 009766625 0 745 0869 0.845
0.110
0.123
0.147
0.168
0218
0.269
0.389
0.501
0.776
standard avg .00 Ioa10 standard leglOOD HA HA HA avg std
5 0 110 0 696970004 -0 967293261 stopo -0 347791 5 625291 4.13969 3.546264 4.437 5
2 5 0 123 0 367940009 -0 911273436 intercept -0.789811 3135577 2.969111 3.373826 3.166 2.5
1 25 0 147 0096910013 -0 831696966 rsq 0 975615 2.432143 1.706851 1.520389 1 886 1.25
0625 0 168 -0 204119663 -0 77555327 1 386396 1063464 1.312016 1.260 0.625
03125 0218 -0 505149978 -0 662206073 0 632692 0.561506 0.551505 0.579 0.3125
0 15625 0 269 -0 806179974 -0 570786213 0 336723 0362506 0.251466 0.314 0.15625
0 078125 0 386 -1 10720997 -0410422704 0126581 0.120674 0074519 0.107 0.078125
00390625 0 501 -1 406239966 -0 300451322 005631 0048394 0.042856 0 049 0.039063
001963125 0 776 -1 709266961 -0 109961766 0018679 0 011373 0.011332 0014 0.019531
0009766625 0 816 -2010299967 -0 06813247 0015007 0 009838 0010329 0.012 0.009766
bHABP C
standards OOI OD2
5 0 127 0.134
2 5 0 123 0136
1 25 0 144 0 154
0 625 0 178 0179
03125 0 227 0 306
0 15625 0292 0315
0078125 0 486 0 446
00390625 0 561 0.61
001963125 0 799 082
0 009766625 0 942 0.856
0.131 
0.129 
0.149 
0.179 
0 267 
0.304 
0 466 
0.586 
0810
standard avg.OO Iea10 standard loglOOO HA HA
5 0 131 0 698970004 -0 884389488 slops -0 360388 2.861661 2.432143
2 5 0 129 0 397940009 -0 88941029 Intsfcspt -0.744107 3.135677 2379099
1 25 0 149 0 096910013 -0 826813732 rsq 0.972332 1.964644 1.609924
0 625 0 179 -0 204119983 -0 74836178 1 047746 1 030481
0 3125 0 267 -0 505149978 -0 574302787 0 509385 0.210063
015625 0 304 -0 806179974 -0517841306 0241385 0192776
0 078125 0 466 -1 10720997 -0 332080315 0 0536 0.068729
0 0390625 0 586 -1 406239965 -0 232473101 0 034806 0027152
0 01953125 0810 -1 709269861 -0 091783147 0012194 0 011291
0 009766625 0899 -2010299967 -0 046240306 0.007483 000994
avg Std
2.642 5
2 757 2.5
1 787 1.25
1.039 0 625
0.360 0.3125
0.217 015625
0 061 0078125
0 031 0.039063
0012 0019531
0009 0009766
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Appendix 3.4
Normal Synovial Ceil Cultures (HA media concentration tig/ml) 
N1
PI P2 PS
Tima (hours) comroi strain control strafe) co^Rni strain
1 3.8 (±2.8) 2.25 (±1.67) 0.32 (±0. 11) 0.24 (±0.05) 2.31 (±3.34) 7.80 (±9.0)
4000 6 1.10 (± 1. 14) 1.06 (±0.51) 0.26 (±0. 19) 0.11 (±0.09) 6.23 (±5.23) 3.61 (± 1.07)
24 2.81 (±2.38) 2.51 (±2.55) 0.99 (±0.46) 0.59 (±0.25) 2.72 (±3.39) 10.12 (±10.6)
1 0.32 (±0. 11) 0.24 (±0.04) 2.31 (±3.34) 6.72 (±8. 16)
6000 6 0.26 (±0. 19) 0.05 (±0.03) 6.23 (±5.23) 3.33 (±2.21)
24 0.99 (±0.46) 0.91 (±0.49) 2.72 (±3.39) 3.69 (±4. 11)
1 1.31 (±0.93) 0.98 (±9.33) 0.32 (±0. 11) 0.16 (±0.01) 2.31 (±3.34) 2.10 (±2.05)
10000 6 1.2 (±0.99) 1.3 (±0.83) 0.26 (±0. 19) 0.13 (±0. 1) 6.23 (±5.23) 2.99 (±0.56)
24 1.6 (1.77)± 1.28 (±0. 73) 0.99 (±0.46) 0.94 (±0. 19) 2.72 (±3.39) 5.05 (±4.23)
N2
PI P2 PS
MB Tims (hours) control strain control strain control strain
4000
1
6
24
6000
1
6
24
2.67 (± 1.72) 
1.13 (±0.83) 
26.62 (±8. 17)
1.99 (±136) 
1.42 (± 1.93)  
32.81 (±14.12)
10000
1
6
24
300
Appendix 3.5
OA Synovial Cell Cultures (HA media concentration iig/mD 
OA1
PI P2 PS
118 Tims (hours) control strain control strain COiNRH strata
4000
1
6
24
6000
1
6
24
9.83 (± 13. 1)  
2.89 (±169; 
7.45(±3.96;
3.95(±3.82) 
5.42(±3.41) 
5.59 (±4. 12)
10000
1
6
24
OA2
PI P2 PS
M8 Tims (hours) control strain control strain COfluvV snvHi
4000
1
6
24
6000
1
6
24
1.49 (±0.53) 
3.63 (±1.42)
2.46 (±1. 16) 
3.82 (±1. 70)
1.77 (± 1.65) 
2.18 (± 1.46) 
6.62 (±5. 18)
1.05 (±0.77; 
1.54 (±0.91)  
4.81 (±3. 79)
0.86 (±0.30) 
1.85 (± 1.81) 
2.07 (±1.55)
0.58 (±0.31)  
2.23 (±2.51)  
1.30 (±0.66)
10000
1
6
24
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OA5
PI P2 PS
118 Time (hours) control strain control strain control strain
4000
1
6
24
6000
1
6
24
2.15 (± 1. 12) 
6.83 (±4.39)  
4.39 (± 1.88)
1.26 (±0.88) 
2.33 (±2. 19)  
3.45 (±0.82)
10000
1
6
24
303
Percentage increases in media HA concentration
Appendix 3.6
normal cells (N1)
I Passage I
us 1 2 3
4000
1
6
24
-40.7
-4.3
-10.6
-25.8
-56.9
-39.8
237.1 
-42.1
272.1
1 -26.4 190.5
6000 6 -79.7 -46.6
24 -7.4 35.7
1 -10.1 -48.8 -9.1
10000 6 -1.7 -49.9 -52.0
24 2.2 -4.2 85.5
OA cells (OA4)
Passage
us Time (hours) 1 2 3
1 103.1 4.4 95.4
4000 6 75.5 -8.2 17.9
24 18.0 -16.0 100.9
1 66.4 90.1 141.9
6000 6 231.5 38.2 -52.0
24 -10.3 21.9
1 39.7 289.3 59.5
10000 6 125.6 82.6 -48.3
24 213.5 13.7 -59.5
Appendix 4.1
ACt Validation Curves
HAS1
o
<
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Appendix 6.2
TRAP assay reagents
Lysis Buffer (1ml)
lOOpl 0.1M Tris-HCL pH8.3
1.5pl lM M gCl2
lOpl 0.1MEGTA
lOOpl Glycerol
lOOpl 5% CHAPS
688.5pl DEPC water
Pigmiy (24 samples)
600pl 2x buffer (Rb) 
4.8pl T4 gene 32 protein 
4.8pl TS primer (lOOng) 
590|il DEPC water
Reaction Buffer (Rb)
20mM Tris-HCL pH8.3 
1.5mM MgCl 
63mM KC1 
0.005% Tween 
ImM EGTA 
50pm dNTPs 
0.1 mg/ml BSA
Final m ix (30 samples^
6pl CX primer (lOOng)
15pl Taq polymerase (2.5U) 
15pl ITAS 
24pl DEPC H20
Gel reagents
25ml acrylamide 
30ml 5 x TBE 
45ml MilliQ water 
500pl APS (1 OOpg/ml) 
lOOpl TEMED
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EFFECTS OF MECHANICAL STRAIN ON HYALURONAN METABOLISM OF CELLS CULTURED FROM THE
SYNOVIUM OF OSTEOARTHRITIC KNEES.
♦ • W i l l i a m s ,  R ,  * D o w t h w a i t e ,  G  P ;  • • W i l l i a m s ,  A  S ;  • A r c h e r ,  C  W  
♦ C a r d i f f  U n i v e r s i t y ,  M u s e u m  A v e n u e ,  C a r d i f f ,  C F 1 0  3 U S ,  U K
Introduction: H y a l u r o n a n  ( H A ) ,  t h e  h i g h  m o l e c u l a r  w e i g h t
p o l y s a c c h a r i d e  c o n s i s t i n g  o f  r e p e a t i n g  g l u c u r o n i c  a n d  N -  
a c e t y l g l u c o s a m i n e  u n i t s ,  i s  s y n t h e s i z e d  d u r i n g  j o i n t  c a v i t a t i o n  ( 1 ) .  H A  
s y n t h e s i s  p e r s i s t s  i n  t h e  a d u l t  j o i n t  h e l p i n g  t o  s u s t a i n  f r i c t i o n  f r e e  
a r t i c u l a t i o n  I m m o b i l i z a t i o n  s t u d i e s  h a v e  s h o w n  t h a t  t h e  r e m o v a l  o f  
m e c h a n i c a l  s t i m u l i  i n t e r f e r e s  w i t h  j o i n t  c a v i t a t i o n  ( 2 & 3 )  a n d  s o  
m e c h a n i c a l l y  i n d u c e d  f a c t o r s  a r e  l i k e l y  t o  p l a y  a  m a j o r  r e g u l a t o r y  r o l e  i n  
j o i n t  m o r p h o g e n e s i s .  T h i s  r o l e  o f  m e c h a n i c a l  s t i m u l i  i n  m a i n t a i n i n g  
h y a l u r o n a n  s y n t h e s i s  i n  t h e  a d u l t  j o i n t  i s  l i k e l y  t o  b e  e s s e n t i a l
P r e v i o u s  w o r k  h a s  s h o w n  t h a t  i t  i s  t h e  s y n o v i a l  f i b r o b l a s t s  w h i c h  
s y n t h e s i s e  H A  w i t h i n  t h e  s y n o v i u m  a s  h i g h  a c t i v i t y  o f  t h e  e n z y m e  
u n d i n e  d i p h o s p h o g l u c o s e  d e h y d r o g e n a s e  ( U D P G D ) ,  r e q u i r e d  f o r  
p r e c u r s o r  s a c c h a r i d e s ,  h a s  a l r e a d y  b e e n  r e p o r t e d  ( 4 ) .  O n c e  s y n t h e s i z e d ,  
H A  i s  s e c r e t e d  i n t o  t h e  s y n o v i a l  c a v i t y  w h e r e  i t  c o m b i n e s  w i t h  t h e  
s y n o v i a l  f l u i d  t o  h e l p  l u b n c a t e  t h e  j o i n t  D u n n g  o s t e o a r t h r i t i s ,  a l o n g  
w i t h  a  c h a n g e  i n  c e l l u l a r  a r c h i t e c t u r e  o f  t h e  s y n o v i u m ,  t h e r e  i s  a  
d e c r e a s e  i n  t h e  U D P G D  a c t i v i t y  o f  t h e  s y n o v i a l  f i b r o b l a s t s  l e a d i n g  t o  a  
s u b s e q u e n t  d e c r e a s e  i n  H A  s y n t h e s i s  ( 5 ) .  T h i s  a d d s  t o  t h e  l o s s  o f  j o i n t  
m o b i l i t y  a n d  k n e e  p a i n  a s s o c i a t e d  w i t h  o s t e o a r t r i t i s
A l t h o u g h  w e  u n d e r s t a n d  h o w  H A  i s  s y n t h e s i z e d ,  t h e  s t i m u l i  
c o n t r o l l i n g  t h i s  s y n t h e s i s  r e m a i n  e l u s i v e  W e  h y p o t h e s i s e  t h a t  
r e s t o r a t i o n  o f  n o r m a l  s y n o v i a l  H A  c o n c e n t r a t i o n s  i s  d e p e n d e n t  u p o n  
m e c h a n i c a l  s t i m u l i  a n d  t h a t  O A  s y n o v i a l  c e l l s  c a n  r e s p o n d  t o  
m e c h a n i c a l  s t i m u l i .  H e r e  w e  s h o w  t h a t  a f t e r  a  b r i e f  p e r i o d  o f  
m e c h a n i c a l  s t r a i n ,  c u l t u r e d  h u m a n  O A  s y n o v i a l  c e l l s  c a n  i n c r e a s e  a n d  
s u s t a i n  m e d i a  H A  c o n c e n t r a t i o n s .
Materials and Methods: S y n o v i u m  w a s  o b t a i n e d  f r o m  p a t i e n t s  ( b o t h  
m a l e  a n d  f e m a l e ,  a g e  r a n g e  5 7 - 7 7  y e a r s )  u n d e r g o i n g  t o t a l  k n e e  j o i n t  
r e p l a c e m e n t  s u r g e r y  w i t h  t h e  r e l e v a n t  e t h i c a l  a p p r o v a l  a n d  p a t i e n t  
c o n s e n t
S y n o v i a l  c e l l s  w e r e  i s o l a t e d  f r o m  d i c e d  t i s s u e  b y  d i g e s t i o n  i n  0 . 2 m g  
m l ' 1 t y p e  1 c o l l a g e n a s e  i n  D M E M / F 1 2  + 5 %  f o e t a l  c a l f  s e r u m  ( F C S )  
F o l l o w i n g  d i g e s t i o n ,  c e l l s  w e r e  i s o l a t e d  t h e n  s u s p e n d e d  i n  D M E M / F 1 2  
c o n t a i n i n g  1 %  p e n i c i l l i n ( 1 0 4 I U m l l ) - s t r e p t a m y c i n ( 1 0 <| i g m r 1) ,  L -  
g l u t a m i n e  ( l g / L X  h y d r o c o r t i s o n e  ( 4 m g / m l ) ,  i n s u l i n - t r a n s f e m n - s e l e n i u m  
( 2 0 0 M M )  a n d  2 0 %  F C S  C e l l s  w e r e  c o u n t e d  a n d  s e e d e d  a t  I x l O 6  c e l l s  
m l ' 1 i n t o  T 7 5  f l a s k s  a n d  a l l o w e d  t o  r e a c h  c o n f l u e n c e  w i t h  a  m e d i a  
c h a n g e  o f  D M E M / F 1 2 +  e v e r y  f o u r  d a y s .
O n c e  c o n f l u e n t ,  c e l l s  w e r e  t r y p s i n i s e d ,  c o u n t e d  a n d  p l a t e d  a t  a  
d e n s i t y  o f  0 . 0 1 5  x  l C f  c e l l s  m l ' 1 w i t h  1 m l  o f  c e l l  s u s p e n s i o n  p l a c e d  i n t o  
a  w e l l  o f  a  4 - w e l l  s t r a i n  p l a t e .  C o n f l u e n t  c e l l s  w e r e  s e r u m  d e p r i v e d  f o r  
1 8  h o u r s  a n d  f r e s h  s e r u m  f r e e  m e d i a  ( D M E M / F 1 2 - )  a d d e d  3 0  m i n u t e s  
p r i o r  t o  s t r a i n  E a c h  e x p e r i m e n t  c o n s i s t e d  o f  6  p l a t e s ,  w i t h  e v e r y  p l a t e  
c o n t a i n i n g  f o u r  w e l l s  P l a t e s  w e r e  s t r a i n e d  a t  4 0 0 0 ,  6 0 0 0  o r  l O O O O p e  a t  
a  f r e q u e n c y  o f  I H z  f o r  1 0  m i n u t e s  u s i n g  a  m e c h a n i c a l  l o a d i n g  j i g .  A l l  
s t r a i n s  w e r e  e a r n e d  o u t  a t  3 7 ° C .  C o n t r o l  p l a t e s  c o n s i s t e d  o f  c e l l s  t h a t  
d i d  n o t  u n d e r g o  s t r a i n  a c t i n g  a s  s t a t i c  c o n t r o l s  a n d  c e l l s  t h a t  w e r e  
s u b j e c t e d  t o  m e d i a  f l o w  w i t h o u t  s t r a i n ,  f l o w  c o n t r o l s .  T h e  m e d i a  f r o m  
e a c h  w e l l  w a s  c o l l e c t e d  a t  1 h o u r ,  6  h o u r s  a n d  2 4  h o u r s .  T h e  m e d i a  H A  
l e v e l s  w e r e  a s s a y e d  u s i n g  a  H A  E L I S A  a s  p r e v i o u s l y  d e s c r i b e d  b y  
F o s a n g  el aJ ( 1 9 9 0 X 6 ) .
R e s a l t s :  F i r s t ,  r e s u l t s  f r o m  s t r a i n e d ,  s t a t i c  c o n t r o l  a n d  f l o w  c o n t r o l  
c e l l s  w e r e  a n a l y s e d  u s i n g  a  o n e - w a y  A N O V A  a n d  S c h e f f e  p o s t  h o c  t e s t .  
T h i s  s h o w e d  t h e r e  w a s  n o  d i f f e r e n c e  i n  h y a l u r o n a n  l e v e l s  b e t w e e n  e a c h  
o f  t h e  i n d i v i d u a l  s t r a i n  p l a t e s ,  n o  d i f f e r e n c e  b e t w e e n  e a c h  o f  t h e  s t a t i c  
c o n t r o l s  a n d  n o  d i f f e r e n c e  b e t w e e n  t h e  f l o w  c o n t r o l  p l a t e s .  
C o m p a r i s o n s  o f  s t a t i c  c o n t r o l  c e l l s  a n d  f l o w  c o n t r o l  c e l l s  s h o w e d  n o  
s i g n i f i c a n t  d i f f e r e n c e s  i n  t h e i r  m e d i a  h y a l u r o n a n  c o n c e n t r a t i o n s
F r o m  t h e  s e v e r a l  c e l l  l i n e s  s u b j e c t e d  t o  t h e  3  d i f f e r e n t  s t r a i n s  i t  c a n  
b e  s e e n  t h a t  o f  t h e  t h r e e  s t r a i n s  t e s t e d  i t  w a s  t h e  l o w e s t  s t r a i n  o f  0 .  4 %  
t h a t  g a v e  t h e  g r e a t e s t  s i g n i f i c a n t  i n c r e a s e  b e t w e e n  s t r a i n e d  a n d  s t a t i c  
c o n t r o l  c e l l s .  T h e  h i g h e s t  s t r a i n  ( 1 % )  p r o d u c e d  a  s i g n i f i c a n t  d e c r e a s e  i n  
h y a l u r o n a n  m e d i a  l e v e l s  a t  2 4  h o u r s
S e l e c t e d  c e l l  l i n e s  w e r e  t h e n  f o l l o w e d  o v e r  a  t i m e  c o u r s e  o f  2 4  h o u r s .  
T h e  H A  m e d i a  f r o m  s t a t i c  c e l l s  c o u l d  b e  s e e n  t o  i n c r e a s e  w i t h  t i m e .
H o w e v e r  w h e n  c e l l s  w e r e  s u b j e c t e d  t o  t h e  0 . 4 %  s t r a i n  s i g n i f i c a n t l y  
h i g h e r  h y a l u r o n a n  m e d i a  l e v e l s  c o u l d  b e  s e e n .  F o r  t h e  0 . 4 %  s t r a i n ,  t h i s  
i n c r e a s e  i n  H A  m e d i a  l e v e l s  w a s  s i g n i f i c a n t l y  d i f f e r e n t  b e t w e e n  s t r a i n e d  
a n d  s t a t i c  c e l l s  a t  e a c h  o f  t h e  t i m e  p o i n t s .  A l l  d a t a  w e r e  a n a l y s e d  u s i n g  a  
o n e - w a y  A N O V A  f o l l o w e d  b y  T u k e y  p o s t  h o c  t e s t .
F i g u r e . ! .  R e l a t i v e  m e d i a  h y a l u r o n a n  l e v e l s  2 4  h o u r s  p o s t  s t r a i n .  * p < 0 . 0 5
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F i g u r e . 2 .  H y a l u r o n a n  m e d i a  l e v e l s  p o s t  4 0 0 0 | i e .  * p < 0 . 0 5
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Discussion: T h e s e  r e s u l t s  d e m o n s t r a t e  t h a t  a l t h o u g h  t h e  s y n o v i a l  c e l l s  
h a v e  b e e n  c u l t u r e d  f r o m  t h e  s y n o v i u m  o f  o s t e o a r t h r i t i c  p a t i e n t s  w h i c h  
s h o w  r e d u c e d  f e v e l s  o f  h y a l u r o n a n ,  t h e y  a r e  a b l e  t o  a l t e r  t h e i r  
h y a l u r o n a n  s y n t h e s i s  w h e n  s u b j e c t e d  t o  m e c h a n i c a l  s t i m u l i .  T h e  
u p r e g u l a t i o n  o f  H A  l e v e l s  w a s  s e e n  p r e d o m i n a t e l y  i n  t h e  c e l l s  s u b j e c t e d  
t o  t h e  l o w e s t  s t r a i n  w h i l e  a  d e c r e a s e  i n  H A  l e v e l s  w a s  s e e n  a t  a  h i g h e r  
s t r a i n .  T h i s  r e s u l t  s u g g e s t s  t h a t  t h e  l o s s  o f  m o b i l i t y  i n  o s t e o a r t h r i t i c  
j o i n t s  c o u l d  b e  a  c o n t r i b u t o r y  f a c t o r  i n  t h e  d e c r e a s e  o f  h y a l u r o n a n  y e t  
t h e  s y n o v i a l  c e l l s  f r o m  O A  s y n o v i u m  c a n  b e  s e e n  t o  i n c r e a s e  h y a l u r o n a n  
s y n t h e s i s  o n  t h e  r e i n t r o d u c t i o n  o f  m e c h a n i c a l  s t i m u l i .  T h e  
d e t e r m i n a t i o n  o f  a n  a p p r o p r i a t e  s t r a i n  a n d  f r e q u e n c y  r e q u i r e d  t o  r e s t o r e  
h y a l u r o n a n  l e v e l s  t o  t h o s e  o f  t h e  n o r m a l  s y n o v i a l  j o i n t  w i l l  b e  i m p o r t a n t  
i n  g e n e r a t i n g  e x e r c i s e  b a s e d  t h e r a p i e s  f o r  o s t e o a r t h r i t i s .
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